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ABSTRACT 
 
The tropical rainforest of Malaysia is considered as one of the most evolved and 
complex ecosystems in the world that serves a vast untapped biodiversity of natural 
resources. Exploitation of medicinal plants for bioactive compounds is of great 
potential and could be an imperative source of providing new vistas for novel drug 
discovery and development. The study was undertaken to evaluate the in vitro 
pharmacological properties of Artabotrys crassifolius including antibacterial, 
antifungal, anticancer and antioxidant activities of the plant. The leaves and bark of 
Artabotrys crassifolius were extracted sequentially using hexane, chloroform and 
ethanol. The prepared crude extracts were subjected to phytochemical screenings for 
the presence of alkaloids, cardiac glycosides, flavonoids, phenolic compounds, 
saponins, tannins and terpenoids. Kirby-Bauer disc diffusion assay was conducted to 
examine the antibacterial and antifungal activities of crude extracts against ATCC and 
clinical strains. The anticancer effect of crude extracts was investigated against human 
breast and colorectal carcinoma cell lines using MTT assay whereas the antioxidant 
potential of crude extracts was assessed using TPC, TFC, ABTS, DPPH and FRAP 
assays. Among the crude extracts studied, hexane and chloroform extracts of bark 
exhibited pronounced antibacterial activities against ATCC and clinical strains with 
zones of inhibition ranging from 8.23±0.25 mm to 13.70±0.26 mm and 7.75±0.25 mm 
to 13.68±0.28 mm respectively. However, all the crude extracts were found to be 
devoid of antifungal activity except for hexane extract of bark which was able to 
inhibit the growth of the tested Candida species with zones of inhibition ranging from 
7.81±0.27 mm to 9.77±0.25 mm. In addition, chloroform extract of bark was highly 
active against all of the tested carcinoma cell lines with GI50 values ranging from  
4.23 µg/mL to 9.45 µg/mL, while hexane extract of bark potently inhibited the growth 
of MDA-468 breast and HCT-116 colorectal carcinoma cell lines with respective GI50 
values of 6.10 µg/mL and 16.45 µg/mL. Furthermore, ethanol extract of bark that 
possessed the highest total phenolic and flavonoid contents (268.29±12.36 mg GAE/g 
and 179.54±4.98 mg CE/g) was shown to demonstrate prominent scavenging 
activities against ABTS cation and DPPH radicals with IC50 values of 16.50 µg/mL 
and 16.54 µg/mL respectively, as well as exceptionally high antioxidant power with 
FRAP value of 1884.35±83.78 µmol Fe(II)/g. The chromatographic separation of 
chloroform extract of bark led to the isolation of four alkaloids, namely artabotrine, 
liridine, atherospermidine and lysicamine. Among the compounds isolated, 
artabotrine displayed high antibacterial properties with respective MIC and MBC 
values ranging from 1.25 µg/mL to 5 µg/mL and 1.25 µg/mL to 20 µg/mL against all 
of the tested ATCC and clinical bacterial strains, with the exception of Actinobacillus 
sp. and Klebsiella sp.. Moreover, artabotrine was highly active in HCT-116 colorectal 
and MCF-7 breast carcinoma cell lines with GI50 YDOXHV RI  ȝ0 DQG  ȝ0
respectively. In conclusion, exploration of the in vitro pharmacological properties of 
Artabotrys crassifolius revealed that artabotrine with dual antibacterial and anticancer 
activities may represent a new generation of potential drug candidates for the 
treatment of bacterial infections and cancer. Hence, further in vivo studies and clinical 
trials are required to ascertain the efficacy, safety and mechanisms of action of 
artabotrine prior to application in the pharmaceutical industry as natural therapeutic 
agents. 
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CHAPTER I 
 
INTRODUCTION 
 
1.1 BACKGROUND  
 
Since time immemorial, plants have been used extensively as a source of 
medicines for the treatment of various human ailments (Hussain and Khan 2010). 
According to the World Health Organisation (WHO), approximately 80% of the 
people in developing countries still rely on traditional medicines for their primary 
health care needs (Cheikhyoussef et al. 2011), and a major part of the traditional 
therapy involves the use of plant extracts or their active constituents (Murugan and 
Rajendran 2011). Furthermore, about 25% to 50% of current pharmaceuticals are 
plant-derived natural products, indicating the significance and efficacy of plants as an 
indispensable pharmacological tool (Cowan 1999). 
 
Over the past few years, there has been a tremendous resurgence of interest in 
medicinal plants (Briskin 2000). This revival might be attributed to several driving 
factors such as rise in population, insufficient supply of drugs in certain parts of the 
world, prohibitive cost of treatments for common ailments, side effects of several 
allopathic drugs in current usage as well as development of resistance to currently 
used drugs for diseases (Panda and Ray 2012; Pathare and Wagh 2012). Consequently, 
exploitation of medicinal plants for bioactive compounds is of great potential and 
could be an imperative source of providing new vistas for novel drug discovery and 
development (Al-Zubairi et al. 2011; Kalaivani et al. 2011). 
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1.2 OBJECTIVES 
 
The tropical rainforest of Malaysia is regarded as one of the most evolved and 
complex ecosystems in the world that serves a vast untapped biodiversity of natural 
resources (Latiff 2011; Poh-Hwa et al. 2011). This unique natural heritage has 
brought renewed interest with the aim of screening indigenous medicinal plants for 
bioactive compounds. To the best of our knowledge, no detailed studies have been 
reported on the in vitro pharmacological properties of Artabotrys crassifolius Hook.f. 
& Thomson. Therefore, the specific objectives in this research were:  
 
i. To determine the extraction yields and phytochemical constituents of 
Artabotrys crassifolius. 
 
ii. To evaluate the in vitro antibacterial activity of Artabotrys crassifolius. 
 
iii. To examine the in vitro antifungal activity of Artabotrys crassifolius. 
 
iv. To investigate the in vitro anticancer effect of Artabotrys crassifolius. 
 
v. To assess the in vitro antioxidant potential of Artabotrys crassifolius. 
 
vi. To explore the in vitro pharmacological activity of isolated compounds from 
Artabotrys crassifolius. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
2.1 THE GENUS ARTABOTRYS 
 
2.1.1 Botanical descriptions 
 
 Artabotrys R.Br. (Arta-: to suspend; -botrys: a bunch of grapes) (Dalzell and 
Gibson 1861; Smith 1997; Schmidt et al. 2002) is one of the largest genera of the 
custard-apple family, Annonaceae Juss. (Murphy 2007; Triastinurmiatiningsih 2007; 
Murphy et al. 2008; Thongpairoj 2008). The genus Artabotrys comprises over 100 
species of woody climbers and scandent shrubs (Cave et al. 1986; Posluszny and 
Fisher 2000; Brophy et al. 2004) distributed mainly in tropical and subtropical regions 
of the world (Chen et al. 2004; Li and Gilbert 2011), especially tropical Africa and 
Eastern Asia (Eloumi-Ropivia et al. 1985; Chan et al. 1987; Sagen et al. 2003; Lan et 
al. 2007; Gupta et al. 2010; Sichaem et al. 2011).  
 
Generally, the leaves are simple, alternate (Aguilar 2001) or opposite (Kessler 
1993), coriaceous (Riffle 1998), glabrous or glabrescent (Oliver 1868), glossy 
(Bentham 1861) and petiolate (Aguilar 2001). Accessory buds in the axils of leaves 
on the orthotropic shoots can either grow out vegetatively as plagiotropic shoots, form 
thorns especially in shady conditions, or develop into sympodial inflorescences, with 
each sympodial unit terminating in a hook (Posluszny and Fisher 2000; Bell and 
Bryan 2008; Mabberley 2008). 
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The flowers are white or yellow (Riffle 1998), highly fragrant (Llamas 2003), 
hermaphrodite (Aguilar 2001) or unisexual (Oliver 1868), solitary or in fascicles 
(Jayanthi 2011), and borne on woody, often stout (Bentham 1861), and almost 
invariably more or less sharply hooked peduncles, which are often leaf-opposed or 
opposite to lateral branches (Oliver 1868). The three sepals are valvate (Aguilar 2001), 
and free (Kessler 1993) or variably united at the base (Lindley and Moore 1866). The 
six petals are valvate (Bentham 1861), in two whorls of three each (Sambamurty 
2005), subequal (Edwards et al. 1819), free, concave at the base (Oliver 1868), and 
connivent over the stamens and carpels (Keng and Keng 1990). The stamens are 
numerous (Chatrou et al. 2012), closely packed (Lindley and Moore 1866), quadrate-
oblong (Oliver 1868) or cuneate (Jayanthi 2011), and have a truncate dilated 
connective apex (Kessler 1993). The carpels are numerous (Sharma 1993), oblong or 
oval (Bentham 1861), and contain two basal ovules in the ovary (Wight and Arnott 
1834). 
 
The fruits consist of monocarps that are cylindrical or ellipsoid, mostly sessile 
(Kessler 1993), indehiscent (Aguilar 2001), and one- or two-seeded (Oliver 1868). 
The seeds are oblong (Aguilar 2001), collateral (Wight and Arnott 1834), erect 
(Miller 1835), and without aril (Loudon et al. 1836). Detailed botanical descriptions 
of Artabotrys species regarding their morphological characters including habit, roots, 
stems, branches, leaves, inflorescences, flowers, fruits, seeds, as well as origin and 
distribution are presented in Table 2.1. 
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TABLE 2.1 Botanical descriptions of Artabotrys species. 
 
Plant species Botanical description Reference 
    
A. blumei Habit Woody climber Bentham (1861) 
 
 
Leaf 
 
Ovate-elliptic or oblong, 5.08±10.16 cm, coriaceous, both surfaces glabrous 
and glossy, vein slender but conspicuous, apex obtusely acuminate 
 
 
Inflorescence Solitary, peduncle hooked 
 
 
Flower 
 
Pedicel 0.85±1.1 cm; sepal short, broad; petal ovate-lanceolate, 1.27±1.9 
cm, thick, pubescent; inner petal same as outer petal; carpel 6±8, pubescent 
  
  
A. brachypetalus Habit Woody climber to 2±10 m tall Oliver (1868); 
Arnold and Gulumian (1984); 
Van Wyk and  
Van Wyk (1997); 
Schmidt et al. (2002); 
Sobiecki (2002); 
Sagen et al. (2003);  
Steenkamp (2003);  
Clarkson et al. (2004); 
Pillay et al. (2008); 
Stafford et al. (2008); 
Bruschi et al. (2011); 
Luo et al. (2011) 
 
 
Stem Greyish brown, pubescent when young, glabrescent 
 
 
Leaf Elliptic to obovate-elliptic, ovate to oblong, 2.5±8.89 cm × 1.5±5 cm, 
coriaceous, abaxially pale green and densely pubescent, adaxially bright 
green and slightly pubescent, margin entire, base scarcely acute or obtuse, 
apex shortly acute to obtuse; petiole 2.11±8.46 mm 
 
 
Inflorescence Solitary, peduncle hooked 
 
 
Flower 2 cm in diameter; pedicel 1.27±2.54 cm; sepal broadly oval or elliptic- 
oblanceolate, 8.46±12.7 mm, outside tomentose; petal creamy yellow, 
broadly ovate, base acute, apex shortly acute or rather obtuse; inner petal 3, 
slightly shorter, glabrous; torus pilose; stamen quadrate-oblong; connective 
apically truncate; carpel numerous 
 
 
Fruit Monocarp blackish purple, ellipsoid or obovoid, 1.27±2.2 cm, glabrous; 
stipitate 6.35±10.58 mm 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. brachypetalus Seed 1 or 2 
 
 
 
Distribution Malawi and Mozambique, Southeastern Africa; Tropical Africa;  
Venda, Zambia and Zimbabwe, Southern Africa 
  
  
A. brevipes Habit Climber Thongpairoj (2008) 
 
 
Branch Slender, pubescent when young, glabrescent, minutely lenticellate 
 
 
Leaf 
 
Oblong-elliptic, 6.5±12 cm × 2.5±4.2 cm, slightly chartaceous, both 
surfaces glabrous except for abaxially sparsely golden pilose midrib, 
venation inconspicuously reticulate, secondary vein 10±12 on each side of 
midrib, anastomosing 3±4 mm before margin, margin ciliate, base cuneate 
to attenuate, apex caudate; petiole 5 mm 
 
 
Inflorescence Extra-axillary, fascicle 2±5-flowered, peduncle hooked 
 
 
Flower 
 
Pedicel 0.5±0.8 cm, pubescent; sepal ovate, 10 mm × 7±8 mm, erect, 
chartaceous, both surfaces puberulent, apex acute; petal green; outer petal 
oblong-elliptic, 3±3.3 cm × 1 cm, base shortly concave, apex obtuse; inner 
petal smaller than outer petal, both surfaces pubescent; stamen numerous, 
oblong, 1 mm; connective apically mucronate; carpel several; ovary 
glabrous; ovule 2, basal placentation; stigma cylindrical 
 
 
Origin Udon Thani, Northeastern Thailand 
 
 
Distribution Thailand; Vietnam 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. burmanicus Habit Climber Thongpairoj (2008) 
 
 
Branch Rusty or tawny pubescent when young 
 
 
Leaf 
 
Oblanceolate to narrowly obovate, 11±18 cm × 4.5±6 cm, chartaceous, both 
surfaces pubescent, midrib abaxially prominent, venation pinnate, 
secondary vein 9±15 on each side of midrib, anastomosing 3±4 mm before 
margin, margin entire, base acute or equal, apex acute to acuminate; petiole 
2±3 mm 
 
 
Inflorescence Terminal or axillary, solitary, peduncle hooked 
 
 
Flower 
 
Pedicel 2±2.8 cm; sepal broadly ovate, 8±10 mm, deflexed, outside 
pubescent, apex acuminate; petal pale green to yellow, flatly ovate, 2.5±3.2 
cm × 1.5±2 cm, very fleshy, both surfaces pubescent, petal vein 
conspicuous, margin slightly revolute, apex acuminate; inner petal 3, 
rhombic, 2.5±3 cm × 1.2±1.5 cm, pubescent, similar to outer petal; stamen 
100, light yellow, oblong, 3 mm, free, glabrous; connective apically acute 
or triangular; carpel 29; ovary ovate-oblong or flask-shaped, 2±2.5 mm, 
grooved down the inner side, glabrous; stigma oblong, 2±2.5 mm, fascicle, 
woolly, mucilage with red smear 
 
 
Origin Kanchanaburi, Western Thailand;  
Phetchaburi and Prachuap Khiri Khan, Central Thailand 
 
 
Distribution Zibingyi, Mandalay, Burma 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. camptopetalus Habit Climber Triastinurmiatiningsih (2007) 
 
 
Branch Black when dry, laterally straight, pubescent when young, lenticellate 
 
 
Leaf 
 
Pale brown when dry, ovate or elliptic, 3±8 cm × 2±4 cm, chartaceous, 
abaxially glabrous, adaxially glossy, midrib abaxially prominent and 
sparsely pubescent, secondary vein 6±8 on each side of midrib, 
anastomosing 3±4 mm before margin, base cuneate, apex shortly 
acuminate; petiole 2±4 mm, sparsely pubescent 
 
 
Inflorescence 3±5-flowered; peduncle 3, terete, sparsely pubescent 
 
 
Flower 
 
Pedicel 0.2±0.3 cm, sparsely pubescent; sepal broadly ovate, 3±5 mm × 3 
mm, erect, fleshy, valvate, sparsely pubescent, apex acute; outer petal 
lingulate, terete, 0.6±0.7 cm × 0.1±0.15 cm, fleshy, recurved, sparsely 
pubescent, apex obtuse; inner petal 0.5±0.6 cm × 0.1±0.15 cm, narrower, 
sparsely pubescent; torus flat; carpel 3, broadly ovoid, 2 mm × 1.5 mm; 
stigma ovoid 
 
 
Fruit Monocarp ellipsoid, 3±3.5 cm × 1.6 cm × 2 cm, glabrous 
 
 
Distribution New Guinea, Indonesia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. desmidantha Habit Climber Triastinurmiatiningsih (2007) 
 
 
Branch Black when dry, laterally straight, pubescent when young, lenticellate 
 
 
Leaf 
 
Elliptic to oblong, 8±12(±13) cm × 3.5±6 cm, thinly coriaceous, both 
surfaces glabrous, abaxially dark brown when dry, adaxially pale brown, 
midrib abaxially prominent and sparsely pubescent, secondary vein 6±8 on 
each side of midrib, anastomosing 3±6 mm before margin, base cuneate, 
apex shortly acuminate; petiole 2±4 mm, pubescent 
 
 
Inflorescence 
 
3±5-flowered; peduncle 3, terete, sparsely pubescent; bract elliptic, 2 mm × 
1.5 mm; flower bud ovoid, 4 mm × 3 mm, villous 
 
 
Flower 
 
Pedicel 0.2±0.3 cm, villous; sepal ovate, 3 mm × 2.5 mm, erect, fleshy, 
valvate, villous, apex acuminate; outer petal lanceolate, flat, 1.5 cm × 0.4 
cm, fleshy, both surfaces villous, apex acute; inner petal flat, 1.3 cm × 0.35 
cm, narrower, villous; torus flat; stamen 14, oblong; connective apically 
flat; carpel 5, broadly cylindrical, 1.5 mm × 0.5 mm; stigma ellipsoid, 1 
mm × 1 mm, villous 
 
 
Distribution New Guinea, Indonesia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. fragrans Habit Liana to 20 m tall Li and Gilbert (2011) 
 
 
Branch Pubescent, glabrescent 
 
 
Leaf 
 
Oblong-lanceolate to oblong, 13±17 cm × 5±6 cm, abaxially densely 
pubescent when young and sparsely puberulent with age, adaxially 
glabrous and glossy, secondary vein 10±12 on each side of midrib, base 
cuneate to obtuse, apex obtuse to shortly acuminate; petiole 5±8 mm, 
pubescent 
 
 
Inflorescence 1±3-flowered; peduncle 2 cm, glabrous 
 
 
Flower 
 
Pedicel 1±1.2 cm, pubescent; sepal triangular, golden pubescent; outer petal 
broadly triangular-ovate, 1.4 cm × 0.9 cm, densely villous except for base, 
base concave; inner petal triangular, 1±1.2 cm, pubescent except for base, 
base concave; connective apically semiorbicular; carpel 4±7, ovoid, 
glabrous 
 
 
Fruit Monocarp ellipsoid, 4 cm × 2 cm, glabrous; epicarp smooth 
 
 
Origin Vietnam 
 
 
Distribution Guangxi and Guizhou, Southern China; Yunnan, Southwestern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. gracilis Habit Climber Triastinurmiatiningsih (2007) 
 
 
Branch Dark-coloured when dry, laterally straight, glabrous when young, 
lenticellate  
 
 
Leaf 
 
Brown when dry, elliptic to oblong, 6±12 cm × 5±7 cm, thinly coriaceous, 
both surfaces glabrous, adaxially glossy, midrib abaxially prominent and 
sparsely pubescent, secondary vein 7±9 on each side of midrib, 
anastomosing 4±6 mm before margin, base cuneate, apex acuminate; 
petiole 2±4 mm, pubescent 
 
 
Inflorescence 
 
5±7-flowered; peduncle 3, terete, sparsely pubescent; bract elliptic, 5±7 mm 
× 1±2 mm, pubescent; flower bud broadly ovoid, 1.5 mm × 2 mm, 
pubescent 
 
 
Flower 
 
Pedicel 0.2±0.25 cm, glabrous; sepal ovate, 2 mm × 2 mm, erect, valvate, 
outside sparsely pubescent, inside glabrous, apex acuminate; outer petal 
pale green, flat, 0.3±0.5 cm × 0.1 cm, linear, fleshy, tomentose, apex acute; 
inner petal terete, 0.2±0.3 cm × 0.1 cm, linear, slightly narrower, villous; 
torus flat; stamen 20±24, oblong, 1±2 mm × 0.5±1 mm; connective apically 
flat; carpel 5, broadly ovoid, 0.4±0.6 mm × 0.3±0.4 mm, glabrous; stigma 
cup-shaped, glabrous 
 
 
Distribution Borneo; New Guinea and Sumatra, Indonesia; Perak, Malaysia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. grandiflorus Habit Climber to 20±25 m tall Chan et al. (1987); 
Chuakul and 
Soonthornchareonnon (2003); 
Chuakul et al. (2004); 
Thongpairoj (2008); 
Eswani et al. (2010) 
 
 
Branch Pale, glabrous, well-marked striations 
 
 
Leaf 
 
Oblong-elliptic, 17±20 cm × 7±10 cm, thinly coriaceous, both surfaces 
glabrous, abaxially dull, adaxially glossy, midrib abaxially prominent, 
venation pinnate, secondary vein 10±12 on each side of midrib, 
anastomosing 3±5 mm before margin, margin entire, base cuneate to 
obtuse, apex abruptly acute or obtuse 
 
 
Inflorescence 1±3-flowered; peduncle hooked 
 
 
Flower 
 
Pedicel 2±3 cm, hirsute; sepal ovate, 5±6 mm × 4±5 mm, outside 
tomentose, apex acuminate; petal pale green, coriaceous, rusty tomentose; 
outer petal broadly elliptic, 2±2.3 cm × 0.5±1 cm, apex acute; inner petal 
slightly shorter; stamen numerous, oblong, 2 mm; connective apically flat; 
carpel 20±25; ovary cylindrical, glabrous; stigma linear 
 
 
Fruit Monocarp obovoid-ellipsoid, glabrous, apex mamillate 
 
 
Origin Krabi, Narathiwat, Pattani, Satun, Songkhla and Surat Thani,  
Southern Thailand 
 
 
Distribution Dungun, Terengganu, Gopeng, Perak, and Jerantut, Pahang, Malaysia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. hainanensis Habit Climbing shrub to 4 m tall Bi et al. (2004);  
Chen et al. (2004); 
Han et al. (2005); 
Li and Gilbert (2011) 
 
 
Branch Glabrous 
 
 
Leaf 
 
Oblong-elliptic to oblong, 7±15 cm × 3±6 cm, chartaceous, both surfaces 
glabrous except for abaxially puberulent midrib, secondary vein 7±9 on 
each side of midrib, base broadly cuneate to obtuse, apex acute to 
acuminate; petiole 4±8 mm, glabrous 
 
 
Inflorescence Leaf-opposed, usually 1-flowered 
 
 
Flower 
 
Pedicel 1.2±1.5 cm; sepal ovate, 4±5 mm, sparsely pubescent; petal 
yellowish white, narrowly lanceolate, 2 cm × 0.2 cm, subequal, base 
slightly broad and concave; stamen oblong, 14 mm × 2 mm; connective 
apically obtuse to subtruncate; carpel 15, slightly longer than stamen; 
stigma shortly clavate 
 
 
Fruit Monocarp ellipsoid, 2.5 cm × 1.2 cm 
 
 
Origin Guangdong, Guangxi and Hainan, Southern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. harmandii Habit Woody climber Chuakul and 
Soonthornchareonnon (2003); 
Chuakul et al. (2006); 
Thongpairoj (2008) 
 
 
Leaf 
 
Oblanceolate, 9±15 cm × 3±7 cm, coriaceous, both surfaces glabrous, 
adaxially glossy, midrib abaxially prominent, base obtuse, apex acute or 
shortly acuminate; petiole 2±8 mm × 1 mm 
 
 
Inflorescence 1±2-flowered; peduncle hooked, 1.8±2.5 cm 
 
 
Flower 
 
Pedicel trigonous, 1.5±2 cm, puberulent; sepal caudate, 6±7 mm, both 
surfaces pubescent, apex acute to acuminate; petal green, flat, slightly 
fleshy, glossy; outer petal ovate to oblong, 1.5±2 cm × 0.6±0.7 cm, both 
surfaces pubescent, apex acute; inner petal rather rhombic, 1.4±1.5 cm × 
0.7±0.8 cm, pubescent, base concave, apex acute; stamen 89, oblong, 2 
mm, glabrous; connective apically suborbicular with sharply apiculate; 
carpel 16, tomentose; ovary ovate to oblong, 1.5±2 mm, grooved down the 
inner side, glabrous; ovule 2, basal placentation; stigma cylindrical, 1±1.5 
mm, slightly bent, tomentose  
 
 
Fruit 
 
Monocarp ellipsoid or obovoid, 3±3.5 cm × 2±2.5 cm, apex acute; stipitate 
5±6 mm, glabrous 
 
 
Seed 2, black, ellipsoid, transversely grooved, apex obtuse 
 
 
Origin Chachoengsao, Chonburi, Prachinburi and Saraburi, Central Thailand; 
Chaiyaphum, Nakhon Ratchasima, Sisaket, Surin and Yasothon, 
Northeastern Thailand; Chanthaburi and Trat, Eastern Thailand  
 
 
Distribution Laos; Pursat, Cambodia; Vietnam 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. hexapetalus Habit Liana or scandent shrub to 8±10 m tall Hedberg et al. (1982); 
Li et al. (1997);  
Li and Yu (1998); 
Riffle (1998);  
Whistler (2000);  
Aguilar (2001);  
Yu et al. (2001);  
Wong and Brown (2002); 
Yu et al. (2002);  
Chuakul and 
Soonthornchareonnon (2003); 
Llamas (2003); 
Chen et al. (2004); 
Mahidol et al. (2005); 
Manner and Elevitch (2006); 
Triastinurmiatiningsih (2007);  
Khare (2008); 
Mishra et al. (2008); 
Thongpairoj (2008); 
Savadi (2009); 
Karthik (2010); 
 
 
Branch 
 
Dark brown when dry, laterally straight, sparsely pubescent when young, 
glabrescent, lenticellate 
 
 
Leaf 
 
Dark green, pale green when dry, elliptic to oblong, lanceolate or 
oblanceolate, oblong to broadly lanceolate or oblanceolate, 5±25 cm × 2.5±
10 cm, chartaceous to thinly coriaceous, abaxially glabrous or only midrib 
puberulent, adaxially glabrous, midrib abaxially prominent, secondary vein 
8±16 on each side of midrib, anastomosing 3±4 mm before margin, margin 
entire, base acute to cuneate, apex acute to shortly acuminate; petiole 2±10 
mm × 3 mm, stout, glabrous or sparsely pubescent 
 
 
Inflorescence 
 
1±4-flowered; peduncle 2, flat, hooked, sparsely pubescent; bract elliptic to 
oblong, 1±2 mm × 0.5±1 mm, pubescent; flower bud broadly ovoid 
 
 
Flower Creamy yellow to greenish yellow, 2.5±3.8 cm in diameter, banana-like 
fragrant; pedicel trigonous, 1.5±2.5 cm, sparsely pubescent or glabrescent; 
sepal green, ovate to triangular, 3±10 mm × 3±8 mm, erect, thinly fleshy or 
coriaceous, reflexed, both surfaces sparsely puberulent or softly pubescent, 
apex acute or acuminate; petal 6, green to bright yellow, 0.15±0.2 cm, free, 
very fleshy, fragrant; outer petal ovate-oblong to oblong-lanceolate, flat, 2±
5 cm × 0.5±1.6 cm, outside basally densely pubescent, contracted nearly to 
kkkkk    
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. hexapetalus Flower 
 
base but basally expanded, vein adaxially conspicuous, margin ciliate and 
revolute, red or pink inside at base, apex acute; inner petal flat, 2±4.2 cm × 
0.3±1.2 cm, smaller, shorter, narrower; torus convex; stamen 29±91, oblong 
to cuneate, 1±2.5 mm, glabrous; connective apically triangular, glabrescent; 
carpel 5±30, oblong or cylindrical, 2 mm × 0.5 mm; ovary ovate-oblong, 
2.5±3 mm, grooved down the inner side, glabrous; stigma cylindrical or 
clavate, 3±3.5 mm, glabrous or densely tomentose 
Jayanthi (2011); 
Li and Gilbert (2011); 
Manjula et al. (2011); 
Rajkumar and  
Rajanna (2011); 
Chatrou et al. (2012) 
 
 
Fruit 
 
Monocarp yellow, ellipsoid to obovoid, globose to ovoid, 2.5±5 cm × 1.5±
2.5 cm, fragrant, glabrous, apex conspicuously mucronate or apiculate; 
stipitate 2±5 mm × 1.5 mm, glabrous or sparsely pubescent, apex mamillate 
 
 
Seed 
 
2, pale or dark brown, ellipsoid or oblong, 1.7±1.9 cm × 1.2±1.4 cm, 
smooth, transversely grooved, apex obtuse to truncate 
 
 
Origin Southern India; Sri Lanka; Thailand 
 
 
Distribution Bangalore, Karnataka, Southwestern India; Bangladesh; Bhutan; Borneo; 
Burma; Fujian, Southeastern China; Guangdong, Guangxi, Guizhou, 
Hainan, Hong Kong and Jiangxi, Southern China; Java, Moluccas, 
Sulawesi and Sumatra, Indonesia; Korogwe, Tanzania, Eastern Africa; 
Malaysia; Philippines; Salem, Tamil Nadu, Southern India; Taiwan; 
Vietnam; Yunnan, Southwestern China; Zhejiang, Eastern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. hongkongensis Habit Climbing shrub to 8 m tall Chen et al. (2004); 
Li and Gilbert (2011)   Branch Hispid 
 
 
Leaf 
 
Oblong-elliptic to oblong, 6±12 cm × 2.5±4 cm, coriaceous, abaxially 
glabrous or only midrib puberulent, adaxially glossy, secondary vein 8±10 
on each side of midrib, base slightly oblique and obtuse; petiole 2±5 mm, 
puberulent 
 
 
Inflorescence 1-flowered; peduncle hooked, puberulent 
 
 
Flower 
 
Pedicel slightly longer than peduncle; sepal triangular-ovate, 5 mm, 
glabrescent; outer petal ovate-lanceolate, 1±1.8 cm, thick, outside densely 
sericeous pubescent, base concave; inner petal basally concave; stamen 
cuneate; connective apically triangular, puberulent; carpel ovate-oblong, 
glabrous; ovule 2, basal placentation; stigma shortly clavate 
 
 
Fruit Monocarp black when dry, ellipsoid, 2±4 cm × 1.5±3 cm, apex subobtuse 
 
 
Origin  Vietnam 
 
 
Distribution  Guangdong, Guangxi, Guizhou, Hainan and Hunan, Southern China; 
Yunnan, Southwestern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. inodorus Habit Climber Triastinurmiatiningsih (2007) 
 
 
Branch 
 
Brown to black when dry, laterally straight, sparsely pubescent when 
young, glabrescent, lenticellate 
 
 
Leaf 
 
Pale green when dry, lanceolate or obovate, 9±13 cm × 3±6 cm, coriaceous, 
both surfaces glabrous, midrib abaxially prominent and sparsely pubescent, 
secondary vein 8±12 on each side of midrib, anastomosing 4±5 mm before 
margin, base cuneate, apex acuminate; petiole 2±4 mm, sparsely pubescent 
 
 
Inflorescence 
 
3±5-flowered; peduncle 3, flat, sparsely pubescent; bract ovate, 2 mm × 1.5 
mm, outside puberulent, inside glabrous; flower bud ellipsoid, 2 mm × 2 
mm, puberulent 
 
 
Flower 
 
Pedicel 0.3±0.5 cm, glabrous; sepal lanceolate, 5 mm × 3 mm, thinly 
fleshy, deflexed, outside puberulent, inside glabrous, apex long acuminate; 
outer petal, terete, triquetrous, 1.5±2 cm × 0.1 cm, linear, fleshy, 
puberulent; inner petal terete, 1.5±1.8 cm × 0.1 cm, narrower; stamen 
oblong; connective apically flat; carpel 3, broadly oblong 
 
 
Fruit Monocarp obovoid, 3±4 cm × 1.5±2 cm; stipitate 0.5 cm 
 
 
Distribution New Guinea, Indonesia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. lowianus Habit Woody climber Thongpairoj (2008) 
 
 
Branch Dark-coloured when dry, glabrous 
 
 
Leaf 
 
Oblong-elliptic, 14±16 cm × 4±5.5 cm, slightly coriaceous, both surfaces 
glabrous, midrib abaxially prominent, venation reticulate, secondary vein 
11±12 on each side of midrib, anastomosing 3 mm before margin, base 
acute or shortly attenuate, apex acuminate to caudate 
 
 
Inflorescence Extra-axillary, fascicle 1±2-flowered; peduncle hooked 
 
 
Flower 
 
Pedicel 0.5±1 cm; sepal triangular, 4±5 mm, small, coriaceous, apex acute; 
petal narrowly elliptic to oblanceolate, 3 cm × 0.8±1 cm, fleshy, base 
concave, apex acute to obtuse; inner petal narrower than outer petal, both 
surfaces puberulent; stamen broadly oblong, 2 mm; connective apically 
obtuse; ovary ovate-oblong, glabrous; stigma clavate 
 
 
Origin  Sop Moei, Mae Hong Son, Northern Thailand 
 
 
Distribution  Perak, Malaysia  
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. macranthus Habit Climber Triastinurmiatiningsih (2007) 
 
 
Branch Pale brown when dry, laterally curved, red villous when young, lenticellate  
 
 
Leaf 
 
Whitish brown when dry, elliptic to oblong, obovate, 17.5±20 cm × 7±8 
cm, coriaceous, villous when young, glabrous with age, midrib abaxially 
prominent and sparsely pubescent, secondary vein 10±11 on each side of 
midrib, anastomosing 2±3 mm before margin, base cuneate, apex shortly 
acuminate; petiole 4±6 mm, glabrous 
 
 
Inflorescence 
 
1±2-flowered; peduncle 2, terete, sparsely pubescent; flower bud ovoid, 3±
4 mm × 2±3 mm, tomentose 
 
 
Flower 
 
Pedicel 1±1.2 cm, tomentose; sepal triangular, 10±20 mm × 5±10 mm, 
erect, fleshy, both surfaces tomentose, apex acute; outer petal greenish 
yellow, oblong, flat, 3.5±4.0 cm × 2.0±2.5 cm, fleshy, pubescent; inner 
petal flat, 3.5±3.8 cm × 1.5±2.0 cm, narrower; torus flat; stamen numerous, 
oblong, 1 mm × 0.5 mm; connective apically flat; carpel 8±12; stigma 
cylindrical bilobed, glabrous 
 
 
Fruit Monocarp oblong, 1.5 cm × 1 cm; stipitate 1.3 cm, pubescent 
 
 
Distribution  Borneo; Moluccas, Sulawesi and Sumatra, Indonesia; Philippines 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. macrophyllus Habit Shrub Oliver (1868) 
 
 
Leaf 
 
Broadly elliptic, 17.78±25.4 cm × 12.7±15.24 cm, base obtuse, apex shortly 
acuminate; petiole 6.35±8.46 mm 
  
Inflorescence Many-flowered; peduncle 5.08 cm, hooked 
  
Flower 
 
Pedicel 0.42 cm; sepal broadly ovate, outside pilose-pubescent, apex 
shortly acuminate; petal 6, oblong-lanceolate, 0.85 cm, subequal 
  
  
A. monteiroae Habit Climbing shrub Kato et al. (1993); 
Van Wyk and  
Van Wyk (1997); 
Nichols (2002); 
Schmidt et al. (2002); 
Clarkson et al. (2004); 
Pillay et al. (2008) 
  
Branch Reddish brown to black, reddish brown pubescent 
  
Leaf 
 
Ovate to oblong-elliptic, both surfaces glabrous, abaxially pale green, 
adaxially dark bluish green, apex abruptly acuminate 
  
Inflorescence Peduncle hooked 
  
Flower Creamy yellow or white, 1 cm in diameter; petal linear, narrow 
  
Fruit Monocarp bright red or red, oval, 1.5 cm × 1 cm 
 
 
Distribution  Kenya, Eastern Africa; Soutpansberg and Zululand, Southern Africa  
 
 
  
A. multiflorus Habit Liana to 20 m tall, 3 cm or less in diameter Thongpairoj (2008); 
Li and Gilbert (2011)   Branch 
 
Grey to dark brown, minutely puberulent or sparsely pubescent when 
young, minutely lenticellate 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. multiflorus Leaf 
 
Elliptic to oblong-elliptic or oblong-oblanceolate, 10±26 cm × 4±9 cm, 
chartaceous to coriaceous, pubescent when young especially abaxially 
midrib, glabrescent, midrib abaxially prominent, venation pinnate, 
secondary vein 9±16 on each side of midrib, anastomosing 5±6 mm before 
margin, margin entire, base cuneate to obtuse, apex acuminate or apiculate 
to cuspidate; petiole 5±15 mm 
 
  
Inflorescence 
 
Terminal or axillary, fascicle 2±3, one apical and another slightly below it 
on outer side, 8±15-flowered; peduncle 1.5±2 cm, stout, sharply curved and 
hooked, bristly 
  
Flower 
 
Pedicel 0.8±1.5 cm, rufous hispid; sepal triangular-ovate, 2±4 mm, erect, 
coriaceous, outside rufous pubescent or puberulent, inside glabrous, apex 
acute; petal light green to yellow, narrowly oblong-lanceolate to oblong, 
flat, 1.8±3.5 cm × 0.6±0.7 cm, subequal, fragrant, both surfaces slightly 
pubescent, base deeply convex, apex obtuse; inner petal 3, slightly smaller, 
narrower and more deeply concave than outer petal, connivent over stamen 
and carpel, outside thinly pubescent but densely grey pubescent on basal 
concave part, inside glabrous; stamen 25, yellow, broadly oblong-cuneate, 
1.5 mm, puberulent; connective apically truncate or slightly concave; 
carpel 10±21, oblong-lanceolate to narrowly oblong, 1.3±2 mm, glabrous; 
ovary ovate-oblong, grooved down the inner side, glabrous; style oblong to 
narrowly clavate, 1.3±1.5 mm; stigma oblong to ellipsoid, smaller than the 
ovary, woolly; boundary of carpel with stigma prominent 
  
Fruit Monocarp 4±6, green, ellipsoid, sessile, apex obtuse 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. multiflorus Origin  Burma; Kanchanaburi, Western Thailand 
 
  
Distribution Burma; Guangxi and Guizhou, Southern China;  
Yunnan, Southwestern China 
  
  
A. oblanceolatus Habit Climber Chuakul and 
Soonthornchareonnon (2003); 
Thongpairoj (2008) 
  
Branch Dark brown, furrow, pubescent 
  
Leaf 
 
Narrowly elliptic, 10±11.4 cm × 3±4 cm, membranous, both surfaces 
glabrescent, midrib abaxially prominent, venation pinnate, secondary vein 
10±11 on each side of midrib, anastomosing 3±4 mm before margin, 
margin entire, base obtuse, apex acuminate; petiole 2±3 mm, rugose 
  
Inflorescence Terminal or extra-axillary, solitary; peduncle 0.5±1 cm, hooked 
  
Flower 
 
Pedicel 0.4±0.6 cm; sepal broadly ovate, 5±6 mm, erect, membranous, 
outside minutely pubescent, apex acute; petal pale green to yellow, broadly 
ovate, flat, 0.8±1 cm × 0.6±0.7 cm, thick, both surfaces white pubescent, 
apex acute; inner petal 3, 0.6±0.7 cm × 0.5±0.6 cm, pubescent, similar to 
outer petal; stamen 65, oblong, 1.5±2 mm, free, glabrous; connective 
apically broadly flat; carpel 11; ovary flask-shaped, 2±3 mm, grooved 
down the inner side; stigma ovate-oblong, woolly 
 
 
Origin  Chaiyaphum and Ubon Ratchathani, Northeastern Thailand;  
Pathum Thani and Saraburi, Central Thailand  
 
 
Distribution  Vietnam 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. odoratissimus Habit Woody climber or scandent shrub Wight and Arnott (1834); 
Miller (1835);  
Bentham (1861); 
Dalzell and Gibson (1861); 
Pardo De Tavera (1901); 
Kamboj and Dhawan (1982); 
Randhawa and   
Mukhopadhyay (1986); 
Hasan et al. (1987); 
Sharma (1993);  
Dey (1996); 
Groom (1997); 
Garg and Siddiqui (1998);  
Baker (1999);  
Dey (2001); 
Sharma et al. (2002); 
Singh et al. (2005);  
Hout et al. (2006); 
Bordoloi et al. (2009); 
Singh et al. (2009); 
Srivastava et al. (2009); 
Gupta et al. (2010);  
Kabir (2010) 
  
Root Branched taproot 
  
Stem Aerial, branched, woody, fragrant 
  
Leaf 
 
Dark green, ovate-elliptic or oblong-lanceolate, 10.16±15.24 cm, scarcely 
coriaceous, both surfaces glabrous and glossy, venation reticulate, margin 
entire, base acute, apex acute; petiole short 
  
Inflorescence Axillary, 1- or 2-flowered; peduncle hooked, glabrous 
  
Flower 
 
Greenish yellow, ripe apple- or jackfruit-like fragrant; sepal 3, green, free, 
small, valvate; petal 6, greenish yellow, oblong-lanceolate to narrowly 
oblong, 2.54 cm, thick, fleshy, valvate, glabrous or rusty pubescent, base 
concave; inner petal similar to outer petal; stamen numerous; carpel many, 
pyriform, free, glabrous; ovule marginal placentation 
  
Fruit Monocarp yellow, oblong 
  
Seed 2, large 
 
 
Origin  China; Indonesia; Jorhat, Assam, Northeastern India; Malwa, Central India 
 
 
Distribution Bangladesh; Kandal, Cambodia; Malay Archipelago 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. oxycarpus Habit Scandent shrub Thongpairoj (2008) 
  
Branch Black and shiny when dry, slender 
  
Leaf 
 
Broadly elliptic, 8±11 cm × 3.8±5 cm, chartaceous, both surfaces glabrous, 
adaxially glossy, midrib abaxially prominent, venation pinnate, secondary 
vein 8±9 on each side of midrib, anastomosing before margin, base obtuse, 
apex acuminate; petiole 3±5 mm 
  
Inflorescence Solitary; peduncle slender, hooked, glabrous 
  
Flower 
 
Pedicel 0.7±1 cm; sepal ovate to triangular, 4±5 mm, coriaceous, glabrous, 
acute apex; petal yellow; outer petal oblong-elliptic, 4±5 cm × 1.3±1.4 cm, 
erect, coriacous, both surfaces pubescent, apex subacute to obtuse; inner 
petal smaller than outer petal; stamen oblong, 2 mm; connective apically 
obtuse or convex; carpel several; ovary glabrous 
  
Fruit 
 
Monocarp narrowly ellipsoid, 2.5±3 cm × 1 cm, sessile, glabrous, base and 
apex acuminate 
 
 
Origin  Toh Moh, Narathiwat, Southern Thailand 
 
 
Distribution Perak, Malaysia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. pilosus Habit Climbing shrub to 5 m tall Chen et al. (2004); 
Wang (2010); 
Li and Gilbert (2011) 
  
Branch Densely tomentose when young 
  
Leaf 
 
Oblong-elliptic to oblong, 5±17 cm × 2±7.5 cm, chartaceous, abaxially 
densely tomentose, adaxially slightly glaucous and glabrous, secondary 
vein 8 on each side of midrib, base obtuse, apex obtuse to acuminate; 
petiole 2 mm, densely tomentose 
  
Inflorescence 
 
Leaf-opposed or extra-axillary, usually 1-flowered; peduncle longer than 
pedicel, flat, densely villous when young, glabrescent 
  
Flower 
 
Pedicel 0.6±1.2 cm, densely pubescent; sepal ovate, 4 mm, outside 
pubescent; petal green to yellow, narrowly oblong, 1.5±1.7 cm, pubescent; 
stamen cuneate; connective apically subtruncate; carpel 8, glabrous 
  
Fruit Monocarp dark brown, oblong-ellipsoid, 1.5±2.2 cm × 1.5 cm, glabrous 
 
 
Origin Guangdong and Hainan, Southern China 
 
 
  
 
 
 
 
 
 
 
 
 
27 
 
TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. punctulatus Habit Climbing shrub to 4 m tall Li and Gilbert (2011) 
  
Branch Puberulent when young 
  
Leaf 
 
Oblong-elliptic, 7±13.5 cm × 3±5.5 cm, chartaceous, abaxially glabrous 
except for puberulent midrib, adaxially minutely punctate, secondary vein 
12±14 on each side of midrib, base oblique to broadly cuneate, apex obtuse 
to acuminate; petiole 5±7 mm, puberulent 
  
Inflorescence Peduncle puberulent 
  
Flower 
 
3±4 cm in diameter; pedicel 1.5±2 cm; sepal broadly triangular-ovate, 5±7 
mm, puberulent, base slightly attenuate; petal brownish green; outer petal 
ovate-oblong, 2.5 cm, base concave; inner petal 2 cm, concave and 
connivent, horizontally spreading from apical 1/3, base attenuate; stamen 
many, cuneate, 1.5 mm; connective apically subtruncate, glabrous; carpel 
20, oblong, glabrous; stigma clavate, longer than ovary, pubescent 
  
Fruit Monocarp fusiform, slightly flattened, 3.5±4 cm × 1.5±1.7 cm 
 
 
Origin  Yunnan, Southwestern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. rhynchocarpus Habit Climbing shrub to 10 m tall Li and Gilbert (2011) 
  
Branch Pilose when young, glabrescent 
  
Leaf 
 
Oblong-lanceolate to oblong, 8±13 cm × 3±4 cm, chartaceous, abaxially 
puberulent, adaxially glabrous, secondary vein 12±14 on each side of 
midrib, base cuneate, apex acuminate; petiole 3±5 mm, pilose 
  
Inflorescence Leaf-opposed, 2±5-flowered; peduncle 0.8±1.5 cm, pilose 
  
Flower 
 
Pedicel 1.2±1.5 cm, pubescent; sepal broadly ovate, 3±4 mm × 3±4 mm, 
both surfaces pilose; petal ovate-oblong, 1.5 cm × 0.6 cm, tawny 
pubescent; stamen cuneate, 1.5 mm; connective apically subtruncate, 
glabrous 
  
Fruit 
 
Monocarp oblong, 4.5±5 cm × 1.5±1.7 cm, apex conspicuously beaked; 
stipitate 5±7 mm 
  
Seed 2, flat, 3 cm × 1.2 cm 
 
 
Origin  Yunnan, Southwestern China 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. siamensis Habit Woody climber Chuakul and 
Soonthornchareonnon (2003); 
Thongpairoj (2008) 
  
Leaf 
 
Broadly elliptic or oblanceolate, 9±12 cm × 4±5 cm, chartaceous to 
coriaceous, abaxially tawny pubescent, adaxially glabrescent except for 
puberulent midrib, midrib abaxially prominent, secondary vein 8±9 on each 
side of midrib, anastomosing 3±4 mm before margin, margin ciliate, base 
obtuse, apex abruptly acute; petiole 3±6 mm × 1±1.5 mm 
  
Inflorescence Extra-axillary, solitary; peduncle flat, 1±1.5 cm, hooked, puberulent 
  
Flower 
 
Green to yellow; pedicel 0.8±1 cm; sepal broadly ovate to orbicular, 4±5 
mm × 6±7 mm, coriaceous, reflexed, both surfaces pubescent, connate at 
base, apex acuminate; petal green to yellow, flat, 0.1 cm, fleshy, fragrant; 
outer petal broadly elliptic, 2.7±3 cm × 0.8±1 cm, both surfaces pubescent, 
apex acute; inner petal rather rhombic, 2.5±2.8 cm × 0.8±1 cm, puberulent; 
stamen 115, narrowly oblong, 2.5±3 mm, glabrous; connective apically 
triangular, shortly tomentose; carpel 25; ovary ovate-oblong, 2.5±3 mm, 
grooved down the inner side, glabrous; ovule 2, basal placentation; stigma 
cylindrical, 2.5±3 mm, slightly concave, woolly 
  
Fruit 
 
Monocarp broadly ellipsoid, 2±2.8 cm × 1.5±2 cm, puberulent, apex acute; 
stipitate 3±5 mm 
 
 
Origin  Kanchanaburi, Western Thailand;  
Phetchaburi, Prachuap Khiri Khan and Ratchaburi, Central Thailand 
 
 
Distribution  Burma; Thailand; Vietnam 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. speciosus Habit Climber Triastinurmiatiningsih (2007) 
  
Branch Black when dry, laterally straight, pubescent when young, lenticellate 
  
Leaf 
 
Dark brown when dry, oblong, 13±16 cm × 3.5±6.5 cm, coriaceous, both 
surfaces glabrous, midrib abaxially prominent and sparsely pubescent, 
secondary vein 10±11 on each side of midrib, anastomosing 4±6 mm before 
margin, base obtuse, apex acuminate; petiole 3±5 mm, slightly pubescent 
  
Inflorescence 
 
5±6-flowered; peduncle 2, terete to subterete, sparsely pubescent; bract 
ovate, 2 mm × 1.5 mm, sparsely pubescent, apex acute; flower bud ovate, 2  
mm × 2 mm, pubescent 
  
Flower 
 
Pedicel 0.4±0.6  cm, sparsely pubescent; sepal triangular, 2±3 mm × 2 mm, 
erect, fleshy, valvate, outside pubescent, inside glabrous, apex acuminate; 
outer petal lanceolate, flat, 2±2.5 cm × 0.1±0.3 cm, thinly fleshy, valvate, 
tomentose; inner petal terete, 2±2.5 cm × 0.1 cm, linear, tomentose; torus 
flat; stamen 20, oblong, 1 mm × 1 mm; connective apically acute; carpel 5, 
broadly ovoid, 1±1.5 mm × 1 mm 
  
Fruit Monocarp ellipsoid, 3±3.5 cm × 2±2.5 cm 
 
 
Distribution  Malaysia; Moluccas and New Guinea, Indonesia 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. spinosus Habit Scandent shrub to 6 m tall Chuakul and 
Soonthornchareonnon (2003); 
Thongpairoj (2008); 
Sichaem et al. (2011) 
  
Stem Light brown, pubescent when young; spines in axillary pairs  
  
Leaf 
 
Narrowly elliptic or oblong-obovate, 6±8 cm × 2.5±4.5 cm, coriaceous, 
both surfaces glabrous, midrib abaxially prominent, secondary vein 7±8 on 
each side of midrib, anastomosing 1±2 mm before margin, base cuneate, 
apex retuse; petiole 2±3 mm × 1 mm 
  
Inflorescence 
 
Fascicle 1±3-flowered; peduncle 1.5±2 cm, hooked; bract triangular, 1.5 
mm × 1.5 mm 
  
Flower 
 
Pedicel 1.3±1.5 cm × 0.1 cm; sepal broadly ovate, 5 mm × 5±7 mm, 
coriaceous, reflexed, both surfaces puberulent, apex acuminate; petal green, 
fleshy, abaxially densely red brown maculate, midrib adaxially prominent; 
outer petal ovate, 2±2.5 cm × 1±1.5 cm, both surfaces white puberulent 
except for tomentose base, base obcordate, apex acute; inner petal, obovate 
or broadly rhombic-elliptic, 1.5±2 cm × 0.6±0.8 cm, puberulent; torus 
sericeous; stamen light yellow, oblong, 2±2.5 mm, glabrous; connective 
apically apiculate, pubescent; carpel 12±13; ovary obclavate or narrowly 
ovate-oblong, 1.8±2 mm, grooved down the inner side, glabrous; stigma 
lingulate, 1±1.5 mm, elongated, woolly 
  
Fruit Monocarp glabrous; stipitate pale green, elliptic, white maculate 
 
 
Origin  Loei, Maha Sarakham, Nakhon Ratchasima, Sisaket and Ubon Ratchatani, 
Northeastern Thailand 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. suaveolens Habit Woody climber or scandent scrub to 25 m tall Pardo De Tavera (1901);  
Maranon (1929); 
Barger and Sargent (1939);  
Eloumi-Ropivia et al. (1985); 
Keng and Keng (1990); 
Aguilar (2001);  
Wiart (2006); 
Triastinurmiatiningsih (2007); 
Thongpairoj (2008) 
  
Branch 
 
Black, laterally straight, glabrous or slightly pubescent when young, 
lenticellate, finely striated  
  
Leaf 
 
Dark green, brown when dry, elliptic to oblong or oval, 4.5±18 cm × 2±6 
cm, chartaceous to thinly coriaceous, both surfaces glabrous and glossy 
except for abaxially midrib, midrib adaxially prominent, secondary vein 8±
10 on each side of midrib, anastomosing 3±5 mm before margin, base acute 
to shortly attenuate or cuneate, apex shortly acuminate to cuspidate; petiole 
2±10 mm, slender, sparsely pubescent 
  
Inflorescence 
 
1±5-flowered; peduncle 3, terete to subterete, hooked, pubescent; bract 
lanceolate, 1.5 mm × 0.5 mm, outside sparsely pubescent, inside glabrous; 
flower bud broadly ovoid, 2  mm × 1.5 mm, pubescent 
  
Flower 
 
Creamy white, fragrant; pedicel 0.4±1 cm, slender, sparsely pubescent; 
sepal broadly ovate, 1.5±2 mm × 1±1.5 mm, erect, fleshy, valvate, outside 
sparsely pubescent, inside glabrous, apex acute or acuminate; petal 6, 
creamy white or yellow, fleshy, fragrant; outer petal terete, linear, minutely 
tomentose or pubescent, claw orbicular, inside glabrous, limb terete, 0.7±
1.5 cm × 0.05±0.1 cm, slender, slightly incurved, apex obtuse; inner petal 
terete, 0.7±1.5 cm × 0.05 cm, linear, slender, pubescent, apex obtuse; torus 
flat; stamen 20±25, broadly oblong, 0.2±1 mm × 0.5 mm, scarcely any 
filament; connective apically flat or discoid, minutely tomentose; 
kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. suaveolens Flower carpel 2±5, broadly ovoid, 0.4±0.5 mm, glabrous; ovary broadly ovoid, 
grooved down the inner side, glabrous; ovule 2, basal placentation; style 
linear, bent; stigma bilobed, rather broadly flattened or cup-shaped, woolly; 
boundary of carpel with stigma prominent 
 
  
Fruit 
 
Monocarp green or yellow, oblong to ellipsoid, 0.7±3.5 cm × 0.5±1.2 cm, 
sessile, glabrous, apex obtuse; stipitate 5±10 mm 
  
Seed 2, brown, ellipsoid, plano-convex 
 
 
Origin  Krabi, Phang Nga, Ranong, Songkhla, Surat Thani, Trang and Yala, 
Southern Thailand; Trat, Southeastern Thailand 
 
 
Distribution  Borneo; Burma; India; Java, Moluccas, New Guinea, Sulawesi and 
Sumatra, Indonesia; Malacca, Malaysia; Philippines 
   
 
A. sumatranus Habit Climber Triastinurmiatiningsih (2007) 
  
Branch 
 
Dark brown or black when dry, laterally straight, sparsely pubescent when 
young, lenticellate 
  
Leaf 
 
Dark brown when dry, elliptic to oblong, obovate, 6±12 cm × 3±6 cm, 
thinly coriaceous, both surfaces glabrous except for abaxially midrib, 
midrib abaxially prominent, secondary vein 7±11 on each side of midrib, 
anastomosing 3±6 mm before margin, base cuneate to attenuate, apex 
shortly acuminate; petiole 3±5 mm, sparsely pubescent 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. sumatranus Inflorescence 
 
3±4-flowered; peduncle 3, flat, sparsely pubescent; bract ovate, 2±3 mm × 
0.5±1 mm, outside pubescent, inside glabrous; flower bud broadly ovoid, 
1.5±2  mm × 1±1.5 mm, pubescent 
 
  
Flower 
 
Pedicel 0.3±0.6  cm, sparsely pubescent; sepal ovate, 3±5 mm × 2±3 mm, 
erect, deflexed, valvate, outside densely pubescent, inside glabrous, 
connate at base, apex caudate; outer petal lanceolate, flat, 1.5±2 cm × 0.1±
0.2 cm, thinly fleshy, densely pubescent, apex acute; inner petal terete, 0.8±
1.7 cm, apex obtuse; torus flat; stamen 20±25, oblong; connective apically 
acute; carpel 3, ovoid, 1±2 mm × 0.5±1 mm, free, glabrous; stigma ovoid 
  
Fruit Monocarp 2±3, ellipsoid, 3±4 cm × 2±2.5 cm; stipitate 1±2 cm 
 
 
Distribution  Borneo; Java, New Guinea and Sumatra, Indonesia 
 
 
  
A. thomsonii Habit Climber Oliver (1868) 
  
Leaf 
 
Oblong-elliptic, 10.16±20.32 cm × 5.08±7.62 cm, both surfaces glabrous or 
glabrescent except for rusty pubescent midrib, midrib abaxially prominent, 
base obtuse, apex shortly or scarcely obtusely acuminate; petiole 2.12±6.35 
mm 
  
Inflorescence Extra-axillary; peduncle woody, hooked 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. thomsonii Flower 
 
Reddish brown, 1.27±1.9 cm; pedicle 1.27±1.9 cm; sepal broadly ovate, 
4.23 mm, very small, apex acute; petal free, linear, narrow; outer petal 3, 
rather longer, dilated, outside rusty pilose, base concave; inner petal 3, 
trigonous, base concave; stamen minute, sessile or subsessile; connective 
apically dilated; ovary, slightly pilose; ovule 2, erect; stigma various, 
ovate-oblong or laterally dilated 
 
  
Fruit 
 
Monocarp numerous, ellipsoid, 1.27±1.7 cm, nearly glabrous, apex shortly 
acute; stipitate 6.67±12.7 mm  
  
Seed 1 
 
 
  
A. uncinatus 
 
Habit Scandent shrub Wu et al. (1989);  
Zhou and Xu (1994); 
Boukouvalas et al. (1995);  
Xu and Dong (1995);  
Hsieh et al. (1999); 
Hsieh et al. (2001);  
Sambamurty (2005); 
Szpilman et al. (2005); 
Li (2006);  
Vardhana (2006); 
Lan et al. (2007); 
Vardhana (2008); 
Zheng and Xing (2009); 
Gothandam et al. (2010) 
  
Leaf Lanceolate or oblong, 8±15 cm, abaxially pale, adaxially glossy 
  
Inflorescence Peduncle hooked 
  
Flower 
 
Greenish yellow, fragrant; sepal ovate, reflexed, apex acute; petal 2±4 cm, 
pubescent 
  
Fruit Monocarp 6±10, green, obovoid 
  
Seed Oblong, deeply grooved on one side 
 
 
Origin Sri Lanka 
 
 
Distribution Guangdong and Hainan, Southern China;  
Kaohsiung, Southwestern Taiwan; Malay Archipelago;  
Pingtung, Southern Taiwan; Vellore, Tamil Nadu, Southern India 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. uniflorus Habit Woody climber Thongpairoj (2008) 
  
Leaf 
 
Oblong-elliptic, 12±16 cm × 2.5±4 cm, membranous to slightly 
chartaceous, abaxially pubescent, adaxially glabrous except for midrib, 
secondary vein 11±14 on each side of midrib, anastomosing 2±4 mm before 
margin, base acute or obtuse, apex acuminate to caudate; petiole 3±5 mm × 
1 mm 
  
Inflorescence 1-flowered; peduncle rather short compressed, woody, hooked 
  
Flower 
 
Pedicel trigonous, 0.6±0.7 cm, tawny tomentose; sepal triangular, 6±7 mm 
× 5±6 mm, coriaceous, reflexed, outside pubescent, inside glabrous, apex 
caudate; petal green, awl-shaped, very thick and hard; outer petal 
triquetrous, limb subulate, 2 cm × 0.4±0.5 cm, grey pubescent; inner petal 
similar to outer petal but slightly smaller; stamen 84, rather broadly oblong, 
1±1.5 mm, glabrous; connective apically orbicular or convex, pubescent; 
carpel 8±9; ovary ellipsoid, 2±2.5 mm, golden pubescent; ovule 2, basal 
placentation; stigma dark colour, oblong, 1±2 mm, shorter but broader, 
puberulent 
  
Fruit Monocarp 5±12, ovoid, 2±2.4 cm × 1.3±1.5 cm, sessile, glabrous, apex 
acuminate 
  
Seed 2, dark brown, oblong-ellipsoid, 1.4±1.5 cm × 0.7±0.8 cm, plano-convex 
 
 
Origin  Phang Nga and Ranong, Southern Thailand 
 
 
Distribution Tenasserim, Southeastern Burma 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. vanprukii Habit Climber Thongpairoj (2008) 
  
Branch Dark-coloured, rusty pubescent when young 
  
Leaf 
 
Elliptic to obovate, 10±13 cm × 5.5±6 cm, coriaceous, abaxially rusty 
tomentose, adaxially brownish grey and glossy except for puberulent 
midrib, midrib abaxially prominent, venation pinnate, secondary vein 11±
12 on each side of midrib, anastomosing 3±4 mm before margin, margin 
entire, base obtuse, apex abruptly acute; petiole 5±10 mm, inflated, 
pubescent 
  
Inflorescence Extra-axillary, 2-flowered; peduncle hooked 
  
Flower 
 
Sepal triangular, 6 mm × 7 mm; petal 6, green, flat, fleshy; outer petal, 
broadly elliptic, 1.4±2 cm × 1.5 cm, both surfaces pubescent, apex acute to 
obtuse; inner petal smaller than outer petal; stamen oblong to cuneate, 2 
mm; connective apically triangular; carpel glabrous; ovary cylindrical, 
glabrous; ovule 2, basal placentation; stigma cylindrical, glabrous 
 
 
Origin  Lampang, Northern Thailand; Prachuap Khiri Khan, Central Thailand 
 
 
Distribution  Thailand; Vietnam 
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TABLE 2.1 Botanical descriptions of Artabotrys species (continued). 
 
Plant species Botanical description Reference 
    
A. venustus Habit Climber to 25 m tall Cave et al. (1986); 
Triastinurmiatiningsih (2007)   Branch Brown when dry, laterally straight, sparsely pubescent when young, 
lenticellate 
  
Leaf 
 
Yellowish brown when dry, elliptic to oblong, 9±15 cm × 3±6 cm, 
coriaceous, both surfaces glabrous, adaxially glossy, midrib abaxially and 
adaxially prominent, secondary vein 7±9 on each side of midrib, 
anastomosing 4±5 mm before margin, base cuneate, apex shortly 
acuminate; petiole 3±5 mm, sparsely pubescent 
  
Inflorescence 3±5-flowered; peduncle 2, subterete, sparsely pubescent 
  
Flower Pedicel 2±2.5 cm, glabrous; sepal ovate, 3±4 mm × 2±3 mm, erect, 
deflexed, outside tomentose, apex caudate; outer petal greenish yellow, 
oblong, flat, 0.6±1 cm × 0.3±0.5 cm, fleshy, tomentose, apex acute; inner 
petal oblong, flat, 0.6±1 cm × 0.2±0.4 cm, narrower; carpel 6, ovoid, 1±2 
mm × 0.5±1 mm; stigma axe-shaped 
 
 
Distribution  Cameron Highlands, Pahang, and Larut, Perak, Malaysia;  
New Guinea and Sumatra, Indonesia 
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2.1.2 Ethnomedicinal and non-medicinal uses 
 
 Artabotrys species have a long history of traditional use for a wide range of 
medical conditions, particularly malaria (Ranganathan et al. 2012a), scrofula (Lan et 
al. 2007) and cholera (Lal and Singh 2012). Table 2.2 lists the applications of 
Artabotrys species as folk medicines for the treatment of various ailments in different 
countries. According to the habitual remedies practised by local communities, roots 
are the most commonly used plant parts, followed by leaves, stems, flowers and fruits. 
Prior to administration, majority of the plant remedies are prepared as decoction and 
infusion by using single plant parts or in combination with different plant parts or 
species. The utilisation of more than one plant species in the preparation of remedies 
could be attributed to their synergistic effects that they could have during ailment 
treatment (Yineger and Yewhalaw 2007). With respect to the mode of administration, 
most of the preparations are taken orally whereas some are applied topically either as 
bath or massage.  
      
In addition to their medicinal applications, Artabotrys species are employed in 
the manufacture of perfumes due to the fragrance of the flowers (George et al. 2011). 
These aromatic flowers are also used as flavouring agents (Seidemann 2005) as well 
as for making stimulating tea-like beverages (Mishra et al. 2008). Furthermore, both 
leaves and fruits of Artabotrys species are utilised as animal feeds, predominantly for 
cattle (Aguilar 2001), chimpanzees (Moore 1994) and goats (Marble 2012). Other 
non-medicinal uses of different plant parts of Artabotrys species are shown in Table 
2.3. 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species. 
 
Plant species Part used Ethnomedicinal use  Region Reference 
     
A. aurantiacus Not specified Treatment of diabetes Congo Basin Forest, 
DR Congo, 
Central Africa 
Bruno et al. (2013) 
     
A. brachypetalus Roots Remedy for abdominal pains during 
pregnancy (mush; orally) 
Muda, Mozambique,  
Southeastern Africa 
Bruschi et al. (2011) 
   
Remedy for abdominal troubles (mixed with 
roots of Combretum erythrophyllum, 
Cyperus sexangularis and Salix mucronata, 
stems of Phragmites mauritianus, and 
sedges)  
Venda,  
Southern Africa 
Mabogo (1990) 
   
Remedy for asthma and cough Machava  
and Massingir, 
Mozambique,  
Southeastern Africa 
Luo et al. (2011) 
   
Remedy for pelvic pains and stomach 
troubles (decoction with stem bark of 
Parinari curatellifolia subsp. mobola and 
Rauvolfia caffra to prepare soft porridge for 
older people)  
Venda,  
Southern Africa 
Mabogo (1990) 
 
Remedy for women with physical defects 
(mixed with roots of Garcinia livingstonei 
and Heteropyxis natalensis)  
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. brachypetalus Roots Treatment of convulsions (infusion; orally) Malawi,  
Southeastern Africa 
Sobiecki (2002);  
Stafford et al. (2008) 
   
Treatment of female infertility, food 
poisoning, general weakness, intestinal 
worms, snake bites, stomach ache and 
venereal diseases  (maceration; orally) 
Manica, Mozambique,  
Southeastern Africa 
Bruschi et al. (2011) 
   
Treatment of impotence (powdered with 
roots of Garcinia livingstonei and 
Securidaca longipedunculata, and added to 
sorghum beer; orally) 
Venda,  
Southern Africa 
Arnold and Gulumian (1984);  
Mabogo (1990); 
Steenkamp (2003) 
 
Treatment of infertility (maceration with 
roots of Antidesma venosum, Dichrostachys 
cinerea subsp. africana and Zantedeschia 
aethiopica; orally twice daily for one week, 
or decoction with roots of Berchemia 
discolor, Capparis tomentosa, Cassytha 
filiformis, Maerua cafra, Osyris lanceolata, 
Sphedamnocarpus galphimiifolius subsp. 
galphimiifolius and Sphedamnocarpus 
pruriens to prepare soft porridge; orally for 
one week) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. brachypetalus Roots Used as aphrodisiac (mixed with root bark 
of Acacia ataxacantha and Wrightia 
natalensis, and bark of Albizia versicolor)  
Venda,  
Southern Africa 
Mabogo (1990) 
   
Used as aphrodisiac and stimulant (infusion) Southern Africa Abdillahi and Van Staden (2012) 
   
Used to improve health of babies (decoction 
with roots of Cardiogyne africana, Celosia 
spp., Ficus platyphylla and Senna petersiana 
to make tea)  
Maputo, Mozambique,  
Southeastern Africa 
Krog et al. (2006) 
   
8VHG WR NHHS EDE\¶V VWRPDFK LQ JRRG
condition and cleanse the blood (infusion 
with roots of Albizia brevifolia, Annona 
senegalensis, Bauhinia galpinii, Carissa 
edulis, Cassine spp., Crotalaria spp., 
Diospyros lycioides, Hippocratea spp., 
Maytenus senegalensis, Piliostigma 
thonningii, Rhoicissus tridentate, 
Sansevieria hyacinthoides and Terminalia 
sericea, root bark of Ficus sycomorus and 
Syzygium cordatum, bark of Acacia albida 
and Syzygium guineense, and fruits of 
Gardenia volkensii to prepare soft porridge 
for baby)  
Venda,  
Southern Africa 
Mabogo (1990) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. brachypetalus Root bark Treatment of gonorrhoea (concoction) Tanzania,  
Eastern Africa 
Nyandoro et al. (2012) 
     
A. grandifolius Flowers Used as cardiotonic (decoction) Krabi and Pattani,  
Southern Thailand 
Chuakul and  
Soonthornchareonnon (2003);  
Chuakul et al. (2004) 
    
Not specified Treatment after childbirth Jerantut, Pahang, 
Malaysia 
Eswani et al. (2010) 
     
A. hainanensis Not specified Treatment of malaria and scrofula Hainan,  
Southern China 
Han et al. (2005) 
  
Used as analgesic, antidotal, antiphlogistic 
and antipyretic 
Bi et al. (2004);  
Chen et al. (2004) 
     
A. harmandii Roots and stems Used as lactagogue Chaiyaphum  
and Yasothon,  
Northeastern Thailand 
Chuakul and 
Soonthornchareonnon (2003) 
    
Stems Remedy for body pains (decoction; orally) Chanthaburi,  
Eastern Thailand 
Chuakul et al. (2006) 
     
 
 
 
 
 
 
 
44 
 
TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. harmandii Not specified Used to promote lactation in breastfeeding 
women (powdered with Albizia myriophylla, 
Alyxia reinwardtii, Amaranthus spinosus, 
Amomum testaceum, Artemisia annua, 
Cinnamomum porrectum, Cinnamomum 
verum, Cyperus rotundus, Dryobalanops 
aromatica (borneol), Euphorbia hirta, 
Oenanthe stolonifera, Syzygium 
aromaticum, Tarenna hoaensis, Tinospora 
tomentosa, Xantolis cambodiana and 
Zingiber officinale) 
Thailand Luecha and Umehara (2013) 
     
A. hexapetalus 
 
Roots and leaves Remedy for abdominal and kidney pains 
(decoction with roots of Uvaria leptocladon) 
Korogwe, Tanzania,  
Eastern Africa 
Hedberg et al. (1982) 
    
Roots and fruits Treatment of malaria and scrofula Southern China Li et al. (1997);  
Li and Yu (1998); 
Aguilar (2001);  
Yu et al. (2001);  
Wong and Brown (2002);  
Yu et al. (2002);  
Mahidol et al. (2005); 
Schobert and Schlenk (2008);  
Karthik (2010);  
Jayanthi (2011); 
Manjula et al. (2011) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. hexapetalus 
 
Leaves Treatment of cholera (decoction) Hazaribagh, 
Jharkhand,  
Eastern India; 
Malay Archipelago; 
Philippines 
Aguilar (2001);  
Brophy et al. (2004); 
Savadi (2009);  
Karthik (2010); 
Jayanthi (2011); 
Lal and Singh (2012) 
   
Treatment of itching Southern India Dhiman et al. (2012) 
    
Flowers Treatment of bad breath, biliousness, 
bladder diseases, blood and heart diseases, 
headache, itching, leucoderma, sweating, 
thirst and vomiting 
India Aguilar (2001);  
Savadi (2009) 
   
Used as cardiotonic Thailand Chuakul and 
Soonthornchareonnon (2003) 
    
Not specified Used as cardiac stimulant, muscle relaxant 
and uterine stimulant  
Bangalore, Karnataka, 
Southwestern India 
Khare (2008);  
Rajkumar and Rajanna (2011) 
     
A. modestus Roots Remedy for diarrheoa and stomach ache 
(decoction) 
Kenya and Tanzania, 
Eastern Africa 
Kokwaro (2009);  
Nyandoro et al. (2012) 
   
Remedy for spiritual ailments (decoction) Duruma, Kenya, 
Eastern Africa 
Pakia (2000) 
   
Remedy for stomach ache Tanzania,  
Eastern Africa 
Burgess et al. (2000) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. modestus Leaves Treatment of nausea and vomiting (infusion) Kenya and Tanzania, 
Eastern Africa 
Kokwaro (2009); 
Nyandoro et al. (2012) 
     
A. monteiroae Roots Remedy for backache, diarrhoea and 
stomach ache (decoction) 
Kenya, Eastern Africa Kato et al. (1993) 
    
Roots and bark Treatment of malaria (decoction; orally) Tanzania,  
Eastern Africa 
Fowler (2011) 
   
Leaves Treatment of malaria (decoction; bathing)  
     
A. oblanceolatus Roots and stems Used as lactagogue Chaiyaphum,  
Northeastern Thailand 
Chuakul and 
Soonthornchareonnon (2003) 
     
A. odoratissimus 
 
Roots Treatment of malaria Thiruvannamalai,  
Tamil Nadu,  
Southern India 
Ranganathan et al. (2012a); 
Ranganathan et al. (2012b); 
Senthilkumar et al. (2014) 
     
 Roots and fruits Treatment of malaria and scrofula China Bordoloi et al. (2009);  
Gupta et al. (2010) 
     
 Stems Treatment of malaria Kandal, Combodia Hout et al. (2006) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. odoratissimus 
 
Leaves  Treatment of cholera (decoction) Malay Archipelago; 
Malwa, Central India; 
Thiruvannamalai,  
Tamil Nadu,  
Southern India 
Pardo De Tavera (1901);  
Hasan et al. (1987);  
Garg and Siddiqui (1998);  
Sharma et al. (2002);  
Singh et al. (2005);  
Bourcet et al. (2008);  
Srivastava et al. (2009); 
Ranganathan et al. (2012a); 
Ranganathan et al. (2012b); 
Senthilkumar et al. (2014) 
     
 Flowers  Treatment of bad breath, biliousness, 
bladder diseases, blood and heart diseases, 
headache, itching, leucoderma, sweating, 
thirst and vomiting 
India  Garg and Siddiqui (1998);  
Sharma et al. (2002);  
Singh et al. (2009) 
     
 Fruits Treatment of topical fungal infection Assam,  
Northeastern India 
Bordoloi et al. (2009); 
Jayanthi (2011) 
     
 Not specified Used as emmenagogue and stimulant Malay Archipelago Pardo De Tavera (1901) 
     
A. pallens  Stem woods Treatment of gastritis (decoction with 
parasitic plant of Buab lum and whole plant 
of Mak dai bai; orally) 
Bolikhamsai, Laos Libman et al. (2006) 
     
A. pilosus  Root, stems and 
leaves 
Treatment of malaria and scrofula Hainan,  
Southern China 
Wang (2010) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. rhopalocarpus Saps  Used as aphrodisiac (orally) Mount Cameroon,  
Central Africa 
Focho et al. (2010);  
Bele et al. (2011) 
     
A. siamensis  Flowers Used as cardiotonic Thailand Chuakul and 
Soonthornchareonnon (2003) 
     
A. spinosus  Stem bark Remedy for venereal diseases Ubon Ratchathani, 
Northeastern Thailand 
Chuakul and 
Soonthornchareonnon (2003) 
     
A. stenopetalus Saps Used as aphrodisiac Zaire, Central Africa Fleischer et al. (1997) 
  
Twigs Used as part of a prescription for the 
promotion of conception 
  
Leaves Treatment of enlarged spleen (orally) 
     
A. suaveolens Roots and bark Used as emmenagogue, and to relieve 
fatigue after childbirth (decoction; orally)  
Philippines Aguilar (2001);  
Wiart (2006) 
     
 Leaves Treatment of cholera (decoction or infusion; 
orally) 
India; Java, Indonesia Pardo De Tavera (1901);  
Maranon (1929);  
Aguilar (2001);  
Wiart (2006) 
     
A. taynguyenensis Not specified Treatment of fever and inflammation Vietnam Thang et al. (2014) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
A. uncinatus Roots Treatment of malaria Southern China; 
Taiwan 
Wu et al. (1989);  
Zhou and Xu (1994);  
Boukouvalas et al. (1995);  
Xu and Dong (1995);  
Hsieh et al. (1999);  
Szpilman et al. (2005);  
Lan et al. (2007); 
Dewick (2011); 
Nyandoro et al. (2012) 
    
Bark Remedy for gastrointestinal diseases 
(toasted; massaging) 
Hainan,  
Southern China 
Zheng and Xing (2009) 
    
Leaves Treatment of cholera (decoction) Malay Archipelago Vardhana (2008) 
    
Fruits Treatment of scrofula Southern Taiwan Hsieh et al. (1999);  
Lan et al. (2007) 
    
Whole plant Treatment of hepatocarcinoma Taiwan Li (2006) 
    
Not specified Treatment of glandular swellings Taiwan Nyandoro et al. (2012) 
  
Treatment of nasopharyngeal carcinoma Hsieh et al. (2001) 
     
A. zeylanicus Flowers  Treatment of vomiting (decoction) Kerala,  
Southwestern India 
Yesodharan and Sujana (2007) 
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TABLE 2.2 Ethnomedicinal uses of Artabotrys species (continued). 
 
Plant species Part used Ethnomedicinal use Region Reference 
     
Artabotrys sp. Roots Remedy for constipation and joint pains 
(decoction; orally) 
Gombak, Selangor, 
Malaysia 
Azliza et al. (2012) 
    
Not specified Treatment of open sores Chiang Rai,  
Northern Thailand 
Anderson (1986) 
     
  Used as stimulant Madagascar Sobiecki (2002) 
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TABLE 2.3 Non-medicinal uses of Artabotrys species. 
 
Plant species Part used Non-medicinal use Region Reference 
     
A. brachypetalus Stems Used for roof and courtyard wall 
construction 
Venda,  
Southern Africa 
Mabogo (1990) 
    
Fruits Used for beverage making Limpopo,  
Southern Africa 
Rampedi (2010) 
    
Woods Used to make household utensils and music 
instruments 
Mutare, Zimbabwe,  
Southern Africa 
Grundy et al. (1993) 
    
Not specified Used as feeds for goats Inhambane, 
Mozambique,  
Southeastern Africa 
Marble (2012) 
    
A. hexapetalus Flowers Used as flavouring in tea Southern India;  
Sri Lanka 
Seidemann (2005) 
   
Used in perfumery as the source of essential 
oils 
Salem, Tamil Nadu, 
Southern India; 
Aguilar (2001); 
Mishra et al. (2008) 
   
Used to prepare stimulating tea-like 
beverages 
  
    
Whole plant Used as ornamental plants Jajpur, Odisha, 
Southeastern India 
Mohanty et al. (2012) 
   
Used for screen planting in large gardens Java, Indonesia; 
Philippines; 
Southern China 
Aguilar (2001) 
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TABLE 2.3 Non-medicinal uses of Artabotrys species (continued). 
 
Plant species Part used Non-medicinal use Region Reference 
     
A. hexapetalus Not specified Used as hair lotion Thoubal, Manipur, 
Northeastern India 
Devi et al. (2014) 
     
A. monteiroae Fruits Used as feeds for chimpanzees Mahale Mountains 
and Ugalla, Tanzania,  
Eastern Africa 
Nishida and Uehara (1983); 
Moore (1994) 
     
A. odoratissimus Flowers Used in perfumery as the source of essential 
oils 
Coimbatore,  
Tamil Nadu,  
Southern India 
George et al. (2011) 
     
A. scytophyllus Flowers Used as flavouring and spices for sauces Madagascar; 
Southeastern Asia 
Seidemann (2005) 
     
A. speciosus Fruits Used to make head and neck garlands Andaman Islands Saxena et al. (2003) 
     
A. suaveolens Stems Used as water substitutes Kuala Pilah,  
Negeri Sembilan, 
Malaysia 
Ong et al. (2011) 
    
Leaves Used as feeds for cattle  Bali, Indonesia Aguilar (2001) 
    
Whole plant Used as living fences    
     
A. taynguyenensis Not specified Used as flavouring Vietnam Thang et al. (2014) 
     
A. thomsonii Stem saps Used as water substitutes Tshopo, DR Congo, 
Central Africa 
Termote et al. (2011) 
     
A. uncinatus Flowers  Used to scent oil Tonga Weiner (1971) 
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2.1.3 Chemical constituents 
 
To date, more than 200 chemical constituents have been identified and isolated 
from the genus Artabotrys, including 68 alkaloids (Hsieh et al. 2001), 28 phenolic 
compounds (Savadi 2009), 67 terpenoids (Fournier et al. 1997) and 40 other related 
compounds (Mahidol et al. 2005). The names and structures of these compounds, as 
well as their corresponding plant sources are given in Table 2.4±2.7. 
 
Alkaloids are a group of natural organic compounds that contain mostly basic 
nitrogen atoms in a heterocyclic ring (Li et al. 2013). The majority of the alkaloids 
found in Artabotrys species are aporphinoids, with anonaine (Sagen et al. 2003), 
asimilobine (Han et al. 2005), atherospermidine (Lan et al. 2007) and norstephalagine 
(Sharma et al. 2002) being isolated as the predominant compounds.   
 
Phenolic compounds are a class of chemical compounds that consist of one or 
more hydroxyl groups attached directly to an aromatic ring (Enache and Oliveira-
Brett 2011). Flavonoids constitute the main group of phenolic compounds occurring 
in Artabotrys species, with catechin (Nyandoro et al. 2012) being the most abundant 
compound obtained.     
 
Terpenoids are a large and diverse group of naturally occurring organic 
chemicals derived from five-carbon isoprene units assembled and modified in 
numerous ways (Meng et al. 2013). Most of the terpenoids present in Artabotrys 
species are sesquiterpenoids, with caryophyllene oxide (Phan et al. 2007) and 
spathulenol (Trang et al. 2014) being identified as the major components.   
54 
 
TABLE 2.4 Occurrence of alkaloids in Artabotrys species. 
 
Compound Structure Plant species Plant part Reference 
     
BUTENOLIDE ALKALOID 
     
Uncinine 
 
A. uncinatus Leaves Hsieh et al. (2001) 
  
Whole plant Li (2006) 
     
PYRROLIDINE ALKALOID 
     
Squamolone 
 
A. uncinatus Stems Hsieh et al. (2001) 
  
Whole plant Li (2006) 
     
TROPANE ALKALOID 
     
Artamodamide 
 
A. modestus Root bark Nyandoro et al. (2012) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
BENZYLTETRAHYDROISOQUINOLINE 
     
Armepavine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
     
Isococlaurine 
 
A. hainanensis Stems Han et al. (2005) 
     
Juzirine 
 
A. hainanensis Stems Han et al. (2005) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Laudanine 
 
A. modestus Root bark Nyandoro et al. (2012) 
   
     
N-demethylarmepavine 
 
A. hainanensis Stems Han et al. (2005) 
     
N-methylcoclaurine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
   
A. odoratissimus Stem bark Sharma et al. (2002)  
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Norjuziphine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
     
Reticuline 
 
A. monteiroae Roots  Kato et al. (1993) 
   
A. uncinatus Leaves, roots 
and stems 
Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Kam (1999) 
     
TETRAHYDROPROTOBERBERINE 
     
10-O-demethyldiscretine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
   
A. uncinatus Roots Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artavenustine 
 
A. uncinatus  Stems Lan et al. (2007) 
   
A. venustus Stem bark Cave et al. (1986); 
Teo et al. (1990); 
Kam (1999) 
     
Discretamine 
 
A. maingayi Bark Cortes et al. (1990); 
Teo et al. (1990); 
Kam (1999) 
   
A. venustus Stem bark Cave et al. (1986); 
Kam (1999) 
     
Discretine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Spinosine 
 
A. hainanensis Stems Han et al. (2005) 
     
Xylopinine 
 
A. grandifolius Stems Chan et al. (1987);  
Teo et al. (1990); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
PROAPORPHINE 
     
Stepharine 
 
A. uncinatus Fruits  Hsieh et al. (1999) 
  
Leaves, roots 
and stems 
Hsieh et al. (2001) 
     
APORPHINOID 
     
Aporphine 
     
3-Hydroxynornuciferine 
 
A. hainanensis Stems Han et al. (2005) 
   
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Anonaine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
   
A. madagascariensis Not specified Maranon (1929) 
   
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
   
A. monteiroae Roots  Kato et al. (1993) 
   
A. odoratissimus Stem bark Sharma et al. (2002)  
   
A. uncinatus Fruits  Hsieh et al. (1999) 
  
Leaves, roots 
and stems 
Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
Artabotrinine 
 
A. suaveolens Bark Barger and Sargent (1939); 
Leboeuf et al. (1982) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Asimilobine 
 
A. brachypetalus Stem bark Sagen et al. (2003) 
   
A. hainanensis Stems Han et al. (2005) 
   
A. monteiroae Roots  Kato et al. (1993) 
   
A. odoratissimus Stem bark Sharma et al. (2002); 
Savadi (2009)  
   
A. uncinatus Fruits  Hsieh et al. (1999) 
  
Leaves, roots 
and stems 
Hsieh et al. (2001) 
  
Stems Lan et al. (2007) 
   
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
Cissaglaberrimine 
 
A. uncinatus Leaves and 
stems 
Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Glaucine 
 
A. lastourvillensis Bark Eloumi-Ropivia et al. (1984); 
Eloumi-Ropivia et al. (1985); 
Cave et al. (1986); 
Guinaudeau et al. (1988) 
     
Isocorydine 
 
A. uncinatus  Roots Hsieh et al. (2001) 
     
Isopiline 
 
A. odoratissimus Stem bark Sharma et al. (2002)  
   
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Lastourvilline 
 
A. lastourvillensis Bark Eloumi-Ropivia et al. (1985);  
Cave et al. (1986); 
Guinaudeau et al. (1988) 
     
Lirinidine 
 
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
N-acetylnorstephalagine 
 
A. uncinatus Roots Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
N-methylisopiline 
 
A. uncinatus Stems Hsieh et al. (2001) 
     
Norcorydine 
 
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
Norisoboldine 
 
A. monteiroae Roots  Kato et al. (1993) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Norisocorydine 
 
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
     
Nornuciferine 
 
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
   
A. uncinatus Leaves and 
roots 
Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Norstephalagine 
 
A. grandifolius Stems Chan et al. (1987);  
Teo et al. (1990); 
Kam (1999) 
   
A. maingayi Bark Cortes et al. (1990); 
Teo et al. (1990); 
Kam (1999) 
   
A. odoratissimus Stem bark Sharma et al. (2002) 
   
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
Nuciferine 
 
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
O-methyl-N-norlirinine 
 
A. uncinatus Stems Hsieh et al. (2001) 
     
Roemerine 
 
A. uncinatus Stems Hsieh et al. (2001) 
     
Stephalagine 
 
A. uncinatus Stems Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Suaveoline 
 
A. suaveolens Bark Barger and Sargent (1939);  
Leboeuf et al. (1982); 
Teo et al. (1990) 
     
Wilsonirine 
 
A. monteiroae Roots  Kato et al. (1993) 
     
 
 
 
 
 
 
 
 
 
70 
 
TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
7-Hydroxyaporphine 
     
Artabonatine B 
 
A. uncinatus Fruits  Hsieh et al. (1999) 
     
Norushinsunine 
 
A. uncinatus Fruits  Hsieh et al. (1999) 
  
Roots Hsieh et al. (2001) 
   
A. venustus Stem bark Cave et al. (1986); 
Guinaudeau et al. (1988); 
Kam (1999) 
     
Ushinsunine 
 
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
5-Oxoaporphine 
     
Artamonteirine 
 
A. monteiroae Stem bark Nyandoro et al. (2012) 
     
7-Oxoaporphine 
     
Artabonatine C 
 
 
A. spinosus Roots  Sichaem et al. (2011) 
   
A. uncinatus Stems Hsieh et al. (2001) 
  
Whole plant Li (2006) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artabonatine D 
 
A. uncinatus Stems Hsieh et al. (2001) 
  
Whole plant Li (2006) 
     
Atherospermidine 
 
A. grandifolius Stems Chan et al. (1987);  
Teo et al. (1990); Kam (1999) 
   
A. maingayi Bark Cortes et al. (1990); 
Teo et al. (1990); Kam (1999) 
   
A. odoratissimus Stem bark Sharma et al. (2002)  
   
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
  
Stems Lan et al. (2007) 
  
Stems and 
stem bark 
Wu et al. (1989);  
Wiart (2006) 
  
Whole plant Li (2006) 
   
A. zeylanicus Stem bark Wijeratne et al. (1995); 
Wijeratne et al. (1996) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Lanuginosine 
 
A. zeylanicus Stem bark Wijeratne et al. (1996) 
     
Liridine 
 
A. hainanensis Stems Han et al. (2005) 
   
A. odoratissimus Stem bark Sharma et al. (2002)  
   
A. spinosus Roots  Sichaem et al. (2011) 
   
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Liriodenine 
 
A. grandifolius Stems Chan et al. (1987);  
Teo et al. (1990); 
Kam (1999) 
   
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
   
A. uncinatus Fruits  Hsieh et al. (1999) 
  
Leaves, roots 
and stems 
Hsieh et al. (2001) 
  
Stems Lan et al. (2007) 
  
Stems and 
stem bark 
Wu et al. (1989);  
Wiart (2006) 
   
A. zeylanicus Stem bark Wijeratne et al. (1996) 
     
Lysicamine 
 
A. maingayi Bark Cortes et al. (1990); 
Kam (1999) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Oxoasimilobine 
 
A. uncinatus Leaves Hsieh et al. (2001) 
     
Oxobuxifoline 
 
A. zeylanicus Stem bark Wijeratne et al. (1996) 
     
Oxocrebanine 
 
A. zeylanicus Stem bark Wijeratne et al. (1996) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
11-Oxoaporphine 
     
Artacinatine 
 
A. spinosus Roots  Sichaem et al. (2011) 
   
A. uncinatus  Stems Hsieh et al. (2001); 
Lan et al. (2007) 
  
Stems and 
stem bark 
Wu et al. (1989) 
     
4,5-Dioxoaporphine 
     
8-Methoxyouregidione 
 
A. zeylanicus Stem bark Wijeratne et al. (1996) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
4,5-Dioxoartacinatine 
 
A. uncinatus  Stems Lan et al. (2007) 
     
Artabotrine 
 
A. hainanensis Stems Han et al. (2005) 
   
A. stenopetalus Stem bark Fleischer et al. (1997) 
   
A. suaveolens Roots and stem 
bark 
Maranon (1929); 
Barger and Sargent (1939);  
Leboeuf et al. (1982) 
   
A. zeylanicus Stem bark Wijeratne et al. (1995); 
Wijeratne et al. (1996); 
Ding et al. (2006);  
Wiart (2006) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Ouregidione 
 
A. zeylanicus Stem bark Wijeratne et al. (1996) 
     
Oxazoloaporphine 
     
Artabonatine A 
 
A. uncinatus Fruits  Hsieh et al. (1999) 
     
Artabonatine E 
 
A. uncinatus Roots Hsieh et al. (2001) 
  
Whole plant Li (2006) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     ¶-Bisdehydroaporphine 
     
Artabonatine F 
 
A. uncinatus Roots Hsieh et al. (2001) 
  
Whole plant Li (2006) 
     
Artabotrysine 
 
A. spinosus Roots  Sichaem et al. (2011) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Bidebiline A 
 
A. spinosus Roots  Sichaem et al. (2011) 
     
MORPHINANDIENONE ALKALOID 
     
Flavinantine 
 
A. uncinatus Roots and 
stems 
Hsieh et al. (2001) 
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TABLE 2.4 Occurrence of alkaloids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Salutaridine 
 
A. uncinatus Leaves, roots 
and stems 
Hsieh et al. (2001) 
     
PROTOALKALOID 
     
Paprazine 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species. 
 
Compound Structure Plant species Plant part Reference 
     
PHENOLIC ACID 
     
Gallic acid 
 
A. hexapetalus Leaves Savadi (2009) 
     
XANTHONOID 
     
Mangiferin 
 
A. hainanensis Leaves Chen et al. (2004) 
     
ANTHRAQUINONE 
     
1-Hydroxy-2,5-
dimethoxy-9,10-
anthraquinone 
 
A. odoratissimus Leaves  Singh et al. (2005) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
1,4,5-Trihydroxy-9,10-
anthraquinone 
 
A. odoratissimus Leaves  Singh et al. (2005) 
     
FLAVONOID 
     
Flavone 
     
5-Hydroxy-¶-
dimethoxyflavone 
 
A. uncinatus  Stems Lan et al. (2007) 
     
Apigenin 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Apigetrin 
(Apigenin 7-O-ȕ-D-
glucopyranoside) 
 
A. hexapetalus Leaves Somanawat et al. (2012) 
     
Apiin  
[Apigenin 7-O-ȕ-D-
apiosyl-ĺ-ȕ-D-
glucopyranoside] 
 
A. hexapetalus Leaves Li et al. (1997);  
Li and Yu (1998); 
Yu et al. (2002); 
Savadi (2009) 
     
Luteolin 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Cynaroside 
(Luteolin 7-O-ȕ-D-
glucopyranoside) 
 
A. hexapetalus Leaves Li et al. (1997);  
Li and Yu (1998); 
Yu et al. (2002); 
Savadi (2009) 
     
Flavonol 
     
Kaempferol 
 
A. hexapetalus Leaves Savadi (2009) 
     
Artabotryside B 
[Kaempferol 3-O-Į-L-
rhamnopyranosyl-ĺ- 
Į-L-arabinofuranoside] 
 
A. hexapetalus Leaves Li et al. (1997);  
Li and Yu (1998); 
Yu et al. (2002); 
Savadi (2009) 
   
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Myricetin 
 
A. hexapetalus Leaves Savadi (2009) 
     
Quercetin 
 
A. hexapetalus Leaves Savadi (2009) 
     
Guaijaverin 
(Quercetin 3-O-Į-L-
arabinopyranoside) 
 
A. hexapetalus Leaves Savadi (2009) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Hyperoside 
(Quercetin 3-O-ȕ-D-
galactopyranoside) 
 
A. hexapetalus Leaves Savadi (2009) 
     
Isoquercetin  
(Quercetin 3-O-ȕ-D-
glucopyranoside) 
 
A. hexapetalus Leaves Savadi (2009) 
     
Artabotryside A 
[Quercetin 3-O-Į-L-
rhamnopyranosyl-ĺ- 
Į-L-arabinofuranoside] 
 
A. hexapetalus Leaves Li et al. (1997);  
Li and Yu (1998); 
Yu et al. (2002); 
Savadi (2009); 
Somanawat et al. (2012) 
   
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Rutin 
[Quercetin 3-O-Į-L-
rhamnopyranosyl-ĺ-
ȕ-D-glucopyranoside] 
 
A. hexapetalus Leaves Somanawat et al. (2012) 
     
Quercetin 3-O-Į-L-
rhampyranosyl rutinoside 
[Quercetin 3-O-Į-L-
rhamnopyranosyl-ĺ-
O-Į-L-rhamnopyranosyl-
ĺ-ȕ-D-
glucopyranoside] 
 
A. hexapetalus Leaves Somanawat et al. (2012) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Flavanonol 
     
Taxifolin 
 
A. hexapetalus Leaves Li et al. (1997);  
Li and Yu (1998); 
Yu et al. (2002); 
Savadi (2009) 
     
Flavanol 
     
Catechin 
 
A. hainanensis Leaves Chen et al. (2004) 
   
A. modestus Stem bark Nyandoro et al. (2012) 
   
A. uncinatus  Stems Lan et al. (2007) 
     
 
 
 
 
 
 
 
90 
 
TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
ISOFLAVONOID 
     
Medicarpin 
 
A. odoratissimus Seeds Singh et al. (2009) 
 
    
LIGNAN 
     
Americanin B 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artabotrycinol 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
     
Isoamericanin A 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
     
Isoamericanol A 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
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TABLE 2.5 Occurrence of phenolic compounds in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Syringaresinol 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species. 
 
Compound Structure Plant species Plant part Reference 
     
HEMITERPENOID 
     
Artabotriol 
 
 
A. hexapetalus 
 
Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
   
A. modestus Stem bark Nyandoro et al. (2012) 
     
MONOTERPENOID 
     
Acyclic 
     
Linalool 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
   
A. odoratissimus Leaves Garg and Siddiqui (1999) 
     
Monocyclic 
     
3,5-Dimethoxy carvacrol 
 
A. brachypetalus Stem bark Odebode et al. (2006) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Į-Phellandrene 
 
A. pallens Leaves Trang et al. (2014) 
 
    
Limonene 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
     
Terpinen-4-ol 
 
A. odoratissimus Leaves Garg and Siddiqui (1999) 
     
Bicyclic 
     
Į-Pinene 
 
A. taynguyenensis Leaves Trang et al. (2014) 
   
A. vinhensis Leaves Trang et al. (2014) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
ȕ-Pinene 
 
A. vinhensis Leaves Trang et al. (2014) 
 
    
Camphene 
 
A. insignis Root bark and 
stem bark 
Fournier et al. (1997) 
   
A. thomsonii Stem bark Fournier et al. (1997) 
   
A. venustus Stem bark Fournier et al. (1997) 
     
SESQUITERPENOID 
     
Monocyclic 
     
ȕ-Elemene 
 
A. lastourvillensis Bark Fournier et al. (1997) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Ȗ-Elemene 
 
A. hongkongensis Leaves Trang et al. (2014) 
 
    
Germacrene B 
 
A. vinhensis Leaves Trang et al. (2014) 
 
    
Germacrene D 
 
A. vinhensis Leaves Trang et al. (2014) 
 
    
Humulene 
Į-Caryophyllene) 
 
A. hexapetalus Aerial parts Wong and Brown (2002) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Yingzhaosu A 
 
A. uncinatus Roots Hedberg et al. (1982); 
Leboeuf et al. (1982); 
Lee and Hufford (1990); 
Zhou and Xu (1994); 
Boukouvalas et al. (1995);   
Xu and Dong (1995); 
Szpilman et al. (2005); 
Dewick (2011) 
     
Yingzhaosu B 
 
A. uncinatus Roots Hedberg et al. (1982); 
Leboeuf et al. (1982); 
Xu and Dong (1995) 
     
Yingzhaosu C 
 
A. uncinatus Not specified Boukouvalas et al. (1995);  
Xu and Dong (1995); 
Dewick (2011) 
     
Yingzhaosu D 
 
A. uncinatus Not specified Xu and Dong (1995) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Bicyclic 
     
1,5-Epoxysalvial-4(14)-
ene 
 
A. insignis Root bark and 
stem bark 
Fournier et al. (1997) 
   
A. rufus Root bark Fournier et al. (1997) 
   
A. thomsonii Stem bark Fournier et al. (1997) 
   
A. venustus Stem bark Fournier et al. (1997) 
     
Į-Muurolene 
 
A. taynguyenensis Leaves Trang et al. (2014) 
 
    
Artabotrol 
 
A. stenopetalus Stem bark Fleischer et al. (1997) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
ȕ-Caryophyllene 
 
A. hexapetalus Aerial parts Wong and Brown (2002) 
   
 Flowers Mahidol et al. (2005); 
Phan et al. (2007); 
Trang et al. (2014) 
   
A. hongkongensis Leaves Trang et al. (2014) 
   
A. rufus Root bark Fournier et al. (1997) 
   
A. vinhensis Leaves Trang et al. (2014) 
     
ȕ-Guaiene 
 
A. lastourvillensis Bark Fournier et al. (1997) 
     
Bicycloelemene 
 
A. pallens Leaves Trang et al. (2014) 
   
A. taynguyenensis Stems Trang et al. (2014) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Bicyclogermacrene 
 
A. taynguyenensis Stems Trang et al. (2014) 
 
    
Cadalene 
 
A. lastourvillensis Bark Fournier et al. (1997) 
   
A. pierreanus Stem bark Fournier et al. (1997) 
     
Caryophyllene oxide 
 
A. hexapetalus Aerial parts Wong and Brown (2002) 
   
 Flowers Phan et al. (2007) 
   
A. insignis Root bark Fournier et al. (1997) 
   
A. lastourvillensis Bark Fournier et al. (1997) 
   
A. odoratissimus Leaves Garg and Siddiqui (1999) 
   
A. pierreanus Stem bark Fournier et al. (1997) 
   
A. rufus Root bark Fournier et al. (1997) 
   
A. stenopetalus Stem bark Fleischer et al. (1997) 
   
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Caryophyllenol 
 
A. insignis Root bark Fournier et al. (1997) 
   
A. rufus Root bark Fournier et al. (1997) 
     
į-Cadinene 
 
A. hongkongensis Leaves Trang et al. (2014) 
 
    
į-Cadinol 
 
A. insignis Root bark Fournier et al. (1997) 
     
į-Selinene 
 
A. taynguyenensis Leaves Trang et al. (2014) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Karatavin 
 
A. modestus Stem bark Nyandoro et al. (2012) 
     
Pogostol O-methyl ether 
 
A. stenopetalus Stem bark Fleischer et al. (1997); 
Booker-Milburn et al. (2003) 
     
Valencene 
 
A. taynguyenensis Leaves Trang et al. (2014) 
 
    
Widdrol 
 
A. insignis Stem bark Fournier et al. (1997) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Tricyclic 
     
1-Methoxy-9-caryolanol 
 
A. uncinatus  Stems Lan et al. (2007) 
     
ȕ-hydroxy-Į-
methoxyaromadendrane 
 
A. uncinatus  Stems Lan et al. (2007) 
     
Į-Copaen-11-ol 
 
A. rufus Root bark Fournier et al. (1997) 
     
Į-Gurjunene 
 
A. pallens Leaves Trang et al. (2014) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Į-Panasinsene 
 
A. taynguyenensis Leaves Trang et al. (2014) 
 
    
ȕ-Gurjunene 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
     
Caryolane-ȕ-diol 
 
A. uncinatus  Stems Lan et al. (2007) 
     
Cloven-ȕĮ-diol 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Cyperene 
 
A. lastourvillensis Bark Fournier et al. (1997) 
   
A. pierreanus Stem bark Fournier et al. (1997) 
     
Cyperenone 
 
A. lastourvillensis Bark Fournier et al. (1997) 
   
A. pierreanus Stem bark Fournier et al. (1997) 
   
A. thomsonii Stem bark Fournier et al. (1997) 
     
Globulol 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
   
A. venustus Stem bark Fournier et al. (1997) 
     
Palustrol 
 
A. thomsonii Stem bark Fournier et al. (1997) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Spathulenol 
 
A. odoratissimus Stem bark Sharma et al. (2002)  
   
A. hongkongensis Leaves Trang et al. (2014) 
   
A. taynguyenensis Stems Trang et al. (2014) 
   
A. thomsonii Stem bark Fournier et al. (1997) 
   
A. uncinatus  Stems Lan et al. (2007) 
     
DITERPENOID 
     
Phytol 
 
A. uncinatus  Stems Lan et al. (2007) 
     
TRITERPENOID 
     
24-Methylene-lanosta-
7,9(11)-dien-ȕ-ol 
 
A. modestus Root bark and  
stem bark 
Nyandoro et al. (2012) 
   
A. odoratissimus Stem bark Hasan et al. (1987); 
Singh et al. (2005); 
Savadi (2009); 
Kaisar et al. (2011) 
   
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
24-Methylene-lanosta-
7,9(11)-diene-3-one 
 
A. uncinatus  Stems Lan et al. (2007) 
     
ȕ-Hydroxy-stigmasta-4-en-3,6-dione-methoxy ester 
 
A. odoratissimus Leaves Khaleel et al. (2014) 
 
    
 
 
 
 
 
 
108 
 
TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Į-Hydroxysitosterol 
 [(24R)-stigmasta-5-en-
ȕĮ-diol] 
 
A. uncinatus  Stems Lan et al. (2007) 
     
Į-Hydroxystigmasterol 
[(22E,24S)-stigmasta-
5,22-dien-ȕĮ-diol] 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artabotryol A 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
     
Artabotryol B 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artabotryol C1 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
     
Artabotryol C2 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
     
 
 
 
 
 
111 
 
TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artabotryol D 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
     
Artabotryol E 
 
A. odoratissimus Seeds  Gupta et al. (2010) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
ȕ-Sitosterol 
(Stigmasta-5-en-ȕ-ol) 
 
A. hainanensis Leaves Chen et al. (2004) 
   
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
   
A. odoratissimus Fruits Singh et al. (2005) 
  
Stem bark Sharma et al. (2002); 
Savadi (2009)  
   
A. suaveolens Not specified Teo et al. (1990) 
   
A. uncinatus  Stems Lan et al. (2007) 
     
Daucosterol 
ȕ-Sitosterol 3-O-ȕ-D- 
glucopyranoside) 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
   
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Polycarpol 
 
A. madagascariensis Fruits and 
leaves 
Murphy (2007); 
Murphy et al. (2008) 
   
A. modestus Stem bark Nyandoro et al. (2012) 
   
A. monteiroae Stem bark Nyandoro et al. (2012) 
   
A. spinosus Roots  Sichaem et al. (2011) 
   
A. suaveolens Not specified Teo et al. (1990) 
     
Stigmasterol 
(Stigmasta-5,22-dien-ȕ-
ol) 
 
A. odoratissimus Stem bark Sharma et al. (2002); 
Savadi (2009)  
   
A. uncinatus  Stems Lan et al. (2007) 
     
Stigmasterol 3-O-ȕ-D-
glucopyranoside 
 
A. uncinatus  Stems Lan et al. (2007) 
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TABLE 2.6 Occurrence of terpenoids in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
TETRATERPENOID 
     
Lutein                                                                                                           A. hexapetalus 
 
Aerial parts Wong and Brown (2002) 
     
NORTERPENOID 
     
7E-9-hydroxy-4,7-
megastigmane-3-one-10-
O-ȕ-D-glucopyranoside 
 
A. hexapetalus Leaves Somanawat et al. (2012) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species. 
 
Compound Structure Plant species Plant part Reference 
     
ALCOHOL 
     
Monohydric  
     
2-Hydroxytricontane 
 
A. odoratissimus Leaves Mehta et al. (1999) 
 
    
2-Methyl-1-butanol 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
2-Phenylethanol 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
     
3-Methyl-1-butanol 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Pentatetracontan-19-ol 
 
A. odoratissimus Leaves Mehta et al. (1999) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Polyhydric 
     
Cyclohexane-1,2,4,5-tetrol 
 
A. modestus Root bark Nyandoro et al. (2012) 
     
Quebrachitol 
 
A. modestus Stem bark Nyandoro et al. (2012) 
     
ALKENE 
     
Dotriacont-7-ene 
 
A. odoratissimus Leaves Sharma et al. (2002) 
 
    
Tetratriacont-10,19-diene 
 
A. odoratissimus Leaves Sharma et al. (2002) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
CARBOXYLIC ACID 
     
Docosanoic acid 
 
A. odoratissimus Seeds Singh et al. (2009) 
     
Fumaric acid 
 
A. hexapetalus Leaves Li and Yu (1998) 
     
Nonanoic acid 
 
A. odoratissimus Leaves Sharma et al. (2002); 
Srivastava et al. (2009) 
 
    
Palmitic acid 
 
A. hexapetalus Seeds Yu et al. (2001);  
Yu et al. (2002); 
Savadi (2009) 
     
Succinic acid 
 
A. hexapetalus Leaves Li and Yu (1998) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
ESTER 
     
2-Methylbutyl acetate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
   
A. vinhensis Leaves Trang et al. (2014) 
     
Artabotrol A 
 
A. madagascariensis Fruits and 
leaves 
Murphy (2007); 
Murphy et al. (2008) 
     
Benzyl benzoate 
 
A. odoratissimus Stem bark Sharma et al. (2002); 
Savadi (2009)  
   
A. vinhensis Leaves Trang et al. (2014) 
 
    
Ethyl 2-methylbutanoate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
     
Ethyl 3-methyl-2-
butenoate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Ethyl acetate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Ethyl butanoate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Ethyl isobutanoate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Ethyl isovalerate 
(Ethyl 3-methylbutanoate) 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
     
Isobutyl acetate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Isobutyl isovalerate 
(Isobutyl 3-
methylbutanoate) 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
 
    
Isopentyl acetate 
 
A. hexapetalus Flowers Mahidol et al. (2005) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Nonacosanoic acid ¶¶-
dihydroxypropyl ester 
 
A. odoratissimus Seeds Singh et al. (2009) 
 
    
Nonacosanyl 
hexacosanoate 
 
A. odoratissimus Leaves Mehta et al. (1999) 
 
    
Pentacosanoic acid 2,-¶-
dihydroxypropyl ester 
 
A. odoratissimus Seeds Singh et al. (2009) 
 
    
Pentadecyl 6-
hydroxydodecanoate 
 
A. odoratissimus Leaves Bourcet et al. (2008) 
     
KETONE 
     
Artamenone 
 
A. modestus Stem bark Nyandoro et al. (2012) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
LACTONE 
     
(2R,3R)-3-hydroxy-2-
methylbutyrolactone 
 
A. hexapetalus Aerial parts Wong and Brown (2002) 
   
A. uncinatus  Stems Lan et al. (2007) 
     
3-Methylene-4-
pentadecyldihydrofuran-2-
one 
 
A. odoratissimus Fruits Bordoloi et al. (2009) 
     
Acetylmelodorinol 
 
A. madagascariensis Fruits and 
leaves 
Murphy (2007); 
Murphy et al. (2008) 
     
Artapetalin A 
 
A. hexapetalus Aerial parts Wong and Brown (2002); 
Schobert and Schlenk (2008); 
Savadi (2009) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Artapetalin B 
 
A. hexapetalus Aerial parts Wong and Brown (2002); 
Savadi (2009) 
   
A. modestus Stem bark Nyandoro et al. (2012) 
     
Artapetalin C 
 
A. hexapetalus Aerial parts Wong and Brown (2002); 
Savadi (2009) 
     
Melodorinol 
 
A. madagascariensis Fruits and 
leaves 
Murphy (2007); 
Murphy et al. (2008) 
     
Tetrahydroxylated monohydrofuranyl acetogenin 
 
A. brachypetalus Root bark Nyandoro et al. (2012) 
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TABLE 2.7 Occurrence of other chemical constituents in Artabotrys species (continued). 
 
Compound Structure Plant species Plant part Reference 
     
Tulipalin B 
 
A. hexapetalus Aerial parts Wong and Brown (2002) 
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2.1.4 Pharmacological properties 
 
As mentioned previously, the genus Artabotrys has been widely employed as 
folk medicines in different parts of the world. The extensive usages coupled with their 
vast beneficial properties have attracted considerable interest of researchers in giving 
scientific credence and validity to the ethnomedicinal uses of Artabotrys species. 
These species could eventually serve as potential therapeutic agents for the treatment 
of various diseases. 
 
Although there are over 100 species in the genus Artabotrys, only 10 species 
have been examined so far. The crude extracts and pure compounds derived from 
Artabotrys species were reported to possess a wide spectrum of in vitro 
pharmacological effects, especially antimicrobial activities (Table 2.8). In an earlier 
study, Srivastava et al. (2009) investigated the antifungal and antiaflatoxigenic 
activities of essential oil from leaves of A. odoratissimus. Through poisoned food 
technique, MIC value of the essential oil against Aspergillus flavus Navjot 4NSt was 
found to be ȝ// DWZKLFK LW GHPRQVWUDWHG VXSeriority over different prevalent 
synthetic fungicides. With respect to the nature of toxicity, the essential oil exhibited 
IXQJLVWDWLF QDWXUH XS WR  ȝ// DQG WXUQHG IXQJLFLGDO QDWXUH DW LQFUHDVHG
concentrations. Besides inhibiting the growth of the toxigenic strain at all levels of 
inoculum density, the essential oil also showed significant efficacy in arresting 
aflatoxin B1 secretion at ȝ// The study therefore recommended the essential oil 
as postharvest antimicrobial food additive in safe preservation of food commodities 
from storage fungi as well as renewable alternative to imported synthetic pesticides in 
postharvest pest management programmes. 
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Apart from being assessed in vitro, Artabotrys species have also been 
evaluated for their in vivo pharmacological properties including antifertility (rat) 
(Karthik et al. 2012), cardiovascular (dog, frog and rabbit) (Trivedi et al. 1971), 
central nervous system (CNS) depressant (rat) (Garg and Siddiqui 1998) and muscle 
contractile activities (rabbit and rat) (Cortes et al. 1990) (Table 2.9). Considering that 
many species belonging to the genus Artabotrys are still poorly investigated, more 
phytochemical and pharmacological studies are necessary in order to elucidate the 
active principles as well as their mechanisms of action. 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species. 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
ANTIBACTERIAL ACTIVITY 
     
Methanol extract A. hexapetalus Leaves Remarkable inhibition against Bacillus megaterium, 
Enterococcus faecalis, Lactobacillus casei, 
Staphylococcus aureus, Streptococcus entericus, 
Streptococcus mutans, Escherichia coli, 
Pseudomonas aeruginosa, Salmonella typhi and 
Xanthomonas campestris, with zones of inhibition 
ranging from 11 mm to 18 mm 
Sowjanya et al. (2013) 
     
Methanol extract A. uncinatus Leaves High antibacterial activity against Bacillus 
megaterium NCIM 2032, Micrococcus luteus 
NCIM 2704, Staphylococcus aureus NCIM 2672, 
Streptococcus lactis NCIM 2606, Enterobacter 
aerogenes NCIM 5139, Escherichia coli NCIM 
2810, Pseudomonas aeruginosa NCIM 2200 and 
Salmonella typhimurium NCIM 2501, with zones of 
inhibition ranging from 7 mm to 16 mm at the 
concentration of 50 mg/disc  
Gothandam et al. (2010) 
     
Water extract A. hexapetalus Flowers Strong antibacterial activity against Staphylococcus 
aureus ATCC 29737, Escherichia coli ATCC 
10536, Pseudomonas aeruginosa ATCC 27853 and 
Salmonella typhi ATCC 14028, with zones of 
inhibition ranging from 17±0.11 mm to 19±0.03 
mm 
Manjula et al. (2011) 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
Water extract A. uncinatus Leaves Superior efficacy against Xanthomonas campestris 
pv. oryzae 
Yenjerappa (2009) 
     
Artamonteirine 
 
A. monteiroae Stem bark Selective activity against Staphylococcus aureus 
ATCC 25923 with MIC value of 2.5 ȝJP/  
Nyandoro et al. (2012) 
     
Not specified A. hexapetalus Leaves High inhibitory effect on Xanthomonas oryzae pv. 
oryzae 
Kagale et al. (2004) 
     
Not specified A. uncinatus Leaves Significant inhibitory effect on Pseudomonas 
fluorescens isolates (Cla1B8, Cla1B10, Cla1B18, 
Cla2B7, P2F2, P2F4, PFK13, PFN3 and PuKL2) 
Foysal et al. (2011) 
     
ANTIFUNGAL ACTIVITY 
     
Chloroform extract A. hexapetalus Flowers Strong antifungal activity against Candida albicans 
and Aspergillus niger with respective zones of 
inhibition of 10±0.98 mm and 9±0.67 mm 
Manjula et al. (2011) 
     
Ethanol extract A. hexapetalus Leaves Absolute fungitoxicity against Colletotrichum 
oxysporum 
Jayanthi (2011) 
     
Methanol extract A. hexapetalus Leaves Remarkable inhibition against Candida albicans, 
Candida rugosa, Aspergillus niger and Rhizopus 
oryzae, with zones of inhibition ranging from 9 mm 
to 14 mm 
Sowjanya et al. (2013) 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
Methanol : water (2:1) 
extract 
A. odoratissimus Leaves Moderate fungitoxicity against aflatoxin B1-
producing strain of Aspergillus flavus NKD-235 
with 72.4±1.0% inhibition of mycelial growth 
Shukla et al. (2012) 
     
Water extract A. odoratissimus Leaves Absolute fungitoxicity against aflatoxigenic strain 
of Aspergillus flavus Navjot 4NSt 
Srivastava et al. (2009) 
     
3-Methylene-4-
pentadecyldihydrofuran
-2-one 
A. odoratissimus Fruits Good inhibitory effect against Alternaria 
tenuissima with respective MIC and IC50 values of 
ȝJP/DQGȝJP/ 
Bordoloi et al. (2009) 
     
8-Methoxyouregidione 
Ouregidione 
Oxocrebanine 
A. zeylanicus Stem bark Preferential toxicity towards DNA repair-deficient 
RS 321N and RS 322YK (RAD 52Y) strains of 
Saccharomyces cerevisiae 
Wijeratne et al. (1996) 
     
Acetogenin A. brachypetalus Stem bark Strong antifungal effect on Aspergillus flavus, 
Aspergillus niger, Botryodiplodia theobromae and 
Fusarium solani, with MIC values of 250 ppm and 
200 ppm in radial growth and mycelial dry weight 
measurements respectively 
Odebode et al. (2006) 
     
Artabotrine 
Atherospermidine 
A. zeylanicus Stem bark Significant selective DNA-damaging activity 
against DNA repair-deficient RS 321N and RS 
322YK (RAD 52Y) strains of Saccharomyces 
cerevisiae, with IC12 values ranging from 1.20 
ȝJP/WRȝJP/ 
Wijeratne et al. (1995) 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
Artabotrol 
Artapetalin B 
A. modestus Stem bark Active against Candida albicans DSM 1665 and 
Cryptococcus neoformans ATCC 90112 
Nyandoro et al. (2012) 
     
Essential oil A. hexapetalus Leaves Moderate fungitoxicity against Aspergillus flavus 
and Aspergillus niger with 54.2% and 46.7% 
inhibition of mycelial growth respectively 
Tripathi and Kumar (2007) 
     
Essential oil A. odoratissimus Leaves Absolute fungitoxicity against Aspergillus flavus 
 ȝ// Aspergillus fumigates  ȝ//
Cladosporium cladosporioides, Curvularia lunata, 
Fusarium oxysporum, Helminthosporium oryzae, 
Macrophomina phaseolina, Microsporum gypseum, 
Mucor racemosus, Penicillium italicum, Pythium 
debaryanum, Rhizoctonia solani, Sclerotium rolfsii 
and Trichoderma viride ȝ// 
Srivastava et al. (2009) 
     
Volatile compound A. uncinatus Leaves Absolute fungitoxicity against Alternaria alternata, 
Curvularia lunata, Fusarium nivale and 
Helminthosporium gramineum 
Kumari (2009); 
Jayanthi (2011) 
     
Not specified A. uncinatus Leaves Absolute fungitoxicity against Ustilago maydis and 
Ustilago nuda 
Aguilar (2001) 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
ANTIPARASITIC ACTIVITY 
     
Dichloromethane : 
methanol (1:1) extract  
A. monteiroae Leaves Good antiprotozoal activity against Plasmodium 
falciparum K1 and Trypanosoma brucei 
rhodesiense STIB 900 with respective IC50 values 
RIȝJP/DQGȝJP/ 
Mokoka et al. (2011) 
     
Dichloromethane : 
methanol (1:1) extract  
A. monteiroae Twigs Promising antiplasmodial activity against 
chloroquine-sensitive D10 strain of Plasmodium 
falciparum with IC50 YDOXHRIȝJP/ 
Clarkson et al. (2004); 
Pillay et al. (2008) 
     
Methanol extract A. hexapetalus Bark Significant anthelmintic activity against Pheretima 
posthuma (earthworm) 
Morshed et al. (2012) 
     
Water extract A. odoratissimus Leaves Strong nematicidal activity against Meloidogyne 
incognita (roundworm) 
Aguilar (2001); 
Jayanthi (2011) 
     
Essential oil A. odoratissimus Leaves Strong anthelmintic activity against Ascaris 
lumbricoides (roundworm), Pheretima posthuma 
(earthworm) and Taenia solium (tapeworm) 
Akhtar et al. (2000); 
Iqbal et al. (2005); 
Hussain (2008);  
Badar (2011); 
Tandon et al. (2011) 
     
Yingzhaosu A A. uncinatus Roots Moderate antimalarial activity against chloroquine-
resistant K1 strain of Plasmodium falciparum with 
IC50 value of 115 nM 
Szpilman et al. (2005) 
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TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
ANTICANCER ACTIVITY 
     
Acetylmelodorinol 
Melodorinol 
 
A. madagascariensis Leaves 
and fruits 
Moderate antiproliferative activity against MDA-
MB-435 breast, HT-29 colon, U937 leukemia, 
H522-T1 non-small cell lung and A2780 ovarian 
carcinoma cell lines, with GI50 values ranging from 
ȝ0WRȝ0 
Murphy et al. (2008) 
     
Artabotrine A. zeylanicus Stem bark Strong inhibitory effect on both camptothecin-
resistance and wild-type P388 leukemia cell lines 
with respective GI50 YDOXHV RI  ȝ0 DQG 
ȝ0 
Wijeratne et al. (1995); 
Ding et al. (2006) 
 
Atherospermidine 
 
A. uncinatus Stems and 
stem bark 
Significant cytotoxicity against KB oral carcinoma 
cell lines with GI50 YDOXHRIȝJP/ 
Wu et al. (1989) 
 
Atherospermidine 
Squamolone 
A. uncinatus Stems Significant cytotoxicity against Hep 2,2,15 and Hep 
G2 hepatocellular carcinoma cell lines with GI50 
YDOXHVUDQJLQJIURPȝJP/WRȝJP/ 
Hsieh et al. (2001) 
 
Liriodenine A. uncinatus Stems and 
stem bark 
Potent cytotoxicity against HCT-8 colorectal, 
L1210 and P388 leukemia, A549 lung, as well as 
KB oral carcinoma cell lines, with GI50 values 
UDQJLQJIURPȝJP/WRȝJP/ 
Wu et al. (1989) 
 
 
 
 
132 
 
TABLE 2.8 In vitro pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
ANTI-INSECT ACTIVITY 
     
Alkaloidal fraction A. odoratissimus Stem bark Significant larvicidal effect against Culex 
quinquefasciatus (mosquito) with LC50 value of  
42.03 ppm 
Kabir (2010) 
 
Artamonteirine 
 
A. monteiroae Stem bark Strong larvicidal potency against Anopheles 
gambiae (mosquito) with LC50 value of  less than 1 
ȝJP/ 
Nyandoro et al. (2012) 
 
Essential oil A. hexapetalus Leaves Moderate repellency (50%) against Bruchus 
pisorum (beetle) with a dose of 0.02 mL  
Kumar (2014) 
 
Essential oil A. hexapetalus Leaves Moderate repellency (70%) against Trogoderma 
granarium (beetle) with a dose of 0.02 mL  
Tripathi and Kumar (2007) 
 
CYTOTOXIC ACTIVITY 
     
Methanol extract A. hexapetalus Bark Significant cytotoxicity against Artemia salina 
(brine shrimp) with LC50 YDOXHRIȝJP/ 
Morshed et al. (2012) 
 
RECEPTOR BINDING ACTIVITY 
     
Methanol extract A. roseus Bark Active against 5-HT1A (5-hydroxytryptamine) 
receptor with 72±1% inhibition of specific binding 
Chung et al. (2005) 
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TABLE 2.9 In vivo pharmacological properties of Artabotrys species. 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
ANTIFERTILITY ACTIVITY 
     
Ethanol : water (70:30) 
extract 
A. hexapetalus Leaves Significant decrease in total sperm count 
(22.67±0.88 × 105), weights of testis (1.165±0.02 
g), epididymis (0.246±0.004 g) and seminal vesicle 
(0.443±0.08 g), serum testosterone and testicular 
cholesterol levels (5.097±0.05 ng/mL and 
4.752±0.701), as well as increase in testicular 
alkaline phosphatase (ALP) level (844.1±6.34) at a 
dose of 600 mg/kg on days 1-45 in male albino rat 
(Wistar) 
Karthik et al. (2012) 
     
Ethanol : water (90:10) 
extract  
Water extract 
A. odoratissimus Leaves Potent anti-implantation activity (60% and 67%) at 
a dose of 150 mg/kg on days 1-7 post-coitum in 
female albino rat 
Kamboj and Dhawan 
(1982) 
     
Ethanol : water (95:5) 
extract  
Water extract 
A. odoratissimus Leaves Significant prolongation of dioestrus stage 
(9.0±0.45 days and 8.6±0.23 days) and anti-
implantation activity (66.6% and 83.3%) at a dose 
of 250 mg/kg on days 1-10 post-coitum in female 
albino rat (Wistar) 
Geetha et al. (2005); 
Tran and Hinds (2012) 
     
Petroleum ether extract A. hexapetalus Leaves High anti-implantation activity (72%) at a dose of 
250 mg/kg on days 1-7 post-coitum in female 
albino rat 
Johri et al. (2009) 
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TABLE 2.9 In vivo pharmacological properties of Artabotrys species (continued). 
 
Extract / Compound Plant species Plant part Pharmacological property Reference 
     
CARDIOVASCULAR ACTIVITY 
     
Ethanol extract A. odoratissimus Fruits Cardiac depressant activity in isolated heart of frog, 
cardiac stimulant activity in hearts of dog (in situ), 
frog and rabbit (isolated), dilatation of perfused 
hind-limb blood vessels of dog, and hypotensive 
effect in anaesthetised dog  
Trivedi et al. (1971) 
     
CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANT ACTIVITY 
     
Essential oil A. odoratissimus Leaves Significant reduction of spontaneous motor activity 
(SMA) (32%), potentiation of pentobarbitone 
sodium-induced hypnosis (204.6±4.827 min), 
manifestation of neurological deficit (45%), and 
conditioned avoidance response (CAR) (40.6%) at a 
dose of 250 mg/kg in albino rat 
Garg and Siddiqui (1998) 
     
MUSCLE CONTRACTILE ACTIVITY 
     
Ethanol extract A. odoratissimus Fruits Relaxant action on isolated ileum of rabbit, and 
spasmogenic effect on uterine smooth muscle of rat 
Trivedi et al. (1971) 
     
Atherospermidine A. maingayi Bark Relaxant activity on oxytocin- or vanadate-induced 
rat uterine contractions in the absence of calcium 
Cortes et al. (1990) 
     
Atherospermidine 
Norstephalagine 
A. maingayi Bark Relaxant activity on rat uterine contractions induced 
by potassium chloride, or rhythmic contractions 
induced by oxytocin in the presence of calcium  
Cortes et al. (1990) 
     
 
135 
 
CHAPTER III 
 
SEQUENTIAL EXTRACTION AND PHYTOCHEMICAL SCREENING OF  
ARTABOTRYS CRASSIFOLIUS 
 
3.1 INTRODUCTION 
 
Extraction as a pharmaceutically used term can be defined as the method of 
separating medicinally active portions of plant tissues from the inactive or inert 
components using selective solvents (Das et al. 2010), which will diffuse into the 
solid plant material and dissolve compounds with similar polarity (Tiwari et al. 2011). 
The quality of an extract is dependent on several parameters including the plant part 
used as starting material, the choice of solvent, and the extraction method (Ncube et al. 
2008). Moreover, extraction of plant tissues with solvents of different polarity ranging 
from hexane to water could provide a comprehensive study for a variety of bioactive 
compounds (Green 2004). 
 
Phytochemical screening is an effective technique for the detection of different 
classes of compounds such as alkaloids, flavonoids and terpenoids (Attard and 
Pacioni 2012). These qualitative chemical tests are useful in establishing profile of the 
extracts for their nature of chemical composition (Ghannadi et al. 2012). Besides 
generating hypotheses regarding the types of secondary metabolites present in an 
extract, the preliminary chemical evaluation also helps in monitoring the presence of 
compounds of interest (Jones and Kinghorn 2005). Hence, phytochemical analysis is 
of paramount importance in identifying new sources of therapeutically and 
industrially valuable compounds (Mungole et al. 2010). 
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3.2 METHODOLOGY 
 
3.2.1 Collection and identification of plant material 
 
The leaves and bark of Artabotrys crassifolius Hook.f. & Thomson (Figure 
3.1), with the local name of akar mempisang, were collected from Kuala Kangsar, 
Perak, Malaysia (ƍ1, ƍ() in March 2011. The plant was identified and 
authenticated by Mr. Kamarudin Saleh, Forest Biodiversity Division, Forest Research 
Institute Malaysia (FRIM). Voucher specimens were prepared and deposited in the 
Kepong Herbarium (KEP) of FRIM (PID 080311±05), and the School of Pharmacy, 
Faculty of Science, The University of Nottingham Malaysia Campus (UNMC 65) for 
future reference. 
 
 
 
FIGURE 3.1 Artabotrys crassifolius Hook.f. & Thomson. 
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3.2.2 Preparation of plant material 
 
(a) Drying and grinding of plant material 
 
 After removal of extraneous matter, the freshly collected leaves and bark were 
air-dried in the shade at room temperature for at least 2 weeks. The dried leaves and 
bark were then finely pulverised by grinding using aluminium collection blender 
(Philips, China), followed by weighing with top loading balance (Sartorius AG, 
Germany) prior to extraction.  
 
(b) Sequential extraction of plant material 
 
 The pulverised leaves (1.30 kg) and bark (4.79 kg) were extracted sequentially 
with solvents of increasing polarity starting from hexane (Friendemann Schmidt, 
Australia), chloroform (Friendemann Schmidt, Australia) and 95% (v/v) of ethanol 
(John Kollin Chemicals, India). Each extraction was performed in triplicate at a solid-
to-solvent ratio of 1:5 (w/v) in a 40°C water bath (Julabo, Germany) for three days. 
The respective extract was subsequently filtered through qualitative filter papers No. 1 
(Whatman International Ltd., England) and the collected filtrate was concentrated to 
dryness under reduced pressure at 40°C using rotary evaporator (Buchi Labortechnik 
AG, Switzerland). Eventually, the dried extract obtained was weighed with analytical 
balance (Sartorius AG, Germany) and stored in glass scintillation vials (Kimble, USA) 
at ±20°C until further use. For stock solutions, each crude extract was dissolved in 
dimethyl sulphoxide (DMSO) (R & M Chemicals, UK) at a concentration of           
100 mg/mL and stored at 4°C.  
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3.2.3 Determination of extraction yield 
 
 For each extraction, the extraction yields of crude extracts were calculated. 
The extraction yield was expressed as the weight percentage of the dried plant extract 
obtained with respect to the dried plant material used (Pin et al. 2010; Kosma et al. 
2011), which was given as follows:   
 
Extraction yield (%) = 
Weight of dried plant extract (g) 
× 100% 
Weight of dried plant material (g) 
 
3.2.4 Evaluation of organoleptic properties 
 
 The organoleptic properties of crude extracts were assessed by their colour, 
texture and odour (Arya et al. 2010). These organoleptic characters were determined 
using the senses of sight (eyes), touch (skin) and smell (nose) (Ma 2006).  
 
(a) Colour 
 
For colour determination, each crude extract was properly examined under 
diffuse daylight. If necessary, an artificial light source with wavelengths similar to 
those of daylight might be used (WHO 2011). 
 
(b) Texture 
 
For texture determination, small quantity of each crude extract was taken and 
examined by rubbing it between the thumb and index finger (Chaturvedi et al. 2011). 
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(c) Odour 
 
 For odour determination, if the crude extract was expected to be innocuous, 
small portion of the respective extract was placed in the palm of the hand or in a 
beaker of suitable size, and examined by slow and repeated inhalation of the air over 
the extract. If no distinct odour was perceptible, the crude extract was rubbed between 
the thumb and index finger or between the palms of the hands using gentle pressure. If 
the crude extract was known to be dangerous, small quantity of boiling water was 
poured onto the respective extract placed in a beaker (Chandel et al. 2011). 
 
3.2.5 Phytochemical screening 
 
The phytochemical screenings of crude extracts were carried out using 
standard procedures. Each crude extract (final concentration of 1 mg/mL) was assayed 
for the presence of phytochemical constituents such as alkaloids, cardiac glycosides, 
flavonoids, phenolic compounds, saponins, tannins and terpenoids.  
 
(a) Test for alkaloids ('UDJHQGRUII¶Vtest)  
 
 Prior to detection of alkaloids, solution A was prepared by dissolving 1.7 g of 
bismuth subnitrate (Mallinckrodt, USA) in 100 mL of 4:1 (v/v) of distilled water and 
acetic acid (Systerm, Malaysia), whereas 40 g of potassium iodide (R & M Chemicals, 
UK) was dissolved in 100 mL of distilled water as solution B. To prepare 
'UDJHQGRUII¶VUHDJHQW 5 mL of solution A and B was added in 20 mL of acetic acid 
and topped up with distilled water to 100 mL (Mehrotra et al. 2011). 
140 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of methanol 
(Friendemann Schmidt, Australia). The mixture was filtered and the filtrate was 
divided into two test tubes with one portion as the control. Another portion of the 
filtrate was treated with 1 mL of 1% (v/v) of hydrochloric acid (HCl) (Systerm, 
Malaysia) and warmed on steam bath, followed by addition of a few drops of 
'UDJHQGRUII¶V UHDJHQW Reddish orange precipitation indicated the presence of 
alkaloids (Magadula and Tewtrakul 2010). 
 
(b) Test for cardiac glycosides (Keller-Kiliani test) 
 
 Approximately 1 mL of each crude extract was mixed with 4 mL of distilled 
water. The mixture was filtered and the filtrate was divided into two test tubes with 
one portion as the control. Another portion of the filtrate was treated with 2 mL of 
acetic acid containing one drop of 5% (w/v) of ferric chloride hexahydrate 
(FeCl3Â6H2O) (Systerm, Malaysia). This was underlayed with 1 mL of concentrated 
sulphuric acid (H2SO4, 98%) (Fisher Scientific, UK). A brown ring at the interface 
indicated the presence of a deoxysugar characteristic of cardenolides. A violet ring 
might appear below the brown ring, while in the acetic acid layer, a greenish ring 
might form just above the brown ring and gradually spread throughout this layer 
(Hussain et al. 2011).  
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(c) Test for flavonoids (Shinoda test) 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of ethanol. 
The mixture was filtered and the filtrate was divided into two test tubes with one 
portion as the control. Another portion of the filtrate was treated with few fragments 
of magnesium ribbon, followed by dropwise addition of concentrated HCl (fuming 
37%). Pink scarlet, crimson red or occasionally green to blue colour appeared after 
few minutes indicated the presence of flavonoids (Itoria et al. 2011). 
 
(d) Test for phenolic compounds (Ferric chloride test) 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of distilled 
water. The mixture was filtered and the filtrate was divided into two test tubes with 
one portion as the control. Another portion of the filtrate was treated with a few drops 
of 5% (w/v) of FeCl3Â6H2O. Bluish-green or bluish-black colour indicated the 
presence of phenolic compounds (Kripa et al. 2011).  
 
(e) Test for saponins (Frothing test) 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of distilled 
water. The mixture was filtered and the filtrate was divided into two test tubes with 
one portion as the control. Another portion of the filtrate was shaken vigorously for   
1 min and allowed to stand for 15 min. Frothing persistence indicated the presence of 
saponins (Vesoul and Cock 2011).  
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(f) Test for tannins (Gelatine-salt test) 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of hot 
distilled water. The mixture was filtered and the filtrate was divided into three test 
tubes. To the first portion of the filtrate, 1 mL of 1% (w/v) of sodium chloride (NaCl) 
(R & M Chemicals, UK) was added as the control. Second portion of the filtrate was 
treated with 1 mL of 1% (w/v) of NaCl and 1 mL of 5% (w/v) of gelatine (R & M 
Chemicals, UK), whereas a few drops of 5% (w/v) of FeCl3Â6H2O were added to the 
third portion of the filtrate. Formation of a precipitate in the second treatment 
suggested the presence of tannins, and a positive response after addition of 
FeCl3Â6H2O to the third portion supported this inference (Jones and Kinghorn 2005).  
 
(g) Test for terpenoids (Salkowski test) 
 
Approximately 1 mL of each crude extract was mixed with 4 mL of 
chloroform. The mixture was filtered and the filtrate was divided into two test tubes 
with one portion as the control. Another portion of the filtrate was carefully treated 
with 3 mL of concentrated H2SO4 to form a layer. A reddish brown colouration of the 
interface indicated the presence of terpenoids (Khan et al. 2011). 
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3.3 RESULTS AND DISCUSSION 
 
3.3.1 Extraction yields of crude extracts of Artabotrys crassifolius 
 
Extraction yield is a measure of the solvent efficiency to extract specific 
components from the original material (Aspe and Fernandez 2011; Tsai et al. 2012). 
The extraction yield in percentage for each crude extract is shown in Figure 3.2 
(Appendix A). Among the different solvents used for extraction, ethanol provided the 
highest yield of crude extracts from both leaves and bark with extraction yields of 
5.00% and 4.02% respectively. In contrast, the lowest extraction yield was recorded 
for hexane extract of bark with 0.53%. This indicates that ethanol is a superior 
extraction solvent to hexane or chloroform in terms of providing a better yield due to 
its high polarity.  
 
3.3.2 Organoleptic properties of crude extracts of Artabotrys crassifolius 
 
Organoleptic evaluation refers to the evaluation of individual drugs and 
formulations by colour, texture and odour (Satheesh et al. 2011; Vishvnath and Jain 
2011). The colour, texture and odour of crude extracts in different solvents were 
characterised (Table 3.1). As compared to hexane and chloroform extracts, ethanol 
extracts were found to be better in retaining the natural fragrances of the plants. This 
may be attributed to the preservative ability of ethanol (reducing breakdown of 
organic compounds by microorganisms), its enhanced extraction capability (more 
fragrant components extracted) or a combination of both (Chan et al. 2008; Arya et al. 
2010). 
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FIGURE 3.2 Extraction yields of crude extracts of Artabotrys crassfolius. 
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TABLE 3.1 Organoleptic properties of crude extracts of Artabotrys crassifolius. 
 
Organoleptic 
property 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol Bark hexane Bark chloroform Bark ethanol 
       
 
    
       
Colour Greenish black Greenish black Brownish black Golden brown Greenish black Brownish black 
       
Texture Waxy Waxy Sticky Waxy Powdery Flaky 
       
Odour Leafy smell Pungent smell Sweet smell Pungent smell Fishy smell Sweet smell 
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3.3.3 Phytochemical screenings of crude extracts of Artabotrys crassifolius 
 
 Prior to pharmacological evaluation of plant extracts, phytochemical screening 
is the initial and essential step towards understanding the nature of active principles in 
medicinal plants (Kakpure and Rothe 2012). Based on the preliminary phytochemical 
analysis of crude extracts presented in Table 3.2±3.9, bark extracts were found to have 
more secondary metabolites than leaves extracts. Both chloroform and ethanol 
extracted the widest range of phytochemical constituents from bark including cardiac 
glycosides, flavonoids, phenolic compounds and terpenoids. The only difference 
detected between these extracts was the presence of alkaloids and saponins in 
chloroform and ethanol extracts of bark respectively. Additionally, hexane extract of 
bark showed positive results for alkaloids, cardiac glycosides and terpenoids.  
 
On the other hand, ethanol extract of leaves possessed similar phytochemical 
constituents to ethanol extract of bark. However, hexane and chloroform extracts of 
leaves exhibited positive reaction only to Keller-Kiliani test for cardiac glycosides. 
Among the phytochemical constituents analysed, tannins were absent in all of the 
tested extracts. This implies that the extracts from leaves and bark may constitute a 
different source of secondary metabolites that can serve as a constructive reference for 
further detailed studies on the pharmacological activities of Artabotrys crassifolius. 
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TABLE 3.2 Phytochemical screenings of crude extracts of Artabotrys crassifolius. 
 
Phytochemical constituent Test used 
Crude extract 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
        
Alkaloids Dragendorff¶V test ± ± ± + + ± 
        
Cardiac glycosides Keller-Kiliani test + + + + + + 
        
Flavonoids Shinoda test ± ± + ± + + 
        
Phenolic compounds Ferric chloride test ± ± + ± + + 
        
Saponins Frothing test ± ± + ± ± + 
        
Tannins Gelatin-salt test ± ± ± ± ± ± 
        
Terpenoids Salkowski test ± ± + + + + 
        
Note: (+) indicates the presence of phytochemical constituents, (±) indicates the absence of phytochemical constituents. 
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TABLE 3.3 Phytochemical analyses for the presence of alkaloids from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation Absence of reddish orange precipitate Absence of reddish orange precipitate Absence of reddish orange precipitate 
    
Inference Negative result for alkaloids Negative result for alkaloids Negative result for alkaloids 
    
Note: Test tube A was served as the control whereas test tube B was treated with 1% (v/v) of HCl and warmed on steam bath, followed by 
DGGLWLRQRIDIHZGURSVRI'UDJHQGRUII¶VUHDJHQW   
 
 
 
 A          B A          B 
 
 A          B 
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TABLE 3.3 Phytochemical analyses for the presence of alkaloids from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation Reddish orange precipitate was observed Reddish orange precipitate was observed Absence of reddish orange precipitate 
    
Inference Positive result for alkaloids Positive result for alkaloids Negative result for alkaloids 
    
Note: Test tube A was served as the control whereas test tube B was treated with 1% (v/v) of HCl and warmed on steam bath, followed by 
DGGLWLRQRIDIHZGURSVRI'UDJHQGRUII¶VUHDJHQW 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.4 Phytochemical analyses for the presence of cardiac glycosides from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
 
 
 
    
Observation Brown ring at the interface was observed Brown ring at the interface was observed Brown ring at the interface was observed 
    
Inference Positive result for cardiac glycosides Positive result for cardiac glycosides Positive result for cardiac glycosides 
    
Note: Test tube A was served as the control whereas test tube B was treated with acetic acid containing one drop of 5% (w/v) of FeCl3Â6H2O, 
and underlayed with concentrated H2SO4. 
 
 
 
 A          B 
 
A          B 
 
 A          B 
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TABLE 3.4 Phytochemical analyses for the presence of cardiac glycosides from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation Brown ring at the interface was observed Brown ring at the interface was observed Brown ring at the interface was observed 
    
Inference Positive result for cardiac glycosides Positive result for cardiac glycosides Positive result for cardiac glycosides 
    
Note: Test tube A was served as the control whereas test tube B was treated with acetic acid containing one drop of 5% (w/v) of FeCl3Â6H2O, 
and underlayed with concentrated H2SO4. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.5 Phytochemical analyses for the presence of flavonoids from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation No colour change was observed No colour change was observed Crimson red colouration was observed 
    
Inference Negative result for flavonoids Negative result for flavonoids Positive result for flavonoids 
    
Note: Test tube A was served as the control whereas test tube B was treated with few fragments of magnesium ribbon, followed by dropwise 
addition of concentrated HCl. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.5 Phytochemical analyses for the presence of flavonoids from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation No colour change was observed Crimson red colouration was observed Pink scarlet colouration was observed 
    
Inference Negative result for flavonoids Positive result for flavonoids Positive result for flavonoids 
    
Note: Test tube A was served as the control whereas test tube B was treated with few fragments of magnesium ribbon, followed by dropwise 
addition of concentrated HCl. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.6 Phytochemical analyses for the presence of phenolic compounds from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation No colour change was observed No colour change was observed Bluish-black colouration was observed 
    
Inference Negative result for phenolic compounds Negative result for phenolic compounds Positive result for phenolic compounds 
    
Note: Test tube A was served as the control whereas test tube B was treated with a few drops of 5% (w/v) of FeCl3Â6H2O. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.6 Phytochemical analyses for the presence of phenolic compounds from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation No colour change was observed Bluish-black colouration was observed Bluish-black colouration was observed 
    
Inference Negative result for phenolic compounds Positive result for phenolic compounds Positive result for phenolic compounds 
    
Note: Test tube A was served as the control whereas test tube B was treated with a few drops of 5% (w/v) of FeCl3Â6H2O. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.7 Phytochemical analyses for the presence of saponins from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation No frothing was observed No frothing was observed Frothing persistence was observed 
    
Inference Negative result for saponins Negative result for saponins Positive result for saponins 
    
Note: Test tube A was served as the control whereas test tube B was shaken vigorously and allowed to stand. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.7 Phytochemical analyses for the presence of saponins from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation No frothing was observed No frothing was observed Frothing persistence was observed 
    
Inference Negative result for saponins Negative result for saponins Positive result for saponins 
    
Note: Test tube A was served as the control whereas test tube B was shaken vigorously and allowed to stand. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.8 Phytochemical analyses for the presence of tannins from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation No appearance of precipitate in test tube 
B while no colour change was observed 
in test tube C 
No appearance of precipitate in test tube 
B while no colour change was observed 
in test tube C 
No appearance of precipitate in test tube 
B while bluish-black colouration was 
observed in test tube C 
    
Inference Negative result for tannins Negative result for tannins Negative result for tannins 
    
Note: Test tube A was served as the control whereas test tubes B and C were treated with 1% (w/v) of NaCl and 5% (w/v) of gelatine, and a few 
drops of 5% (w/v) of FeCl3Â6H2O respectively.   
 
        A       B   C 
 
        A       B   C 
 
        A       B   C 
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TABLE 3.8 Phytochemical analyses for the presence of tannins from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation No appearance of precipitate in test tube 
B while no colour change was observed 
in test tube C 
No appearance of precipitate in test tube 
B while bluish-black colouration was 
observed in test tube C 
No appearance of precipitate in test tube 
B while bluish-black colouration was 
observed in test tube C 
    
Inference Negative result for tannins Negative result for tannins Negative result for tannins 
    
Note: Test tube A was served as the control whereas test tubes B and C were treated with 1% (w/v) of NaCl and 5% (w/v) of gelatine, and a few 
drops of 5% (w/v) of FeCl3Â6H2O respectively.   
 
 
        A       B   C 
 
        A       B   C 
 
        A       B   C 
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TABLE 3.9 Phytochemical analyses for the presence of terpenoids from crude extracts of Artabotrys crassifolius. 
 
Phytochemical 
analysis 
Crude extract 
Leaves hexane Leaves chloroform Leaves ethanol 
    
 
   
    
Observation Green colouration of the interface was 
observed 
Green colouration of the interface was 
observed 
Reddish brown colouration of the 
interface was observed 
    
Inference Negative result for terpenoids Negative result for terpenoids Positive result for terpenoids 
    
Note: Test tube A was served as the control whereas test tube B was treated with concentrated H2SO4. 
 
 
 
 A          B 
 
 A          B 
 
 A          B 
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TABLE 3.9 Phytochemical analyses for the presence of terpenoids from crude extracts of Artabotrys crassifolius (continued). 
 
Phytochemical 
analysis 
Crude extract 
Bark hexane Bark chloroform Bark ethanol 
    
 
   
    
Observation Reddish brown colouration of the 
interface was observed 
Reddish brown colouration of the 
interface was observed 
Reddish brown colouration of the 
interface was observed 
    
Inference Positive result for terpenoids Positive result for terpenoids Positive result for terpenoids 
    
Note: Test tube A was served as the control whereas test tube B was treated with concentrated H2SO4. 
 A          B 
 
 A          B 
 
 A          B 
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3.4 CONCLUSION 
 
The preliminary qualitative phytochemical analysis of crude extracts of 
Artabotrys crassifolius revealed the presence of alkaloids, cardiac glycosides, 
flavonoids, phenolic compounds, saponins and terpenoids. Consequently, the 
chemical profile of crude extracts can help to provide guidance for further 
investigations in pharmacological properties of Artabotrys crassifolius. 
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CHAPTER IV 
 
IN VITRO ANTIBACTERIAL ACTIVITY OF ARTABOTRYS CRASSIFOLIUS 
 
4.1 INTRODUCTION 
 
Bacteria are unicellular prokaryotic microorganisms that exhibit different 
cellular sizes and shapes ranging from spheres to rods and spirals (Charalampopoulos 
and Rastall 2009). In the human body, most of the bacteria are rendered harmless or 
beneficial by the protective effects of the immune system (Cioffi and Rai 2012). 
Nevertheless, some species of bacteria are pathogenic and capable of causing 
infectious diseases such as anthrax, bubonic plague, cholera, leprosy, syphilis and 
tuberculosis (Liu 2011).  
 
In spite of the widespread availability of antibacterial therapies, bacterial 
infections continue to pose a significant threat to public health worldwide (Bow 2013; 
Gaca et al. 2013). More importantly, the clinical efficacy of many existing 
antibacterial drugs is declining precipitously due to the emergence and dissemination 
of multiple drug resistant pathogens (Jahan et al. 2013). These bacteria are endowed 
with the ability to become resistant to antibiotics through mutation or gene transfer 
(Aggarwal et al. 2013; Omar et al. 2013), which further leads to higher morbidity, 
prolonged length of stay, increased mortality, and costly healthcare as compared to 
antibiotic-susceptible microorganisms (Morales et al. 2012). Therefore, alternative 
antibacterial agents with diverse chemical structures as well as novel mechanisms of 
actions are urgently required to combat the new and re-emerging bacterial infections.  
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4.2 METHODOLOGY 
 
4.2.1 Microorganisms and culture media 
 
The microorganisms used in the current study can be categorised into two 
main groups, namely Gram-positive and Gram-negative bacteria as shown in Table 
4.1. Thirty bacterial strains including American Type Culture Collection (ATCC) and 
clinical strains were procured from the Biosciences Laboratory, Faculty of Science, 
University of Nottingham Malaysia Campus, and the Bacteriology Unit, Department 
of Medical Microbiology and Immunology, Universiti Kebangsaan Malaysia Medical 
Centre (UKMMC) respectively (Appendix B1±B2). Table 4.1 also includes the types 
of culture media required for the growth of the respective bacteria. 
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TABLE 4.1 Types of microorganisms and culture media. 
 
Microorganism Bacterial strain Culture medium 
ATCC strain 
   
Gram-positive bacteria Bacillus cereus ATCC 10876 Tryptic soy broth  
(Difco Laboratories, USA)   
 
Bacillus subtilis ATCC 21332 
   
 
Listeria monocytogenes ATCC 15313 Tryptic soy agar  
(HiMedia, India)   
 
Micrococcus luteus ATCC 10240 
   
 
Proteus vulgaris ATCC 13315 
 
   
 
Rhodococcus equi ATCC 33701 
 
   
 
Staphylococcus aureus ATCC 11632 
 
   
 
Staphylococcus epidermidis ATCC 12228 
 
   
 
Streptococcus pyogenes ATCC 19615 (Group A Streptococcus, GAS)  
 
   
Gram-negative bacteria Citrobacter freundii ATCC 22636 
 
   
 
Escherichia coli ATCC 10536 
 
   
 
Klebsiella pneumoniae ATCC 13883 
 
   
 
Pseudomonas aeruginosa ATCC 10145 
 
   
 
Salmonella enteritidis ATCC 13076 
 
   
 
Salmonella typhimurium ATCC 14028 
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TABLE 4.1 Types of microorganisms and culture media (continued). 
 
Microorganism Bacterial strain Culture medium 
Clinical isolate 
   
Gram-positive bacteria Enterococcus faecalis Tryptic soy broth  
   
 
Methicillin-resistant Staphylococcus aureus (MRSA) Tryptic soy agar  
   
 
Methicillin-sensitive Staphylococcus aureus (MSSA) 
  
   
 
Oxacillin-resistant coagulase-negative staphylococci (ORCNS) 
 
   
 
Oxacillin-sensitive coagulase-negative staphylococci (OSCNS) 
 
   
 
Streptococcus agalactiae (Group B Streptococcus, GBS)  
 
   
 
Streptococcus pneumoniae 
 
   
Gram-negative bacteria Actinobacillus sp. 
 
   
 
Enterobacter sp. 
 
   
 
Escherichia coli 
 
   
 
Extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) 
 
   
 
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-KP) 
 
   
 
Klebsiella sp. 
 
   
 
Moraxella sp. 
 
   
 
Serratia sp. 
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4.2.2 Preparation of culture media 
 
(a) Preparation of broth medium 
 
 Tryptic soy broth (TSB) was prepared by suspending 30 g of TSB powder in  
1 L of sterile distilled water. The solution was mixed thoroughly and warmed slightly 
to completely dissolve the powder before dispensing into universal bottles. After 
autoclaving at 121°C for 15 min, the broth was allowed to cool down to room 
temperature before storing at 4°C until further use.  
 
(b) Preparation of agar medium 
 
 Tryptic soy agar (TSA) was prepared by suspending 40 g of TSA powder in   
1 L of sterile distilled water. The solution was mixed thoroughly and heated to boiling 
to dissolve the powder completely, followed by autoclaving at 121°C for 15 min. The 
autoclaved medium was allowed to cool down by immersing into a 45°C to 50°C 
water bath (Julabo, Germany) before pouring into sterile Petri dishes (Favorit, 
Malaysia) in laminar flow cabinet (Esco Micro, Malaysia). After pouring, the molten 
agar was allowed to solidify and dried for 30 minutes before covering the plates to 
prevent formation of water on the agar surface. The prepared agar medium was stored 
in a 4°C chiller until further use. 
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4.2.3 Maintenance and storage of stock cultures 
 
(a) Preparation of plate cultures 
 
 The streak plate method was employed to obtain pure bacterial cultures. A 
sterile inoculating loop was dipped into the culture of bacteria and streaked in a 
pattern over the surface of the TSA plate. The inoculating loop was sterilised 
following each streak series. As the pattern was traced, bacteria were rubbed off the 
loop onto the medium. The last cells to be rubbed off the loop were far enough apart 
to grow into isolated colonies. Streaked plates were incubated at 35°C for 24 h. 
 
(b) Preparation of broth cultures 
 
The bacterial cell suspension was prepared by picking a single isolated colony 
from freshly streaked plate with a sterile inoculating loop and transferring into 
universal bottles containing sterile TSB. The prepared cell suspension was vortexed 
thoroughly and incubated at 35°C for 24 h.   
 
(c) Preparation of glycerol stocks 
 
The glycerol stock was prepared by transferring the bacterial cell suspension 
into cryovials containing a final concentration of 20% (v/v) of sterile glycerol (R & M 
Chemicals, UK). The prepared glycerol stock of bacteria was well-mixed before 
storing at ±20°C for 24 h and subsequently at ±80°C for long-term storage.  
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4.2.4 Kirby-Bauer disc diffusion assay 
 
The antibacterial activities of crude extracts were evaluated against 30 ATCC 
and clinical strains using Kirby-Bauer disc diffusion method according to the 
guidelines of the Clinical and Laboratory Standards Institute (CLSI) (CLSI 2012), 
formerly known as National Committee for Clinical Laboratory Standards (NCCLS). 
 
(a) Preparation of Mueller-Hinton agar 
 
Mueller-Hinton agar (MHA) (Difco Laboratories, USA) was prepared from a 
FRPPHUFLDOO\DYDLODEOHGHK\GUDWHGEDVHDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
Immediately after autoclaving, the agar medium was allowed to cool in a 45°C to 
50°C water bath. The freshly prepared and cooled medium was poured into plastic, 
flat-bottomed Petri dishes on a level, horizontal surface to give a uniform depth of 
approximately 4 mm, which corresponded to 25 mL to 30 mL of medium for plates 
with a diameter of 100 mm. The agar medium was allowed to cool further to room 
temperature, and unless the plates were used the same day, stored in a 2°C to 8°C 
refrigerator.  
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(b) Preparation of impregnated filter paper discs 
 
Qualitative filter paper No. 1 (Whatman International Ltd., England) was used 
to prepare discs approximately 6 mm in diameter, which were sterilised by 
autoclaving at 121°C for 15 min. Sterile filter paper discs were impregnated with     
ȝ/RIHDFKFUXGHH[WUDFWPJP/WRJLYHDILnal concentration of 1 mg/disc. 
Streptomycin sulphate ȝJGLVF (Fisher BioReagents, China) and DMSO (R & M 
Chemicals, UK) were served as positive and negative controls respectively. 
Impregnated discs were left to dry under laminar flow cabinet overnight.  
 
(c) Preparation of inoculum 
 
 At least three to five well-isolated colonies of the same morphological type 
were selected from an agar plate culture. The top of each colony was touched with a 
loop, and the growth was transferred into a universal bottle containing sterile TSB. 
The broth culture was incubated at 35°C for 2 h to 6 h until it achieved or exceeded 
the turbidity of the 0.5 McFarland standard. The turbidity of the actively growing 
broth culture was adjusted with sterile saline or broth to obtain a turbidity optically 
comparable to that of the 0.5 McFarland standard using a UV/Vis spectrophotometer 
(Biochrom Libra, UK) at 625 nm. The absorbance at 625 nm should be in the range of 
0.08 to 0.13 for the 0.5 McFarland standard. This resulted in a suspension containing 
approximately 1 × 108 CFU/mL to 2 × 108 CFU/mL. 
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(d) Inoculation of test plates 
 
 Optimally, within 15 min after adjusting the turbidity of the inoculum 
suspension, a sterile cotton swab was dipped into the adjusted suspension. The swab 
was rotated several times and pressed firmly on the inside wall of the universal bottle 
above the fluid level to remove excess inoculum from the swab. The dried surface of a 
MHA plate was inoculated by streaking the swab over the entire sterile agar surface. 
This procedure was repeated by streaking two more times, rotating the plate 
approximately 60° each time to ensure an even distribution of inoculum. As a final 
step, the rim of the agar was swabbed. The lid was left ajar for 3 min to 5 min, but no 
more than 15 min, to allow for any excess surface moisture to be absorbed before 
applying the impregnated discs. 
 
(e) Application of discs to inoculated agar plates 
 
 The impregnated disc was placed individually using sterile forceps onto the 
surface of the inoculated agar plate. Each disc was pressed down to ensure complete 
contact with the agar surface. Eight discs were placed in each plate. The plates were 
inverted and placed in an incubator (Binder, Germany) set to 35°C within 15 min after 
the discs were applied.  
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(f) Reading plates and interpreting results 
 
After 16 h to 18 h of incubation, each plate was examined. The diameters of 
the zones of complete inhibition (as judged by the unaided eye) were measured, 
including the diameter of the disc. Zones were measured to the nearest whole 
millimetre, using sliding callipers (American Scientific LLC, USA) or a ruler, which 
was held on the back of the inverted Petri plate. The Petri plate was held a few inches 
above a black, non-reflecting background and illuminated with reflected light. 
Eventually, the sizes of the zones of inhibition were interpreted. 
 
4.2.5 Statistical analysis 
 
 Statistical analysis of experimental data was performed using Microsoft Office 
Excel data analysis software. Data were presented by descriptive analysis as mean and 
standard deviation of three independent experiments performed in triplicate. 
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4.3 RESULTS AND DISCUSSION 
 
Plants constitute a vast untapped source of medicines with great therapeutic 
values (Nakhuru et al. 2013). The prospects for the development of antibacterial drugs 
from medicinal plants appear to be rewarding as they can mitigate the adverse effects 
that are often associated with synthetic antibiotics (Majumdar and Parihar 2012; 
Sharma et al. 2014). In the present study, Kirby-Bauer disc diffusion assay was 
conducted to evaluate the antibacterial activities of crude extracts against ATCC and 
clinical strains. This qualitative method is extensively used for antibiotic 
susceptibility testing in which filter paper discs impregnated with antibacterial agents 
are applied on the inoculated agar plate (Hakonen et al. 2014). The efficacy of these 
agents can subsequently be determined by measuring the diameter of the zones of 
inhibition that resulting from their diffusion into the agar medium around the discs 
(Johnson et al. 2012). 
 
The inhibitory effects of crude extracts on the growth of ATCC and clinical 
bacterial strains are depicted in Figure 4.1±4.4 (Appendix B3±B4). Among the crude 
extracts investigated, hexane and chloroform extracts of bark demonstrated potent 
antibacterial activities against ATCC and clinical strains with zones of inhibition 
ranging from 8.23±0.25 mm to 13.70±0.26 mm and 7.75±0.25 mm to 13.68±0.28 mm 
respectively. However, all extracts of leaves were found to be less effective in 
inhibiting the growth of the tested bacteria. This was in contrary to the studies of 
Gothandam et al. (2010) and Sowjanya et al. (2013), in which methanol extract of 
leaves (Artabotrys uncinatus and Artabotrys hexapetalus) displayed remarkable 
antibacterial activity with zones of inhibition ranging from 7 mm to 18 mm. 
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FIGURE 4.1 Antibacterial activities of crude extracts of Artabotrys crassifolius against ATCC strains. Results are expressed as mean ± 
standard deviation of three independent experiments performed in triplicate, n = 9. 
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FIGURE 4.1 Antibacterial activities of crude extracts of Artabotrys crassifolius against ATCC strains (continued). Results are expressed 
as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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FIGURE 4.1 Antibacterial activities of crude extracts of Artabotrys crassifolius against ATCC strains (continued). Results are expressed 
as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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FIGURE 4.2 Antibacterial activities of crude extracts of Artabotrys crassifolius against clinical isolates. Results are expressed as mean ± 
standard deviation of three independent experiments performed in triplicate, n = 9. 
0 
5 
10 
15 
20 
25 
E. faecalis MRSA MSSA ORCNS OSCNS 
Zo
n
e 
o
f i
nh
ib
iti
on
 
(m
m
) 
Microorganism 
Leaves hexane 
Leaves chloroform 
Leaves ethanol 
Bark hexane 
Bark chloroform 
Bark ethanol 
Streptomycin sulphate 
178 
 
 
 
FIGURE 4.2 Antibacterial activities of crude extracts of Artabotrys crassifolius against clinical isolates (continued). Results are expressed 
as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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FIGURE 4.2 Antibacterial activities of crude extracts of Artabotrys crassifolius against clinical isolates (continued). Results are expressed 
as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
0 
5 
10 
15 
20 
25 
ESBL-EC ESBL-KP Klebsiella sp. Moraxella sp. Serratia sp. 
Zo
n
e 
o
f i
nh
ib
iti
on
 
(m
m
) 
Microorganism 
Leaves hexane 
Leaves chloroform 
Leaves ethanol 
Bark hexane 
Bark chloroform 
Bark ethanol 
Streptomycin sulphate 
180 
 
   
 
FIGURE 4.3 Zone of inhibition of crude extracts of Artabotrys crassifolius against ATCC bacterial strains using Kirby-Bauer disc 
diffusion assay. The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, (5) bark 
chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.3 Zone of inhibition of crude extracts of Artabotrys crassifolius against ATCC bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.3 Zone of inhibition of crude extracts of Artabotrys crassifolius against ATCC bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.3 Zone of inhibition of crude extracts of Artabotrys crassifolius against ATCC bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.3 Zone of inhibition of crude extracts of Artabotrys crassifolius against ATCC bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
P. aeruginosa ATCC 10145 S. enteritidis ATCC 13076 S. typhimurium ATCC 14028 
2 
3 1 
7 8 
4 
5 
6 
1 
2 
3 
4 
5 
6 
7 8 
1 
2 
3 
4 
5 
6 
7 8 
185 
 
   
 
FIGURE 4.4 Zone of inhibition of crude extracts of Artabotrys crassifolius against clinical bacterial strains using Kirby-Bauer disc 
diffusion assay. The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, (5) bark 
chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.4 Zone of inhibition of crude extracts of Artabotrys crassifolius against clinical bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.4 Zone of inhibition of crude extracts of Artabotrys crassifolius against clinical bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.4 Zone of inhibition of crude extracts of Artabotrys crassifolius against clinical bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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FIGURE 4.4 Zone of inhibition of crude extracts of Artabotrys crassifolius against clinical bacterial strains using Kirby-Bauer disc 
diffusion assay (continued). The numbers indicate: (1) leaves hexane, (2) leaves chloroform, (3) leaves ethanol, (4) bark hexane, 
(5) bark chloroform, (6) bark ethanol, (7) streptomycin sulphate, and (8) DMSO.  
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Moreover, the positive control, streptomycin sulphate, created zones of 
inhibition ranging from 7.30±0.26 mm to 19.79±0.26 mm against all of the tested 
ATCC and clinical bacterial strains, with the exception of S. epidermidis ATCC 
12228, K. pneumoniae ATCC 13883, P. aeruginosa ATCC 10145, E. faecalis, MRSA, 
Enterobacter sp., E. coli, Moraxella sp. and Serratia sp.. In contrast, no inhibitory 
activity was observed in the negative control, DMSO. This implies that DMSO, the 
solvent used for the reconstitution of crude extracts, does not influence the 
susceptibility of the ATCC and clinical bacterial strains to the corresponding extracts. 
 
Considering the zones of inhibition produced by crude extracts, S. pneumoniae 
and S. agalactiae were found to be the most sensitive bacteria, followed by P. 
vulgaris ATCC 13315, L. monocytogenes ATCC 15313, ESBL-KP, Actinobacillus sp., 
MSSA, Klebsiella sp., S. aureus ATCC 11632, B. cereus ATCC 10876, M. luteus 
ATCC 10240, R. equi ATCC 33701, B. subtilis ATCC 21332, ORCNS, OSCNS, 
Enterobacter sp., E. faecalis, Moraxella sp. and S. epidermidis ATCC 12228, with S. 
pyogenes ATCC 19615, C. freundii ATCC 22636, E. coli ATCC 10536, K. 
pneumoniae ATCC 13883, P. aeruginosa ATCC 10145, S. enteritidis ATCC 13076, S. 
typhimurium ATCC 14028, MRSA, E. coli, ESBL-EC and Serratia sp. being the least 
susceptible to crude extracts. This suggests that the respective extracts may be more 
effective in inhibiting the growth of Gram-positive bacteria. 
 
In general, Gram-negative bacteria are more resistant to plant-based 
antibacterial agents in comparison to Gram-positive bacteria (Biswas et al. 2013). The 
susceptibility differences between these two groups of bacteria can be attributed to 
their distinct cell wall structures (Singariya et al. 2012).  
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Gram-negative bacteria are characterised by an outer membrane that encloses 
a comparatively thin layer of peptidoglycan (Silhavy et al. 2010). The outer 
membrane has a phospholipid-rich inner leaflet of similar composition to the 
cytoplasmic membrane, while the outer leaflet facing the extracellular environment is 
composed primarily of lipopolysaccharides (LPS) (Clifton et al. 2013), which provide 
an effective permeability barrier against hydrophobic compounds (Touw et al. 2010). 
In addition to these structural components, the asymmetric lipid bilayer also contains 
porins, which form water-filled channels that selectively facilitate the passage of 
hydrophilic compounds based on their molecular weight and ionic charge 
(Raghavendra 2011; Van Dam et al. 2014).    
 
On the other hand, Gram-positive bacteria possess a relatively thick 
peptidoglycan layer with lipoteichoic acids (LTA) anchored to the cytoplasmic 
membrane (Karlsson et al. 2002). Nonetheless, they are devoid of a highly 
impermeable outer membrane, making them more susceptible to antibacterial 
compounds (Ipharraguerre and Clark 2003). These chemical composition and 
organisation of bacterial cell wall may rationalise the variations in the sensitivity of 
the ATCC and clinical bacterial strains to the crude extracts.  
 
With regard to the phytochemical screening of crude extracts (Tan et al. 2013), 
the occurrence of alkaloids, cardiac glycosides and terpenoids in hexane and 
chloroform extracts of bark may explain their superior activity as compared to the 
other crude extracts studied. This warrants further isolation and characterisation of the 
potentially active principles from the respective crude extracts.  
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4.4 CONCLUSION 
 
 Assessment of the in vitro antibacterial activity of Artabotrys crassifolius 
revealed that hexane and chloroform extracts of bark may be an important source of 
novel antibacterial compounds in view of their prominent inhibitory activities 
particularly against Gram-positive bacteria. Hence, further studies are required to 
isolate and characterise the bioactive compounds responsible for the observed 
antibacterial properties of Artabotrys crassifolius. 
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CHAPTER V 
 
IN VITRO ANTIFUNGAL ACTIVITY OF ARTABOTRYS CRASSIFOLIUS 
 
5.1 INTRODUCTION 
 
Candida is a genus of yeast-like fungi that reproduce by budding or fission 
(Vazquez and Sobel 2011). Many species of this genus are harmless commensals that 
exist as part of the normal human microflora of the skin, oral cavity, respiratory, 
gastrointestinal and genitourinary tracts (Shamim et al. 2004; Herrera et al. 2010). 
Nonetheless, certain Candida species are responsible for causing opportunistic 
mycoses ranging from superficial mucosal infections to life-threatening systemic 
diseases, predominantly in immunocompromised patients with cancer, human 
immunodeficiency virus (HIV) infection or organ transplantation (Shin et al. 2005).  
 
In spite of the availability of wide array of antifungal agents, candidiasis 
remains as the fourth leading cause of nosocomial infections with an unacceptably 
high mortality rate (Santos et al. 2008; Papon et al. 2013). More crucially, majority of 
the clinically used antifungal drugs are associated with various drawbacks including 
high toxicity (Omran and Esmailzadeh 2009), limited efficacy (Supreetha et al. 2011), 
narrow spectrum of activity (Moussa et al. 2011) as well as poor tolerability (Ishida et 
al. 2011). Their widespread usage has also led to the rapid development of drug 
resistant strains during the course of therapy (Nayak et al. 2010). Consequently, it is 
imperative to search for alternative strategies for the effective management of 
Candida infections.   
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5.2 METHODOLOGY 
 
5.2.1 Microorganisms and culture media 
 
The microorganisms used in the present study were clinical isolates as shown 
in Table 5.1. Four fungal strains were procured from the Mycology Unit, Department 
of Medical Microbiology and Immunology, Universiti Kebangsaan Malaysia Medical 
Centre (UKMMC) (Appendix C1). Table 5.1 also includes the types of culture media 
required for the growth of the respective fungi. 
 
TABLE 5.1 Types of microorganisms and culture media. 
 
Microorganism Fungal strain Culture medium 
Clinical isolate 
   
Yeasts Candida albicans Potato dextrose broth  
(EMD Chemicals Inc., Germany)   
 
Candida glabrata 
   
 
Candida parapsilosis Potato dextrose agar  
(Merck, Germany)   
 
Candida tropicalis 
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5.2.2 Preparation of culture media 
 
(a) Preparation of broth medium 
 
 Potato dextrose broth (PDB) was prepared by suspending 24 g of PDB powder 
in 1 L of sterile distilled water. The solution was mixed thoroughly and heated to 
boiling with frequent agitation to dissolve the powder completely before dispensing 
into universal bottles. After autoclaving at 121°C for 15 min, the broth was allowed to 
cool down to room temperature before storing at 4°C until further use.  
 
(b) Preparation of agar medium 
 
 Potato dextrose agar (PDA) was prepared by suspending 39 g of PDA powder 
in 1 L of sterile distilled water. The solution was mixed thoroughly and heated in a 
boiling water bath (Julabo, Germany) or in a current of steam to dissolve the powder 
completely, followed by autoclaving at 121°C for 15 min. The autoclaved medium 
was allowed to cool down by immersing into a 45°C to 50°C water bath before 
pouring into sterile Petri dishes (Favorit, Malaysia) in laminar flow cabinet (Esco 
Micro, Malaysia). After pouring, the molten agar was allowed to solidify and dried for 
30 minutes before covering the plates to prevent formation of water on the agar 
surface. The prepared agar medium was stored in a 4°C chiller until further use. 
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5.2.3 Maintenance and storage of stock cultures 
 
(a) Preparation of plate cultures 
 
The streak plate method was employed to obtain pure yeast cultures. A sterile 
inoculating loop was dipped into the culture of yeasts and streaked in a pattern over 
the surface of the PDA plate. The inoculating loop was sterilised following each 
streak series. As the pattern was traced, yeasts were rubbed off the loop onto the 
medium. The last cells to be rubbed off the loop were far enough apart to grow into 
isolated colonies. Streaked plates were incubated at 35°C for 24 h. 
 
(b) Preparation of broth cultures 
 
The yeast cell suspension was prepared by picking a single isolated colony 
from freshly streaked plate with a sterile inoculating loop and transferring into 
universal bottles containing sterile PDB. The prepared cell suspension was vortexed 
thoroughly and incubated at 35°C for 24 h.   
 
(c) Preparation of glycerol stocks 
 
The glycerol stock was prepared by transferring the yeast cell suspension into 
cryovials containing a final concentration of 20% (v/v) of sterile glycerol (R & M 
Chemicals, UK). The prepared glycerol stock of yeasts was well-mixed before storing 
at ±20°C for 24 h and subsequently at ±80°C for long-term storage. 
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5.2.4 Kirby-Bauer disc diffusion assay 
 
The antifungal activities of crude extracts were examined against 4 clinical 
isolates using Kirby-Bauer disc diffusion method according to the guidelines of the 
Clinical and Laboratory Standards Institute (CLSI) (CLSI 2004), formerly known as 
National Committee for Clinical Laboratory Standards (NCCLS). 
 
(a) Preparation of supplemented Mueller-Hinton agar 
 
Mueller-Hinton agar (Difco Laboratories, USA) was prepared from a 
FRPPHUFLDOO\DYDLODEOHGHK\GUDWHGEDVHDFFRUGLQJWRWKHPDQXIDFWXUHU¶V instructions, 
and supplemented with 2% (w/v) of D(+)-glucose anhydrous (Systerm, Malaysia) and 
 ȝJP/ RI PHWK\OHQH EOXH (R & M Chemicals, UK) (MH-GMB). Immediately 
after autoclaving, the agar medium was allowed to cool in a 45°C to 50°C water bath. 
The freshly prepared and cooled medium was poured into plastic, flat-bottomed Petri 
dishes on a level, horizontal surface to give a uniform depth of approximately 4 mm, 
which corresponded to 25 mL to 30 mL of medium for plates with a diameter of     
100 mm. The agar medium was allowed to cool further to room temperature, and 
unless the plates were used the same day, stored in a 2°C to 8°C refrigerator.  
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(b) Preparation of impregnated filter paper discs 
 
Qualitative filter paper No. 1 (Whatman International Ltd., England) was used 
to prepare discs approximately 6 mm in diameter, which were sterilised by 
autoclaving at 121°C for 15 min. Sterile filter paper discs were impregnated with     
ȝ/RIHDFKFUXGHH[WUDFWPJP/WRJLYHDILQDOFRQFHQWUDWLRQRIPJGLVF
Amphotericin B (1 ȝJGLVF Sigma-Aldrich, USA) and DMSO (R & M Chemicals, 
UK) were served as positive and negative controls respectively. Impregnated discs 
were left to dry under laminar flow cabinet overnight.  
 
(c) Preparation of inoculum 
 
 Inoculum was prepared by picking five distinct colonies of approximately       
1 mm in diameter from a 24 h-old culture grown on PDA. Colonies were suspended in 
5 mL of sterile saline. The resulting suspension was vortexed for 15 s and the 
turbidity was adjusted either visually or with a UV/Vis spectrophotometer (Biochrom 
Libra, UK) by adding sufficient sterile saline or more colonies to adjust the 
transmittance to that produced by a 0.5 McFarland standard at 530 nm wavelength. 
The absorbance at 530 nm should be in the range of 0.12 to 0.15 for the 0.5 
McFarland standard. This yielded a yeast stock suspension of 1 × 106 cells/mL to       
5 × 106 cells/mL.   
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(d) Inoculation of test plates 
 
 Optimally, within 15 min after adjusting the turbidity of the inoculum 
suspension, a sterile cotton swab was dipped into the adjusted suspension. The swab 
was rotated several times and pressed firmly against the inside wall of the universal 
bottle above the fluid level to remove excess inoculum from the swab. The dried 
surface of a MH-GMB agar plate was inoculated by evenly streaking the swab over 
the entire sterile agar surface. This procedure was repeated by streaking two more 
times, rotating the plate approximately 60° each time to ensure an even distribution of 
inoculum. As a final step, the rim of the agar was swabbed. The lid was left ajar for   
3 min to 5 min, but no more than 15 min, to allow for any excess surface moisture to 
be absorbed before applying the impregnated discs. 
 
(e) Application of discs to inoculated agar plates 
 
 The impregnated disc was placed individually using sterile forceps onto the 
surface of the inoculated agar plate. Each disc was pressed down to ensure complete 
contact with the agar surface. Eight discs were placed in each plate. The plates were 
inverted and placed in an incubator (Binder, Germany) set to 35°C within 15 min after 
the discs were applied. 
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(f) Reading plates and interpreting results 
 
After 20 h to 24 h of incubation, each plate was examined. The diameters of 
the zones of complete inhibition (as judged by the unaided eye) were measured, 
including the diameter of the disc. Zones were measured to the nearest whole 
millimetre at the point at which there was a prominent reduction in growth, using 
sliding callipers (American Scientific LLC, USA) or a ruler, which was held on the 
back of the inverted Petri plate. The Petri plate was held a few inches above a black, 
non-reflecting background and illuminated with reflected light. Eventually, the sizes of 
the zones of inhibition were interpreted. 
 
5.2.5 Statistical analysis 
 
 Statistical analysis of experimental data was performed using Microsoft Office 
Excel data analysis software. Data were presented by descriptive analysis as mean and 
standard deviation of three independent experiments performed in triplicate. 
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5.3 RESULTS AND DISCUSSION 
 
Plants have received considerable research attention from the scientific 
community as potential candidates for the development of antifungal drugs (Ferreira 
et al. 2013). The utilisation of medicinal plants appears to be an alternative to 
synthetic antibiotics in the prevention and treatment of Candida infections because 
they are relatively safe, easily accessible as well as inexpensive (Maharajan et al. 
2012; Doddanna et al. 2013). In the current study, Kirby-Bauer disc diffusion assay 
was performed to examine the antifungal activities of crude extracts against clinical 
isolates. This qualitative method is widely employed for antibiotic susceptibility 
testing in which filter paper discs impregnated with antifungal agents are applied on 
the inoculated agar plate (Hakonen et al. 2014). The efficacy of these agents can 
subsequently be determined by measuring the diameter of the zones of inhibition that 
resulting from their diffusion into the agar medium around the discs (Johnson et al. 
2012). 
  
The inhibitory effects of crude extracts on the growth of clinical fungal strains 
are illustrated in Figure 5.1±5.2 (Appendix C2). All the crude extracts were found to 
be devoid of antifungal activity except for hexane extract of bark which was able to 
inhibit the growth of the tested Candida species with zones of inhibition ranging from 
7.81±0.27 mm to 9.77±0.25 mm. Different observation was reported by Sowjanya et 
al. (2013), in which methanol extract of leaves (Artabotrys hexapetalus) demonstrated 
strong antifungal activity against C. albicans and C. rugosa with zones of inhibition 
of 14 mm and 13 mm respectively. 
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FIGURE 5.1 Antifungal activities of crude extracts of Artabotrys crassifolius against clinical isolates. Results are expressed as mean ± 
standard deviation of three independent experiments performed in triplicate, n = 9. 
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FIGURE 5.2 Zone of inhibition of crude extracts of Artabotrys crassifolius 
against clinical fungal strains using Kirby-Bauer disc diffusion 
assay. The numbers indicate: (1) leaves hexane, (2) leaves chloroform, 
(3) leaves ethanol, (4) bark hexane, (5) bark chloroform, (6) bark 
ethanol, (7) amphotericin B, and (8) DMSO.  
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Furthermore, the positive control, amphotericin B, produced zones of 
inhibition ranging from 18.76±0.25 mm to 24.74±0.25 mm against the tested Candida 
species. On the contrary, no inhibitory activity was detected in the negative control, 
DMSO. This implies that DMSO, the solvent used for the reconstitution of crude 
extracts, does not affect the susceptibility of the clinical fungal strains to the 
respective extracts. 
 
Candida albicans is the most commonly isolated etiologic agent of candidiasis 
(Jabra-Rizk et al. 2004). Nevertheless, there has been a significant epidemiological 
shift in the species of Candida causing nosocomial candidemia, with the emergence 
of non-albicans Candida species, particularly those exhibiting reduced susceptibility 
or intrinsic resistance to antifungal drugs (Bruder-Nascimento et al. 2010; Eggimann 
et al. 2012). The emerging species of clinical importance include C. glabrata,            
C. krusei, C. parapsilosis and C. tropicalis (Kemoi et al. 2013). Among the Candida 
species evaluated in the present study, C. parapsilosis was shown to be the most 
sensitive species, followed by C. glabrata and C. tropicalis, with C. albicans being 
the least susceptible to hexane extract of bark. This suggests that the corresponding 
extract may be more effective in inhibiting the growth of non-albicans Candida 
species. 
  
With regard to the phytochemical analysis of crude extracts (Tan et al. 2013), 
the occurrence of alkaloids, cardiac glycosides and terpenoids in hexane extract of 
bark may explain its superior activity as compared to the other crude extracts tested. 
This warrants further isolation and characterisation of the potentially active principles 
from the respective crude extract. 
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5.4 CONCLUSION 
 
Investigation of the in vitro antifungal activity of Artabotrys crassifolius 
revealed that hexane extract of bark may be an important source of novel antifungal 
compounds in consideration of its prominent inhibitory activity predominantly against 
non-albicans Candida species. Therefore, further studies are required to isolate and 
characterise the bioactive compounds responsible for the observed antifungal 
properties of Artabotrys crassifolius. 
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CHAPTER VI 
 
IN VITRO ANTICANCER EFFECT OF ARTABOTRYS CRASSIFOLIUS 
 
6.1 INTRODUCTION 
 
Cancer is a group of diseases characterised by uncontrolled growth and spread 
of abnormal cells, which can lead to death if left untreated (Goyal 2012). The etiology 
of cancer can be associated with both external factors, including tobacco, infectious 
organisms, chemicals and radiation, as well as internal factors, such as inherited 
mutations, hormones, immune conditions and mutations occurring from metabolism 
(Sandeep et al. 2012). These causal factors may act synergistically or sequentially to 
initiate or promote carcinogenesis (Madan and Esmaeili 2012). 
 
Despite the considerable progress made over the last few decades in oncology 
research and treatment, cancer remains as one of the foremost causes of morbidity and 
mortality worldwide, with 12.7 million new cases and 7.6 million deaths in 2008 
(Msyamboza et al. 2012). More significantly, the most common cancer treatments are 
restricted to surgery, radiation and chemotherapy (Topcul and Cetin 2013), which are 
severely fraught with challenges concerned with adverse side effects of drugs (Jiang 
et al. 2010) due to their non-specific systemic distribution (Drabu et al. 2010), 
inadequate drug concentrations reaching the tumour (Wang et al. 2009), intolerable 
toxicity (Jeyaraj et al. 2013), and development of multiple drug resistance acquired 
upon repeated chemotherapeutic cycles (Shahbazi et al. 2012). Hence, there is clearly 
a need for novel chemotherapeutic agents with enhanced potency and specificity.  
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6.2 METHODOLOGY 
 
6.2.1 Cell lines and culture media 
  
The cell lines used in the current study were derived from human carcinoma as 
shown in Table 6.1. Three human carcinoma cell lines were procured from the Centre 
for Biomolecular Sciences, University of Nottingham UK Campus.  
 
TABLE 6.1 Types of human cell lines. 
 
Human cell line 
Origin Designation 
  
Breast carcinoma MCF-7 (estrogen receptor-positive, ER+) 
  
Breast carcinoma MDA-468 (estrogen receptor-negative, ER±) 
  
Colorectal carcinoma HCT-116 
  
 
Each cell line was routinely maintained in Roswell Park Memorial Institute 
(RPMI) 1640 medium (Sigma-Aldrich, USA) supplemented with 2 mM of L-
glutamine (Sigma-Aldrich, USA) and 10% (v/v) of foetal bovine serum (FBS) 
(Sigma-Aldrich, USA) at 37°C in a humidified 5% (v/v) of CO2 incubator (Binder, 
Germany), and subcultured twice weekly to maintain continuous logarithmic growth.   
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6.2.2 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay 
 
The anticancer effects of crude extracts were investigated against human 
breast and colorectal carcinoma cell lines using MTT assay according to the methods 
of Vasselin et al. (2006) and Bradshaw et al. (2008). Each cell line was seeded in 96-
well microtiter plates (Jet Biofil, China) at a density of 5 × 103 cells/well, and allowed 
to adhere for 24 h before crude extracts were introduced. Serial dilutions of crude 
extracts (final concentrations ranging from 6.25 µg/mL to 200 µg/mL) were prepared 
in medium immediately prior to assay. Viable cell masses at the time of crude extract 
addition (time zero) and following 72 h exposure were determined by cell-mediated 
reduction of MTT. A final concentration of 400 µg/mL of MTT (Sigma-Aldrich, USA) 
was added to each well, and plates were incubated at 37°C for 4 h to allow reduction 
of MTT by viable cells to an insoluble formazan product. The well supernatant was 
subsequently aspirated and the cellular formazan was solubilised by addition of 
DMSO (R & M Chemicals, UK) and glycine buffer (pH 10.5) (Sigma-Aldrich, USA) 
in a ratio of 4:1 (v/v). Quercetin (Sigma-Aldrich, Germany) was used as positive 
control. Eventually, the absorbance was read at 550 nm using an Anthos Labtec 
systems plate reader as a measure of cell viability. 
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Using the eight absorbance measurements [time zero (Tz), control growth (C), 
and test growth in the presence of crude extracts at the six concentration levels (Ti)], 
the percentage growth was calculated at each of the crude extract concentration levels 
(Noolvi et al. 2011). Percentage growth inhibition was calculated as: 
 
[(Ti ± Tz)/(C ± Tz)] × IRUFRQFHQWUDWLRQVIRUZKLFK7L7] 
[(Ti ± Tz)/Tz] × 100 for concentrations for which Ti < Tz 
 
Three dose response parameters were calculated for each crude extract. 
Growth inhibition of 50% (GI50) was calculated from [(Ti ± Tz)/(C ± Tz)] × 100 = 50, 
which was the crude extract concentration resulting in a 50% reduction in the net cell 
growth during the incubation. The crude extract concentration resulting in total 
growth inhibition (TGI) was calculated from Ti = Tz. The LC50 (concentration of 
crude extract resulting in a 50% reduction of initial cells at the end of the treatment as 
compared to that at the beginning) indicating a net loss of cells following treatment 
was calculated from [(Ti ± Tz)/Tz)] × 100 = ±50. Values were calculated for each of 
these three parameters if the level of activity was reached; however, if the effect was 
not reached or was exceeded, the value for that parameter was expressed as greater or 
less than the maximum or minimum concentration tested (Mayer and Bracher 2011). 
 
6.2.3 Statistical analysis 
 
 Statistical analysis of experimental data was performed using Microsoft Office 
Excel data analysis software. Data were presented by descriptive analysis as mean and 
standard deviation of three independent experiments performed in triplicate. 
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6.3 RESULTS AND DISCUSSION 
 
Plants have an almost unlimited capacity to synthesize diverse secondary 
metabolites that attract researchers and scientists in the quest for new 
chemotherapeutics (Talib and Mahasneh 2010). The continuing exploration for novel 
chemical classes of anticancer agents in medicinal plants is one of the realistic and 
promising approaches for cancer prevention (Vijayarathna and Sasidharan 2012).  
 
In the present study, MTT assay was conducted to investigate the anticancer 
effects of crude extracts on the growth of human breast and colorectal carcinoma cell 
lines. This colourimetric method is based on the capacity of mitochondrial succinate 
dehydrogenase enzymes in living cells to reduce the yellow water soluble substrate 
(MTT) into an insoluble, purple coloured formazan product which is measured 
spectrophotometrically. Since reduction of MTT can only occur in metabolically 
active cells, the level of activity is a measure of the cell viability (Mattana et al. 2012).  
 
According to the American National Cancer Institute (NCI), crude extracts 
could be considered as active for a GI50 value of less than 20 µg/mL (Hashim et al. 
2012). Based on the NCI criterion, chloroform extract of bark was highly active 
against all of the tested carcinoma cell lines with GI50 values ranging from             
4.23 µg/mL to 9.45 µg/mL (Figure 6.1±6.3; Appendix D). Furthermore, hexane 
extract of bark potently inhibited the growth of MDA-468 breast and HCT-116 
colorectal carcinoma cell lines with respective GI50 values of 6.10 µg/mL and      
16.45 µg/mL. This indicates that the non-polar active principles present in the bark 
may be responsible for the anticancer activity of this plant. 
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FIGURE 6.1 Anticancer effects of crude extracts of Artabotrys crassifolius against MCF-7 (ER+) breast carcinoma cell line. Results are 
expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
-150 
-100 
-50 
0 
50 
100 
150 
0 50 100 150 200 250 
M
C
F-
7 
(E
R+
) b
re
a
st
 c
a
rc
in
o
m
a
 c
el
l g
ro
w
th
 (%
) 
Concentration (µg/mL) 
Leaves hexane 
Leaves chloroform 
Leaves ethanol 
Bark hexane 
Bark chloroform 
Bark ethanol 
212 
 
 
 
FIGURE 6.2 Anticancer effects of crude extracts of Artabotrys crassifolius against MDA-468 (ER±) breast carcinoma cell line. Results 
are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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FIGURE 6.3 Anticancer effects of crude extracts of Artabotrys crassifolius against HCT-116 colorectal carcinoma cell line. Results are 
expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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For better visualisation of the differences in achieving complete cell growth 
inhibition for all the crude extracts, TGI concentrations were expressed. In MCF-7 
breast carcinoma cell line, chloroform and hexane extracts of bark were less potent as 
shown by their respective TGI values of 32.73 µg/mL and 54.63 µg/mL. In MDA-468 
breast carcinoma cell line, chloroform extract of bark induced total growth inhibition 
at the lowest concentration of 11.11 µg/mL, whereas hexane extract of bark displayed 
a comparable TGI value of 28.01 µg/mL. In HCT-116 colorectal carcinoma cell line, 
chloroform extract of bark exhibited a 1.75-fold lower TGI concentration than that of 
hexane extract of bark. However, no total growth inhibition was obtained upon 
treatment with ethanol extract of leaves and bark.   
   
At doses higher than the TGIs, net cell killing was observed in all of the tested 
carcinoma cell lines. Chloroform extract of bark demonstrated the highest cytotoxic 
action with LC50 values ranging from 33.06 µg/mL to 48.84 µg/mL, while hexane 
extract of bark showed less pronounced cytotoxicity with LC50 values ranging from 
40.14 µg/mL to 105.61 µg/mL. Considering the TGI concentrations and the net cell 
killing achieved by crude extracts, MDA-468 breast carcinoma cell line was found to 
be the most sensitive cell line, followed by HCT-116 colorectal carcinoma cell line, 
with MCF-7 breast carcinoma cell line being the least susceptible to crude extracts.  
 
With respect to the phytochemical screening of crude extracts (Tan et al. 
2013), the presence of alkaloids, cardiac glycosides and terpenoids in chloroform and 
hexane extracts of bark may explain their superior activity in comparison to the other 
crude extracts studied. This necessitates further isolation and characterisation of the 
potentially active principles from the respective crude extracts. 
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Although anticancer activities of isolated compounds from Artabotrys species 
have been previously published, no detailed anticancer studies have been reported on 
the crude extracts from which they were derived. This study could be useful prior to 
the selection of active extracts for isolation and characterisation. 
 
6.4 CONCLUSION 
 
Examination of the in vitro anticancer effect of Artabotrys crassifolius 
revealed that chloroform and hexane extracts of bark may be a significant source of 
novel anticancer compounds in view of their promising inhibitory activities 
particularly against MDA-468 breast carcinoma cell line. Therefore, further studies 
are needed to isolate and characterise the bioactive compounds responsible for the 
observed anticancer properties of Artabotrys crassifolius.     
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CHAPTER VII 
 
IN VITRO ANTIOXIDANT POTENTIAL OF ARTABOTRYS CRASSIFOLIUS 
 
7.1 INTRODUCTION 
 
 Free radicals are atomic or molecular species that can exist independently with 
one or more unpaired electrons in their outermost shell (Craft et al. 2012). They are 
generated as by-products during normal cellular metabolism (Barrera 2012). Due to 
their highly reactive and unstable properties in nature (Kamboj et al. 2014), they are 
capable of inducing oxidative damage to all the major classes of biomolecules 
including carbohydrates, lipids, proteins, and nucleic acids (Khasawneh et al. 2011). 
These damages are further implicated in the pathogenesis of atherosclerosis, cancer, 
diabetes mellitus, ischemia and reperfusion injury, neurodegenerative diseases, 
obstructive sleep apnea, rheumatoid arthritis as well as senescence (Droge 2002).  
 
 Although the human body possesses the comprehensive network of 
antioxidant defence and repair systems, these endogenous protective mechanisms are 
inadequate to counteract the damaging effects of free radicals completely (Lima-
Saraiva et al. 2012). More importantly, the application of currently available synthetic 
antioxidants such as butylated hydroxyanisole (BHA), butylated hydroxytoluene 
(BHT), gallic acid esters and tert-butylhydroquinone (TBHQ) is often restricted 
because of their low solubility, moderate antioxidant activity and possible toxicity 
(Kiran et al. 2012). Therefore, the exploration of alternative antioxidants from natural 
sources is highly desirable.  
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7.2 METHODOLOGY 
 
7.2.1 Determination of total phenolic content (TPC) 
 
 The total phenolic contents of crude extracts were assessed using Folin-
Ciocalteu (FC) assay according to the methods of Zongo et al. (2010) and Lee and 
Vairappan (2011). In a 96-well microtiter plate (Jet Biofil, China), 100 µL of            
10% (v/v) of FC reagent (R & M Chemicals, UK) was added to 5 µL of each crude 
extract (final concentration of 50 µg/mL). After 5 min incubation at room temperature, 
80 µL of 7.5% (w/v) of sodium carbonate (Na2CO3) (R & M Chemicals, UK) was 
added to each well containing the previous mixture. The plate was shaken gently and 
incubated for 30 min at room temperature in the dark. Gallic acid (final concentrations 
ranging from 5 µg/mL to 25 µg/mL) (R & M Chemicals, UK) was used to establish 
the standard curve. Eventually, the absorbance was measured at 765 nm against the 
corresponding blank solution using Varioskan Flash microplate reader with SkanIt 
Software 2.4.3 RE (Thermo Scientific, Malaysia). The total phenolic content was 
expressed as gallic acid equivalents (GAE) in milligram per gram of extract           
(mg GAE/g extract) (Iqbal et al. 2012), which was calculated by the following 
equation: 
 
T1 = C1 × 
V 
, 
M 
 
where T1 is the total phenolic content, mg/g of extract, in GAE; C1 is the 
concentration of gallic acid established from the calibration curve, mg/mL; V is the 
volume of crude extract, mL; M is the weight of crude extract, g. 
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7.2.2 Determination of total flavonoid content (TFC) 
 
The total flavonoid contents of crude extracts were assessed using aluminium 
chloride colourimetric assay according to the methods of Tavares et al. (2010) and 
Yang et al. (2012). In a 96-well microtiter plate, 15 µL of 5% (w/v) of sodium nitrite 
(NaNO2) (Merck, Germany) was added to 5 µL of each crude extract (final 
concentration of 50 µg/mL). The plate was allowed to stand for 6 min at room 
temperature and subsequently 30 µL of 10% (w/v) of aluminium chloride hexahydrate 
(AlCl3Â6H2O) (R & M Chemicals, UK) was added to the mixture. After a further        
5 min incubation at room temperature, 100 µL of 1 M of sodium hydroxide (NaOH) 
(Merck, Germany) was added to the mixture and immediately diluted by the addition 
of 55 µL of distilled water. (+)-Catechin hydrate (final concentrations ranging from   
5 µg/mL to 25 µg/mL) (Sigma-Aldrich, Indonesia) was used to establish the standard 
curve. Eventually, the absorbance was measured at 510 nm against the corresponding 
blank solution using Varioskan Flash microplate reader with SkanIt Software 2.4.3 
RE. The total flavonoid content was expressed as catechin equivalents (CE) in 
milligram per gram of extract (mg CE/g extract) (Vyas 2010), which was calculated 
by the following equation: 
 
T2 = C2 × 
V 
, 
M 
 
where T2 is the total flavonoid content, mg/g of extract, in CE; C2 is the concentration 
of catechin established from the calibration curve, mg/mL; V is the volume of crude 
extract, mL; M is the weight of crude extract, g. 
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7.2.3 ¶-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) cation 
radical scavenging assay 
 
The antioxidant potentials of crude extracts were assessed using ABTS cation 
radical scavenging assay according to the methods of Bunea et al. (2011) and 
Sampath and Vasanthi (2013). The ABTS cation radical was produced by reacting     
7 mM of ABTS diammonium salt solution (Sigma-Aldrich, Canada) with 2.45 mM of 
potassium peroxodisulphate solution (K2S2O8) (Fluka, Germany) in equal volume. 
The mixture was allowed to stand in the dark at room temperature for 12 h to 16 h. 
Prior to assay, the ABTS working solution was prepared by diluting the stock solution 
with methanol (Friendemann Schmidt, Australia) to an absorbance of 0.70±0.02 at 
734 nm. In a 96-well microtiter plate, 195 µL of the diluted ABTS solution was added 
to 5 µL of each crude extract (final concentrations ranging from 3.125 µg/mL to     
100 µg/mL). The plate was shaken gently and incubated for 6 min at room 
temperature in the dark. Trolox (final concentrations ranging from 3.125 µg/mL to 
100 µg/mL) (Acros Organics, Belgium) was used as positive control. Eventually, the 
absorbance was measured at 734 nm against the corresponding blank solution using 
Varioskan Flash microplate reader with SkanIt Software 2.4.3 RE. The percentage of 
ABTS cation radical scavenging activity was calculated by the following equation:  
 
ABTS cation  
radical scavenging activity (%) = 
[A0 ± (A1 ± A2)] 
× 100% , 
A0 
 
where A0 is the absorbance of negative control; A1 is the absorbance of reaction 
mixture; A2 is the absorbance of crude extract or positive control. The IC50 value was 
determined from the plotted graph of scavenging activity against the concentration of 
crude extracts or positive control (Yang et al. 2011). 
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7.2.4 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay 
 
The antioxidant potentials of crude extracts were assessed using DPPH radical 
scavenging assay according to the methods of Yang et al. (2009) and Mutee et al. 
(2010). In a 96-well microtiter plate, 195 µL of 0.1 mM of DPPH (Sigma-Aldrich, 
USA) was added to 5 µL of each crude extract (final concentrations ranging from 
3.125 µg/mL to 100 µg/mL). The plate was shaken gently and incubated for 30 min at 
room temperature in the dark. L(+)-ascorbic acid (final concentrations ranging from 
3.125 µg/mL to 100 µg/mL) (Systerm, Malaysia) was used as positive control. 
Eventually, the absorbance was measured at 517 nm against the corresponding blank 
solution using Varioskan Flash microplate reader with SkanIt Software 2.4.3 RE. The 
percentage of DPPH radical scavenging activity was calculated by the following 
equation:  
 
DPPH 
radical scavenging activity (%) = 
[A0 ± (A1 ± A2)] 
× 100% , 
A0 
 
where A0 is the absorbance of negative control; A1 is the absorbance of reaction 
mixture; A2 is the absorbance of crude extract or positive control. The IC50 value was 
determined from the plotted graph of scavenging activity against the concentration of 
crude extracts or positive control (Tibuhwa 2012). The antioxidant activity index 
(AAI) (Zongo et al. 2011) was calculated as follows: 
 
AAI = 
Final concentration of DPPH (µg/mL) 
IC50 value of crude extract (µg/mL) 
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7.2.5 Ferric reducing antioxidant power (FRAP) assay 
 
The antioxidant potentials of crude extracts were assessed using FRAP assay 
according to the methods of Gan et al. (2010) and Song et al. (2010). The FRAP 
reagent was freshly prepared by mixing 300 mM of acetate buffer (pH 3.6) [mixture 
of sodium acetate trihydrate (Merck, Germany) and glacial acetic acid (Systerm, 
Malaysia)], 10 mM of 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ) (Sigma-Aldrich, 
Switzerland) in 40 mM of hydrochloric acid (HCl) (Systerm, Malaysia), and 20 mM 
of ferric chloride hexahydrate (FeCl3Â6H2O) (Systerm, Malaysia) in a volume ratio of 
10:1:1 respectively. Prior to assay, the FRAP reagent was warmed to 37°C in a water 
bath (Julabo, Germany). In a 96-well microtiter plate, 195 µL of the FRAP reagent 
was added to 5 µL of each crude extract (final concentrations ranging from          
3.125 µg/mL to 100 µg/mL). The plate was shaken gently and incubated at 37°C for  
4 min. Ferrous sulphate heptahydrate (FeSO4Â7H2O) (final concentrations ranging 
from 50 µM to 250 µM) (Systerm, Malaysia) was used to establish the standard curve. 
Eventually, the absorbance was measured at 593 nm against the corresponding blank 
solution using Varioskan Flash microplate reader with SkanIt Software 2.4.3 RE. The 
FRAP value was expressed as FeSO4Â7H2O equivalents, Fe(II) in micromole per gram 
of extract [µmol Fe(II)/g extract], which was calculated by the following equation: 
 
T3 = C3 × 
V 
, 
M 
 
where T3 is the FRAP value, µmol/g of extract, in Fe(II); C3 is the concentration of 
FeSO4Â7H2O established from the calibration curve, µmol/L; V is the volume of crude 
extract, L; M is the weight of crude extract, g. 
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7.2.6 Statistical analysis 
 
Statistical analysis of experimental data was performed using Microsoft Office 
Excel data analysis software. Data were presented by descriptive analysis as mean and 
standard deviation of three independent experiments performed in triplicate. 
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7.3 RESULTS AND DISCUSSION 
 
Plants represent an invaluable source of raw materials for the development of 
natural antioxidants (Ghasemzadeh et al. 2012). Nevertheless, due to the diverse and 
complex nature of the phytochemical constituents, there is no single universal method 
that can accurately evaluate the antioxidant activities of plant extracts (Ksiksi and 
Hamza 2012). In the current study, TPC, TFC, ABTS, DPPH and FRAP assays were 
performed to assess the antioxidant potentials of crude extracts.  
 
7.3.1 Total phenolic contents of crude extracts of Artabotrys crassifolius 
  
Folin-Ciocalteu assay is extensively used for the quantification of total 
phenolic content (Prasain et al. 2008). This method is based on the reduction of 
phosphomolybdic and phosphotungstic acid complexes to blue chromogens in the 
presence of phenolic compounds under alkaline conditions (Mehran et al. 2014).    
 
The total phenolic contents of crude extracts were calculated from the 
regression equation of the calibration curve of gallic acid (y = 0.0384x, R2 = 0.9996) 
(Figure 7.1; Appendix E1). According to Rufino et al. (2010), the content of total 
phenolics of crude extracts could be categorised into three classes: low (less than     
10 mg GAE/g), medium (ranging from 10 mg GAE/g to 50 mg GAE/g) and high 
(more than 50 mg GAE/g). Under this classification, ethanol extract of bark and 
leaves demonstrated remarkably high total phenolic contents of 268.29±12.36 mg 
GAE/g and 154.91±4.26 mg GAE/g respectively (Figure 7.2; Appendix E2). This 
may be due to the greater solubility of phenolic compounds in ethanol.  
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FIGURE 7.1 Standard curve of gallic acid for the determination of total phenolic contents of crude extracts of Artabotrys crassifolius. 
Results are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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FIGURE 7.2 Total phenolic contents of crude extracts of Artabotrys crassifolius. Results are expressed as mean ± standard deviation (error 
bar) of three independent experiments performed in triplicate, n = 9. 
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7.3.2 Total flavonoid contents of crude extracts of Artabotrys crassifolius 
 
Aluminium chloride assay is widely employed for the estimation of total 
flavonoid content (Corpuz et al. 2013). This method is based on the development of 
acid-stable complexes between aluminium chloride and the C-4 keto group along with 
either the C-3 or C-5 hydroxyl group of flavones and flavonols. Additionally, 
aluminium chloride also forms acid-labile complexes with the ortho-dihydroxyl 
groups in the A- or B-ring of flavonoids (Rajanandh and Kavitha 2010). These 
complexes subsequently produce pink chromogens upon reacting with sodium nitrite 
under alkaline conditions (Kaur 2010).   
 
The total flavonoid contents of crude extracts were determined from the 
regression equation of the calibration curve of catechin (y = 0.0184x, R2 = 0.9964) 
(Figure 7.3; Appendix E1). Their content of total flavonoids expressed as catechin 
equivalents was recorded in the range from 6.29±4.27 mg/g to 179.54±4.98 mg/g 
(Figure 7.4; Appendix E2).  
 
Among the crude extracts examined, ethanol extract of bark displayed the 
highest total flavonoid content (179.54±4.98 mg CE/g), which was approximately 
2.13-fold greater than that of ethanol extract of leaves (84.47±6.61 mg CE/g). On the 
contrary, the content of total flavonoids was found to be comparatively low in both 
hexane extracts of leaves (9.48±4.53 mg CE/g) and bark (6.29±4.27 mg CE/g). This 
indicates that ethanol has superior extraction capacity as well as selectivity for 
flavonoids in comparison to hexane. 
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FIGURE 7.3 Standard curve of catechin for the determination of total flavonoid contents of crude extracts of Artabotrys crassifolius. 
Results are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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FIGURE 7.4 Total flavonoid contents of crude extracts of Artabotrys crassifolius. Results are expressed as mean ± standard deviation (error 
bar) of three independent experiments performed in triplicate, n = 9. 
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7.3.3 Antioxidant potentials of crude extracts of Artabotrys crassifolius using 
ABTS cation radical scavenging assay 
 
ABTS assay is commonly employed for the determination of antioxidant 
capacity of plant extracts (Contreras-Calderon et al. 2011). This method is based on 
the reduction of blue-green chromogens produced from the reaction between ABTS 
and potassium peroxodisulphate in the presence of electron-donating antioxidants 
(Ahmed 2012). 
 
Figure 7.5 depicts the ABTS cation radical scavenging activities of crude 
extracts (Appendix E3). At 100 µg/mL concentration, ethanol extract of bark and 
leaves exhibited the maximum scavenging effects of 99.86±0.06% and 99.76±0.26% 
against ABTS cation radical respectively, which were similar to that of the standard, 
trolox (99.72±0.15%), a water-soluble vitamin E analogue. 
 
The cut-off point for antioxidant potentials of crude extracts was suggested to 
be 50 µg/mL (Omisore et al. 2005). According to Kuete and Efferth (2010) and Chew 
et al. (2011), the radical scavenging ability of crude extracts could be classified based 
on their IC50 values as follows: high antioxidant capacity (IC50 value less than           
50 µg/mL), moderate antioxidant capacity (IC50 value ranging from 50 µg/mL to    
100 µg/mL) and low antioxidant capacity (IC50 value more than 100 µg/mL). Under 
this categorisation, ethanol extract of bark and leaves demonstrated high antioxidant 
capacity with respective IC50 values of 16.50 µg/mL and 30.77 µg/mL whereas trolox 
gave an IC50 value of 6.88 µg/mL. This implies that the corresponding extracts may 
function as effective scavengers of ABTS cation radical. 
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FIGURE 7.5 Antioxidant potentials of crude extracts of Artabotrys crassifolius using ABTS cation radical scavenging assay. Results are 
expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
0 
25 
50 
75 
100 
125 
0 25 50 75 100 125 
A
BT
S 
ca
tio
n 
ra
di
ca
l s
ca
v
en
gi
ng
 a
ct
iv
ity
 (%
) 
Concentration (µg/mL) 
Leaves hexane 
Leaves chloroform 
Leaves ethanol 
Bark hexane 
Bark chloroform 
Bark ethanol 
Trolox 
231 
 
7.3.4 Antioxidant potentials of crude extracts of Artabotrys crassifolius using 
DPPH radical scavenging assay 
 
 DPPH assay is widely used for the evaluation of radical scavenging activity of 
plant extracts (Ndhlala et al. 2010). This method is based on the reduction of purple-
coloured DPPH radical (2,2-diphenyl-1-picrylhydrazyl) to yellow-coloured non-
radical form of DPPH (2,2-diphenyl-1-picrylhydrazine) in the presence of hydrogen-
donating antioxidants (Murali et al. 2011).  
 
The scavenging effects of crude extracts on DPPH radical are illustrated in 
Figure 7.6 (Appendix E4). All the crude extracts showed a concentration-dependent 
increase in scavenging DPPH radical. At a concentration of 100 µg/mL, the highest 
DPPH radical scavenging activity was observed in ethanol extract of bark 
(95.47±2.37%; IC50 value of 16.54 µg/mL), which had comparable scavenging effect 
to that of the positive control, ascorbic acid (95.34±0.64%; IC50 value of 7.59 µg/mL), 
a water-soluble form of vitamin C.   
 
According to the scale proposed by Scherer and Godoy (2009), crude extracts 
could be considered to show poor antioxidant activity when AAI less than 0.5, 
moderate antioxidant activity when AAI ranging from 0.5 to 1.0, strong antioxidant 
activity when AAI ranging from 1.0 to 2.0, and very strong antioxidant activity when 
AAI more than 2.0. Based on this classification, ethanol extract of bark displayed very 
strong antioxidant activity with an AAI value of 2.32, while the AAI value of ascorbic 
acid was found to be 5.07. This suggests that the respective extract may possess 
compounds with hydrogen-donating ability that can efficiently scavenge DPPH 
radical. 
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FIGURE 7.6 Antioxidant potentials of crude extracts of Artabotrys crassifolius using DPPH radical scavenging assay. Results are 
expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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7.3.5 Antioxidant potentials of crude extracts of Artabotrys crassifolius using 
FRAP assay 
 
FRAP assay is extensively applied for the measurement of reducing power of 
plant extracts (Magalhaes 2007). This method is based on the reduction of colourless 
ferric complex (Fe3+-tripyridyltriazine) to blue-coloured ferrous complex (Fe2+-
tripyridyltriazine) in the presence of electron-donating antioxidants under acidic 
conditions (Irshad et al. 2012). 
 
The FRAP values of crude extracts were obtained from the regression 
equation of the calibration curve of FeSO4Â7H2O (y = 0.0111x, R2 = 0.9963) (Figure 
7.7; Appendix E5). Their FRAP values expressed as FeSO4Â7H2O equivalents, Fe(II) 
were varied from 67.64±23.40 µmol/g to 1884.35±83.78 µmol/g (Figure 7.8; 
Appendix E6). 
 
According to Wong et al. (2006) and Oonsivilai et al. (2008), crude extracts 
could be classified into four categories based on their antioxidant power: low [less 
than 10 µmol Fe(II)/g], medium [ranging from 10 µmol Fe(II)/g to 100 µmol Fe(II)/g], 
high [ranging from 100 µmol Fe(II)/g to 500 µmol Fe(II)/g], and extremely high 
[more than 500 µmol Fe(II)/g]. Based on this categorisation, ethanol extract of bark 
and leaves exhibited exceptionally high antioxidant power with respective FRAP 
values of 1884.35±83.78 µmol Fe(II)/g and 979.57±57.17 µmol Fe(II)/g. In contrast, 
medium antioxidant power was detected in both hexane extracts of leaves 
[92.26±5.99 µmol Fe(II)/g] and bark [67.64±23.40 µmol Fe(II)/g]. This may be 
attributed to the better electron-donating capabilities of ethanol extracts as compared 
to hexane extracts. 
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FIGURE 7.7 Standard curve of FeSO4Â7H2O for the antioxidant potentials of crude extracts of Artabotrys crassifolius using FRAP assay. 
Results are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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FIGURE 7.8 Antioxidant potentials of crude extracts of Artabotrys crassifolius using FRAP assay. Results are expressed as mean ± 
standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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With respect to the phytochemical analysis of crude extracts (Tan et al. 2013), 
the presence of cardiac glycosides, flavonoids, phenolic compounds, saponins and 
terpenoids in ethanol extract of bark may explain its superior activity in comparison to 
the other crude extracts tested. This necessitates further isolation and characterisation 
of the potentially active principles from the respective crude extract. Considering that 
no literature review has been assembled to comprehensively address the antioxidant 
properties of Artabotrys species, this study could be the first report providing new 
insights into the antioxidant activity in the genus Artabotrys.      
 
7.4 CONCLUSION 
 
 Evaluation of the in vitro antioxidant potential of Artabotrys crassifolius 
revealed that ethanol extract of bark may be a significant source of novel antioxidant 
compounds in consideration of its promising scavenging activity predominantly 
against ABTS cation radical. Consequently, further studies are needed to isolate and 
characterise the bioactive compounds responsible for the observed antioxidant 
properties of Artabotrys crassifolius. 
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CHAPTER VIII 
 
IN VITRO PHARMACOLOGICAL ACTIVITY OF ISOLATED 
COMPOUNDS FROM ARTABOTRYS CRASSIFOLIUS 
 
8.1 INTRODUCTION  
 
Over the last century, natural products have provided considerable value to the 
pharmaceutical industry in the discovery of novel chemical structures and bioactive 
lead molecules for drug development (Baker et al. 2007). Numerous natural products 
and their synthetically modified derivatives such as morphine and aspirin have been 
developed clinically to treat human diseases in all therapeutic areas, particularly 
infectious diseases and oncology (Brahmachari 2012).    
 
Despite the availability of various approaches in drug discovery and 
development including synthetic and combinatorial chemistry, as well as computer-
based molecular modeling design, none of them can substitute the central role of 
natural products as the majority of core structures or scaffolds for synthetic 
compounds are based upon natural products (Jesus 2003; Chinyama 2009; Veeresham 
and Chitti 2013). More significantly, not all natural products can be prepared by total 
synthesis, and many of them possess highly complex structures that are too difficult 
and economically infeasible to synthesize on an industrial scale (Ige et al. 2012). 
Consequently, isolation and characterisation of pharmacologically active compounds 
from natural products remain to be the only viable option. 
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8.2 METHODOLOGY 
 
8.2.1 Isolation and characterisation 
 
The chloroform extract of bark (24.79 g), which exerted pronounced 
antibacterial and anticancer activities, was subjected to silica gel 60 (0.063±0.200 mm, 
70±230 mesh ASTM) (Merck, Germany) column chromatography eluted with 
hexane±chloroform (100:0 to 10:90, v/v) (Friendemann Schmidt, Australia) and 
chloroform±methanol (100:0 to 80:20, v/v) (Friendemann Schmidt, Australia) to 
afford 141 fractions. Each collected fraction was monitored by analytical thin layer 
chromatography (TLC) on silica gel 60 F254 aluminium sheets (0.2 mm thickness) 
(Merck, Germany) using chloroform±methanol (95:5, v/v) as eluent. The spots were 
visualised under ultraviolet (UV) light at 254 nm and 365 nm, followed by spraying 
ZLWK'UDJHQGRUII¶s reagent for alkaloid detection. Fractions with similar TLC profiles 
were combined to give 9 major fractions (A±I).  
 
Fraction C was purified by Sephadex LH-20 (GE Healthcare, Sweden) column 
chromatography eluted with chloroform to furnish 7 subfractions (C1±7). 
Subfractions C2±4 were washed with diethyl ether (RCI Labscan, Thailand) and 
recrystallised from chloroform to afford compound 1 (10.9 mg). Fraction D was 
repeatedly chromatographed over silica gel column using chloroform±methanol 
(100:0 to 80:20, v/v) as eluent to yield 10 subfractions (D1±10). Subfractions D2±4 
were purified by preparative TLC on silica gel 60 F254 glass plates (2 mm thickness) 
(Merck, Germany) eluted with chloroform±methanol (98:2, v/v) to furnish compound 
2 (3.0 mg).  
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Fractions E±G were separately chromatographed over Sephadex LH-20 
column using chloroform as eluent, followed by purification on silica gel column 
eluted with chloroform±methanol (100:0 to 80:20, v/v) to give 9 subfractions (EG1±9). 
Subfractions EG4±7 were further purified on preparative TLC plates using 
chloroform±methanol (98:2, v/v) as eluent to yield compounds 3 (2.9 mg) and            
4 (10.3 mg).  
 
The structures of the isolated compounds were elucidated on the basis of 
spectroscopic analysis including single-crystal X-ray diffraction (compound 1) and 
one-dimensional nuclear magnetic resonance (NMR) (compounds 2, 3 and 4), as well 
as comparison with data reported in the literature.  
 
A suitable crystal of compound 1 was selected and measured on a SuperNova, 
single source at offset, Atlas diffractometer. The crystal was kept at 120(2) K during 
data collection. Using Olex2 (Dolomanov et al. 2009), the structure was solved with 
the olex2.solve structure solution program using Charge Flipping and refined with the 
XL (Sheldrick 2008) refinement package using Least Squares minimisation.  
 
The proton NMR (1H NMR) spectra of compounds 2, 3 and 4 were recorded 
on a Bruker Avance 3400 spectrometer at 400 MHz using deuterated chloroform 
(CDCl3) (Sigma-Aldrich, USA) as solvent. Chemical shifts į DUH reported in parts 
per million (ppm) relative to the residual solvent peak. 
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8.2.2 Determination of minimum inhibitory concentration (MIC) 
  
The minimum inhibitory concentrations (MIC) of isolated compounds were 
evaluated against ATCC and clinical strains using broth microdilution method 
according to the guidelines of the CLSI (CLSI 2012), formerly known as National 
Committee for Clinical Laboratory Standards (NCCLS). 
 
(a) Preparation of Mueller-Hinton broth 
 
Mueller-Hinton broth (MHB) (Difco Laboratories, USA) was prepared from a 
FRPPHUFLDOO\DYDLODEOHGHK\GUDWHGEDVHDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
After autoclaving at 121°C for 15 min, the broth was allowed to cool down to room 
temperature before storing at 4°C until further use.  
 
(b) Preparation of microdilution plates 
 
In a 96-well microtiter plate (Jet Biofil, China), 175 µL of MHB was added to 
5 µL of each isolated compound (final concentrations ranging from 0.3125 µg/mL to 
20 µg/mL) prior to inoculation. Streptomycin sulphate (final concentrations ranging 
from 0.3125 µg/mL to 20 µg/mL) (Fisher BioReagents, China) and DMSO (R & M 
Chemicals, UK) were served as positive and negative controls respectively.  
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(c) Preparation of inoculum 
 
A standardised inoculum was prepared using the growth method as described 
in Chapter 4.2.4(c). Optimally within 15 min of preparation, the adjusted inoculum 
suspension was diluted in water, saline, or broth to obtain a final test concentration of 
bacteria of approximately 5 × 105 CFU/mL in each well.   
 
(d) Inoculation of microdilution plates 
 
Within 15 min after the inoculum was standardised, each well of a 
microdilution plate was inoculated with 20 µL of the prepared inoculum using a 
multichannel pipette. To prevent drying, each plate was sealed in a plastic bag, with 
plastic tape, or with a tight-fitting plastic cover before incubating. 
 
(e) Incubation of microdilution plates 
 
 The inoculated microdilution plates were incubated at 35°C for 16 h to 20 h in 
an ambient air incubator (Binder, Germany) within 15 min of adding the inoculum. 
To maintain the same incubation temperature for all cultures, microdilution plates 
should not be stacked more than four high.  
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(f) Reading MIC results 
 
The amount of growth in the wells containing isolated compounds was 
compared with that in the positive growth control wells (without isolated compounds) 
used in each set of tests when determining the growth endpoints. Eventually, the MIC 
value was recorded as the lowest concentration of each isolated compound that 
completely inhibited the growth of bacteria in the microdilution wells as detected by 
the unaided eye. 
 
8.2.3 Determination of minimum bactericidal concentration (MBC) 
 
The minimum bactericidal concentrations (MBC) of isolated compounds were 
evaluated according to the guidelines of the CLSI (CLSI 1999), formerly known as 
1&&/6$IWHU0,&GHWHUPLQDWLRQDQDOLTXRWRIȝ/ZDVUHPRYHGIURPHDFKZHOO
showing inhibition of growth and subcultured on Mueller-Hinton agar (MHA) (Difco 
Laboratories, USA) plates. The plates were incubated at 35°C for 24 h. Eventually, 
the MBC value was taken as the lowest concentration of each isolated compound that 
resulted in 99.9% killing of the final inoculum.           
 
8.2.4 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay  
 
The anticancer effects of isolated compounds were investigated against human 
breast and colorectal carcinoma cell lines using MTT assay as described in Chapter 
6.2.2. 
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8.2.5 Statistical analysis 
 
 Statistical analysis of experimental data was performed using Microsoft Office 
Excel data analysis software. Data were presented by descriptive analysis as mean and 
standard deviation of three independent experiments performed in triplicate. 
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8.3 RESULTS AND DISCUSSION 
 
Plants provide a rich and intriguing source of secondary metabolites that differ 
widely in terms of their chemical structures, pharmacological properties and 
mechanisms of actions (Shukla et al. 2012; Amari et al. 2014). This considerable 
untapped potential has resulted in the search for natural alternatives, with the 
objective of discovering promising active lead compounds which can serve as novel 
therapeutic agents or templates for the design and synthesis of new drug entities (Nino 
et al. 2012; Daniels and Malomo 2014). In the present study, MIC, MBC and MTT 
assays were conducted to explore the pharmacological activities of isolated 
compounds. 
 
8.3.1 Isolation and characterisation of bioactive compounds from Artabotrys 
crassifolius 
 
The chromatographic separation of chloroform extract of bark of Artabotrys 
crassifolius led to the isolation of four alkaloids. The structures of the compounds 
were characterised as artabotrine (1) (Figure 8.1), liridine (2), atherospermidine (3) 
and lysicamine (4) (Figure 8.2). All these compounds were isolated for the first time 
from this plant. Interestingly, the 4,5-dioxoaporphine alkaloid, artabotrine, exists only 
in the genus Artabotrys (Wijeratne et al. 1996; Fleischer et al. 1997; Han et al. 2005) 
whereas liridine, atherospermidine and lysicamine are 7-oxoaporphine alkaloids 
commonly found in almost all the genera of the family Annonaceae (Leboeuf et al. 
1982; Torres et al. 2007; Ortiz et al. 2007; Malebo et al. 2013). 
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(1) 
 
FIGURE 8.1 X-ray structure of artabotrine. 
 
Artabotrine (1) was obtained as orange-red crystals. The crystal data and 
structure refinement, fractional atomic coordinates and equivalent isotropic 
displacement parameters, anisotropic displacement parameters, bond lengths, bond 
angles, torsion angles, as well as hydrogen atom coordinates and isotropic 
displacement parameters are shown in Table 8.1±8.7. 
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TABLE 8.1 Crystal data and structure refinement for artabotrine. 
 
Crystal data and structure refinement 
  
Empirical formula C18H11NO5 
  
Formula weight 321.28 
  
Temperature (K) 120(2) 
  
Crystal system monoclinic 
  
Space group P21/n 
  
a (Å) 8.2597(4) 
  
b (Å) 9.9728(5) 
  
c (Å) 16.4041(8) 
  Į (°) 90.00 
  ȕ (°) 93.833(5) 
  Ȗ (°) 90.00 
  
Volume (Å3) 1348.21(12) 
  
Z 4 
  ȡcalc (mg/mm3) 1.583 
  
ȝ (mm±1) 0.985 
  
F(000) 664.0 
  
Crystal size (mm3) 0.6056 × 0.5003 × 0.399 
  
ĬUDQJHIRUGDWDcollection (°) 10.82 to 150.22° 
  
Index ranges ±K±N±O 
  
Reflections collected 10238 
  
Independent reflections 2727[Rint = 0.0169] 
  
Data/restraints/parameters 2727/0/218 
  
Goodness-of-fit on F2 1.069 
  
Final R indexes [,! ı,] R1 = 0.0330, wR2 = 0.0919 
  
Final R indexes [all data] R1 = 0.0349, wR2 = 0.0938 
  
Largest diff. peak/hole (e Å±3) 0.26/±0.20 
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TABLE 8.2 Fractional atomic coordinates (×104) and equivalent isotropic 
displacement parameters (Å2 × 103) for artabotrine. Ueq is defined 
as 1/3 of the trace of the orthogonalised UIJ tensor. 
 
Atom x y z U(eq) 
     
N1 1652.3(10) ±819.0(9) 3276.2(5) 17.4(2) 
     
C2 719.4(12) ±1948.2(11) 3287.0(6) 18.5(2) 
     
C3B 1971.1(12) ±562.6(10) 4754.0(6) 15.3(2) 
     
C3 406.9(12) ±2485.1(11) 4137.4(6) 19.0(2) 
     
C3A 1016.7(12) ±1719.9(11) 4851.3(6) 16.9(2) 
     
C4A 1298.7(12) ±1464.6(11) 6282.3(6) 18.4(2) 
     
C4 668.1(12) ±2188.4(11) 5628.1(6) 18.7(2) 
     
O5 1135.6(10) ±1722.0(9) 7091.9(4) 24.9(2) 
     
C6 1976.0(13) ±662.8(12) 7538.4(6) 21.2(2) 
     
C7B 2633.0(12) 183.6(10) 5442.0(6) 15.6(2) 
     
C7C 3647.0(12) 1352.3(10) 5335.5(6) 16.1(2) 
     
C7A 2246.3(12) ±328.5(11) 6197.2(6) 16.8(2) 
     
O7 2723.6(9) 166.3(8) 6946.9(4) 22.42(19) 
     
C8 4340.5(13) 2125.3(11) 5989.0(6) 18.9(2) 
     
C9 5363.6(13) 3181.2(11) 5848.1(7) 20.7(2) 
     
C10 5723.8(13) 3519.0(11) 5049.1(7) 20.5(2) 
     
C11 5019.8(13) 2810.7(11) 4399.2(7) 19.3(2) 
     
C11A 3979.3(12) 1720.1(10) 4529.7(6) 16.8(2) 
     
C12A 2329.9(12) ±103.1(10) 3955.3(6) 15.7(2) 
     
C12 3291.7(12) 976.8(10) 3847.0(6) 17.3(2) 
     
O13 1872.3(9) ±270.7(8) 2509.5(4) 19.80(19) 
     
C14 3258.0(13) ±870.0(12) 2154.6(6) 22.4(2) 
     
O15 166.9(9) ±2504.0(9) 2667.9(5) 24.4(2) 
     
O16 ±350.3(10) ±3529.1(9) 4168.4(5) 28.2(2) 
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TABLE 8.3 Anisotropic displacement parameters (Å2 × 103) for artabotrine.  
The anisotropic displacement factor exponent takes the form: ±ʌ2 
[h2a*2U11 + ... + 2hka × b × U12]. 
 
Atom U11 U22 U33 U23 U13 U12 
       
N1 19.6(4) 22.8(5) 10.0(4) 1.4(3) 1.7(3) 1.3(3) 
       
C2 15.9(5) 22.6(5) 16.8(5) ±2.9(4) 0.5(4) 3.1(4) 
       
C3B 14.3(5) 18.1(5) 13.7(5) 0.6(4) 1.9(4) 4.3(4) 
       
C3 17.2(5) 22.0(5) 17.9(5) ±0.4(4) 1.5(4) 1.8(4) 
       
C3A 14.7(5) 20.5(5) 15.4(5) 0.2(4) 1.0(4) 3.6(4) 
       
C4A 17.3(5) 24.6(5) 13.5(5) 3.6(4) 2.9(4) 3.6(4) 
       
C4 16.4(5) 21.5(5) 18.3(5) 2.3(4) 2.1(4) 0.3(4) 
       
O5 30.0(4) 32.2(5) 12.6(4) 2.9(3) 2.5(3) ±6.3(3) 
       
C6 21.4(5) 29.1(6) 13.3(5) 2.4(4) 2.4(4) ±0.3(4) 
       
C7B 14.7(5) 18.5(5) 13.7(5) 0.3(4) 1.1(4) 5.2(4) 
       
C7C 15.8(5) 17.3(5) 15.2(5) 0.3(4) 1.1(4) 4.9(4) 
       
C7A 15.9(5) 21.3(5) 13.0(5) ±0.7(4) 0.2(4) 4.4(4) 
       
O7 27.0(4) 29.8(4) 10.5(3) 0.0(3) 1.6(3) ±4.2(3) 
       
C8 20.5(5) 19.9(5) 16.5(5) ±0.7(4) 1.1(4) 4.4(4) 
       
C9 21.7(5) 19.0(5) 21.2(5) ±4.2(4) ±1.0(4) 3.1(4) 
       
C10 19.1(5) 16.2(5) 26.3(6) 0.0(4) 2.4(4) 2.5(4) 
       
C11 20.8(5) 17.9(5) 19.6(5) 3.1(4) 3.3(4) 4.0(4) 
       
C11A 16.4(5) 17.5(5) 16.4(5) 1.1(4) 0.9(4) 5.4(4) 
       
C12A 15.9(5) 19.0(5) 12.3(5) ±0.7(4) 0.1(4) 5.2(4) 
       
C12 19.1(5) 19.6(5) 13.4(4) 2.6(4) 2.4(4) 4.8(4) 
       
O13 21.7(4) 27.6(4) 10.3(3) 2.8(3) 2.3(3) 4.7(3) 
       
C14 21.5(5) 28.2(6) 18.0(5) ±1.8(4) 5.3(4) 1.8(4) 
       
O15 24.9(4) 31.5(4) 16.9(4) ±6.2(3) 1.2(3) ±3.0(3) 
       
O16 34.1(5) 27.5(4) 22.8(4) ±1.6(3) ±0.1(3) ±10.1(3) 
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TABLE 8.4 Bond lengths for artabotrine. 
 
Atom Atom Length (Å) 
   
N1 C2 1.3654(14) 
   
N1 C12A 1.4074(13) 
   
N1 O13 1.3944(11) 
   
C2 C3 1.5320(14) 
   
C2 O15 1.2185(13) 
   
C3B C3A 1.4127(15) 
   
C3B C7B 1.4297(14) 
   
C3B C12A 1.4374(14) 
   
C3 C3A 1.4591(14) 
   
C3 O16 1.2174(14) 
   
C3A C4 1.4049(14) 
   
C4A C4 1.3672(15) 
   
C4A O5 1.3681(12) 
   
C4A C7A 1.3893(15) 
   
O5 C6 1.4374(14) 
   
C6 O7 1.4445(13) 
   
C7B C7C 1.4526(15) 
   
C7B C7A 1.3967(14) 
   
C7C C8 1.4105(14) 
   
C7C C11A 1.4162(14) 
   
C7A O7 1.3587(12) 
   
C8 C9 1.3793(16) 
   
C9 C10 1.4043(16) 
   
C10 C11 1.3750(15) 
   
C11 C11A 1.4113(15) 
   
C11A C12 1.4287(14) 
   
C12A C12 1.3570(15) 
   
O13 C14 1.4475(13) 
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TABLE 8.5 Bond angles for artabotrine. 
 
Atom Atom Atom Angle (Û) 
    
C2 N1 C12A 127.08(9) 
    
C2 N1 O13 116.29(8) 
    
O13 N1 C12A 116.50(8) 
    
N1 C2 C3 115.45(9) 
    
O15 C2 N1 122.99(10) 
    
O15 C2 C3 121.56(10) 
    
C3A C3B C7B 121.52(9) 
    
C3A C3B C12A 120.94(9) 
    
C7B C3B C12A 117.53(9) 
    
C3A C3 C2 118.55(9) 
    
O16 C3 C2 117.08(9) 
    
O16 C3 C3A 124.36(10) 
    
C3B C3A C3 120.12(9) 
    
C4 C3A C3B 121.60(10) 
    
C4 C3A C3 118.26(10) 
    
C4 C4A O5 127.29(10) 
    
C4 C4A C7A 122.64(9) 
    
O5 C4A C7A 110.07(9) 
    
C4A C4 C3A 116.48(10) 
    
C4A O5 C6 106.34(8) 
    
O5 C6 O7 106.97(8) 
    
C3B C7B C7C 121.06(9) 
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TABLE 8.5 Bond angles for artabotrine (continued). 
 
Atom Atom Atom Angle (Û) 
    
C7A C7B C3B 114.32(9) 
    
C7A C7B C7C 124.61(10) 
    
C8 C7C C7B 123.73(9) 
    
C8 C7C C11A 118.27(10) 
    
C11A C7C C7B 117.99(9) 
    
C4A C7A C7B 123.44(10) 
    
O7 C7A C4A 109.67(9) 
    
O7 C7A C7B 126.88(10) 
    
C7A O7 C6 106.79(8) 
    
C9 C8 C7C 120.80(10) 
    
C8 C9 C10 120.66(10) 
    
C11 C10 C9 119.69(10) 
    
C10 C11 C11A 120.57(10) 
    
C7C C11A C12 120.37(10) 
    
C11 C11A C7C 119.94(10) 
    
C11 C11A C12 119.68(9) 
    
N1 C12A C3B 117.68(9) 
    
C12 C12A N1 120.28(9) 
    
C12 C12A C3B 122.04(9) 
    
C12A C12 C11A 120.98(9) 
    
N1 O13 C14 110.79(7) 
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TABLE 8.6 Torsion angles for artabotrine. 
 
A B C D Angle (Û) 
     
N1 C2 C3 C3A 4.09(14) 
     
N1 C2 C3 O16 ±176.32(9) 
     
N1 C12A C12 C11A 179.54(9) 
     
C2 N1 C12A C3B ±2.42(15) 
     
C2 N1 C12A C12 177.27(9) 
     
C2 N1 O13 C14 ±87.92(10) 
     
C2 C3 C3A C3B ±4.42(14) 
     
C2 C3 C3A C4 177.41(9) 
     
C3B C3A C4 C4A 0.09(15) 
     
C3B C7B C7C C8 ±179.70(9) 
     
C3B C7B C7C C11A ±0.86(14) 
     
C3B C7B C7A C4A ±0.07(15) 
     
C3B C7B C7A O7 179.21(9) 
     
C3B C12A C12 C11A ±0.78(15) 
     
C3 C3A C4 C4A 178.24(9) 
     
C3A C3B C7B C7C 178.41(9) 
     
C3A C3B C7B C7A ±0.26(14) 
     
C3A C3B C12A N1 2.12(14) 
     
C3A C3B C12A C12 ±177.57(9) 
     
C4A O5 C6 O7 ±3.80(11) 
     
C4A C7A O7 C6 ±2.80(11) 
     
C4 C4A O5 C6 ±178.51(10) 
     
C4 C4A C7A C7B 0.44(17) 
     
C4 C4A C7A O7 ±178.95(9) 
     
O5 C4A C4 C3A ±179.67(10) 
     
O5 C4A C7A C7B 179.79(9) 
     
O5 C4A C7A O7 0.41(12) 
     
O5 C6 O7 C7A 4.07(11) 
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TABLE 8.6 Torsion angles for artabotrine (continued). 
 
A B C D Angle (Û) 
     
C7B C3B C3A C3 ±177.85(9) 
     
C7B C3B C3A C4 0.26(15) 
     
C7B C3B C12A N1 ±178.70(8) 
     
C7B C3B C12A C12 1.61(15) 
     
C7B C7C C8 C9 176.49(9) 
     
C7B C7C C11A C11 ±177.05(9) 
     
C7B C7C C11A C12 1.73(14) 
     
C7B C7A O7 C6 177.84(10) 
     
C7C C7B C7A C4A ±178.69(9) 
     
C7C C7B C7A O7 0.59(17) 
     
C7C C8 C9 C10 0.68(16) 
     
C7C C11A C12 C12A ±0.95(15) 
     
C7A C4A C4 C3A ±0.43(16) 
     
C7A C4A O5 C6 2.18(11) 
     
C7A C7B C7C C8 ±1.17(16) 
     
C7A C7B C7C C11A 177.67(9) 
     
C8 C7C C11A C11 1.85(14) 
     
C8 C7C C11A C12 ±179.36(9) 
     
C8 C9 C10 C11 1.55(16) 
     
C9 C10 C11 C11A ±2.04(15) 
     
C10 C11 C11A C7C 0.32(15) 
     
C10 C11 C11A C12 ±178.47(9) 
     
C11 C11A C12 C12A 177.83(9) 
     
C11A C7C C8 C9 ±2.35(15) 
     
C12A N1 C2 C3 ±0.70(15) 
     
C12A N1 C2 O15 179.43(9) 
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TABLE 8.6 Torsion angles for artabotrine (continued). 
 
A B C D Angle (Û) 
     
C12A N1 O13 C14 95.91(10) 
     
C12A C3B C3A C3 1.29(15) 
     
C12A C3B C3A C4 179.40(9) 
     
C12A C3B C7B C7C ±0.76(14) 
     
C12A C3B C7B C7A ±179.43(9) 
     
O13 N1 C2 C3 ±176.41(8) 
     
O13 N1 C2 O15 3.73(15) 
     
O13 N1 C12A C3B 173.27(8) 
     
O13 N1 C12A C12 ±7.03(13) 
     
O15 C2 C3 C3A ±176.04(9) 
     
O15 C2 C3 O16 3.54(16) 
     
O16 C3 C3A C3B 176.03(10) 
     
O16 C3 C3A C4 ±2.14(16) 
     
 
TABLE 8.7 Hydrogen atom coordinates (Å × 104) and isotropic displacement 
parameters (Å2 × 103) for artabotrine. 
 
Atom x y z U(eq) 
     
H4 28 ±2967 5695 22 
     
H6A 2812 ±1040 7934 25 
     
H6B 1205 ±128 7842 25 
     
H8 4100 1916 6533 23 
     
H9 5829 3685 6296 25 
     
H10 6451 4234 4958 25 
     
H11 5236 3058 3858 23 
     
H12 3511 1242 3309 21 
     
H14A 3322 ±543 1594 34 
     
H14B 3139 ±1848 2148 34 
     
H14C 4251 ±625 2481 34 
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FIGURE 8.2 Chemical structures of liridine, atherospermidine and lysicamine. 
 
Liridine (2): C19H15NO4, Orange amorphous solid. 1H NMR (400 MHz, 
CDCl3) į9.15 (1H, d, H-11), 9.01 (1H, d, H-5), 8.62 (1H, dd, H-8), 8.26 (1H, d, H-4), 
7.78 (1H, ddd, H-10), 7.58 (1H, ddd, H-9), 4.23 (3H, s, 3-OMe), 4.14 (3H, s, 2-OMe), 
4.11 (3H, s, 1-OMe) (Figure 8.3) (Li et al. 2009; Costa et al. 2011b). 
 
Atherospermidine (3): C18H11NO4, Orange amorphous solid. 1H NMR       
(400 MHz, CDCl3į8.97 (1H, d, H-5), 8.62 (1H, dd, H-8), 8.62 (1H, d, H-11), 8.22 
(1H, d, H-4), 7.77 (1H, ddd, H-10), 7.56 (1H, ddd, H-9), 6.37 (2H, s, 1-OCH2O-2), 
4.34 (3H, s, 3-OMe) (Figure 8.4) (Ortiz et al. 2007; Costa et al. 2011b). 
 
Lysicamine (4): C18H13NO3, Yellow amorphous solid. 1H NMR (400 MHz, 
CDCl3) į22 (1H, d, H-11), 8.96 (1H, d, H-5), 8.63 (1H, dd, H-8), 7.85 (1H, d, H-4), 
7.81 (1H, ddd, H-10), 7.62 (1H, ddd, H-9), 7.28 (1H, s, H-3), 4.15 (3H, s, 2-OMe), 
4.06 (3H, s, 1-OMe) (Figure 8.5) (Husain et al. 2012; Lin et al. 2014). 
 
1 
2 
3 4 
5 
7 
8 
9 
10 
11 
6 1 
2 
3 4 4 
1 
2 
3 
5 5 
6 6 
7 7 
8 8 
9 9 
10 10 
11 11 
256 
 
 
 
FIGURE 8.3 1H NMR spectrum of liridine. 
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FIGURE 8.4 1H NMR spectrum of atherospermidine. 
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FIGURE 8.5 1H NMR spectrum of lysicamine. 
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8.3.2 Minimum inhibitory concentrations of isolated compounds from 
Artabotrys crassifolius 
 
The cut-off point for antibacterial compounds was suggested to be 25 µM 
(Cos et al. 2006). According to Kuete (2010), the antibacterial activity of pure 
compounds could be classified into three categories: high (MIC
 
value less than         
10 µg/mL), moderate (MIC
 
value ranging from 10 µg/mL to 100 µg/mL) and low 
(MIC
 
value more than 100 µg/mL). Based on this categorisation, artabotrine (1) 
demonstrated high antibacterial properties with MIC values ranging from 1.25 µg/mL 
to 5 µg/mL against all of the tested ATCC and clinical bacterial strains except for 
Actinobacillus sp. and Klebsiella sp. (Table 8.8±8.9).  
 
Furthermore, liridine (2) and lysicamine (4) strongly inhibited the growth of B. 
subtilis ATCC 21332, M. luteus ATCC 10240 and R. equi ATCC 33701 with MIC 
values ranging from 0.625 µg/mL to 2.5 µg/mL and 5 µg/mL to 10 µg/mL 
respectively. Different observation was reported by Costa et al. (2011a), in which 
liridine and lysicamine (Guatteria blepharophylla) exhibited no significant activity 
against B. subtilis ATCC 5061, M. luteus ATCC 4698 and R. equi ATCC 6939. This 
implies that the susceptibility of the tested bacteria to the corresponding compounds 
may be strain-specific. 
 
Nonetheless, atherospermidine (3) showed a MIC value of greater than         
20 µg/mL when tested on ATCC and clinical bacterial strains, which was less active 
as compared to that of the positive control, streptomycin sulphate (MIC values 
ranging from 0.3125 µg/mL to 20 µg/mL). 
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TABLE 8.8 Minimum inhibitory concentrations of isolated compounds from Artabotrys crassifolius against ATCC strains. 
 
Microorganism 
Minimum inhibitory concentration (MIC) (µg/mL) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA      
      
B. cereus ATCC 10876 1.25 5 >20 10 2.5 
      
B. subtilis ATCC 21332 2.5 0.625 >20 10 0.625 
      
L. monocytogenes ATCC 15313 1.25 1.25 >20 2.5 0.3125 
      
M. luteus ATCC 10240 5 1.25 >20 10 1.25 
      
P. vulgaris ATCC 13315 1.25 >20 >20 10 5 
      
R. equi ATCC 33701 1.25 2.5 >20 5 1.25 
      
S. aureus ATCC 11632 2.5 >20 >20 >20 10 
      
Note: Results are from three independent experiments performed in triplicate, n = 9. 
 
 
 
 
 
 
261 
 
TABLE 8.9 Minimum inhibitory concentrations of isolated compounds from Artabotrys crassifolius against clinical strains. 
 
Microorganism 
Minimum inhibitory concentration (MIC) (µg/mL) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA 
     
      
MSSA 5 >20 >20 20 10 
      
ORCNS 1.25 >20 >20 20 2.5 
      
OSCNS 2.5 1.25 >20 10 0.3125 
      
S. agalactiae  5 1.25 >20 5 1.25 
      
S. pneumoniae 2.5 10 >20 2.5 0.3125 
      
GRAM-NEGATIVE BACTERIA 
     
      
Actinobacillus sp. >20 >20 >20 >20 20 
      
ESBL-KP 2.5 2.5 >20 10 0.3125 
      
Klebsiella sp. >20 >20 >20 >20 >20 
      
Note: Results are from three independent experiments performed in triplicate, n = 9. 
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8.3.3 Minimum bactericidal concentrations of isolated compounds from 
Artabotrys crassifolius 
 
The minimum bactericidal concentrations of isolated compounds are given in 
Table 8.10±8.11. All the isolated compounds, with the exception of atherospermidine 
(3), displayed MBC values ranging from 0.625 µg/mL to 20 µg/mL against most of 
the tested ATCC and clinical bacterial strains, which were comparable to that of the 
positive control, streptomycin sulphate (MBC values ranging from 0.3125 µg/mL to 
20 µg/mL). 
 
According to Krishnan et al. (2010), antibacterial compounds could be 
categorised into two classes: bacteriostatic (MBC/MIC ratio more than 4) and 
bactericidal (MBC/MIC ratio less than or equal to 4). Under this classification, 
artabotrine (1) exerted bactericidal activity against B. cereus ATCC 10876, B. subtilis 
ATCC 21332, L. monocytogenes ATCC 15313, M. luteus ATCC 10240, P. vulgaris 
ATCC 13315, R. equi ATCC 33701, MSSA, OSCNS, S. agalactiae, S. pneumoniae 
and ESBL-KP with MBC/MIC ratios ranging from 1 to 4 (Table 8.12±8.13). 
However, the respective compound was bacteriostatic for both S. aureus ATCC 
11632 and ORCNS with MBC/MIC ratio of 8. 
 
In addition, liridine (2) and lysicamine (4) presented equivalent MIC and 
MBC values (MBC/MIC ratio of 1) against B. subtilis ATCC 21332, L. 
monocytogenes ATCC 15313, S. agalactiae and S. pneumoniae. This suggests that the 
corresponding compounds may possess absolute bactericidal effects on the tested 
bacteria. 
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TABLE 8.10 Minimum bactericidal concentrations of isolated compounds from Artabotrys crassifolius against ATCC strains. 
 
Microorganism 
Minimum bactericidal concentration (MBC) (µg/mL) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA      
      
B. cereus ATCC 10876 1.25 10 >20 10 2.5 
      
B. subtilis ATCC 21332 2.5 0.625 >20 10 0.625 
      
L. monocytogenes ATCC 15313 2.5 1.25 >20 2.5 0.3125 
      
M. luteus ATCC 10240 5 2.5 >20 10 1.25 
      
P. vulgaris ATCC 13315 5 >20 >20 10 5 
      
R. equi ATCC 33701 2.5 5 >20 10 1.25 
      
S. aureus ATCC 11632 20 >20 >20 >20 20 
      
Note: Results are from three independent experiments performed in triplicate, n = 9. 
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TABLE 8.11 Minimum bactericidal concentrations of isolated compounds from Artabotrys crassifolius against clinical strains. 
 
Microorganism 
Minimum bactericidal concentration (MBC) (µg/mL) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA 
     
      
MSSA 20 >20 >20 20 10 
      
ORCNS 10 >20 >20 >20 2.5 
      
OSCNS 5 2.5 >20 20 0.625 
      
S. agalactiae  5 1.25 >20 5 1.25 
      
S. pneumoniae 2.5 10 >20 2.5 0.3125 
      
GRAM-NEGATIVE BACTERIA 
     
      
Actinobacillus sp. >20 >20 >20 >20 >20 
      
ESBL-KP 2.5 5 >20 20 0.625 
      
Klebsiella sp. >20 >20 >20 >20 >20 
      
Note: Results are from three independent experiments performed in triplicate, n = 9. 
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TABLE 8.12 MBC/MIC ratios of isolated compounds from Artabotrys crassifolius against ATCC strains. 
 
Microorganism 
MBC/MIC ratio 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA      
      
B. cereus ATCC 10876 1 2 NA 1 1 
      
B. subtilis ATCC 21332 1 1 NA 1 1 
      
L. monocytogenes ATCC 15313 2 1 NA 1 1 
      
M. luteus ATCC 10240 1 2 NA 1 1 
      
P. vulgaris ATCC 13315 4 NA NA 1 1 
      
R. equi ATCC 33701 2 2 NA 2 1 
      
S. aureus ATCC 11632 8 NA NA NA 2 
      
Note: NA indicates not available. 
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TABLE 8.13 MBC/MIC ratios of isolated compounds from Artabotrys crassifolius against clinical strains. 
 
Microorganism 
MBC/MIC ratio 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Streptomycin sulphate 
      
GRAM-POSITIVE BACTERIA 
     
      
MSSA 4 NA NA 1 1 
      
ORCNS 8 NA NA NA 1 
      
OSCNS 2 2 NA 2 2 
      
S. agalactiae  1 1 NA 1 1 
      
S. pneumoniae 1 1 NA 1 1 
      
GRAM-NEGATIVE BACTERIA 
     
      
Actinobacillus sp. NA NA NA NA NA 
      
ESBL-KP 1 2 NA 2 2 
      
Klebsiella sp. NA NA NA NA NA 
      
Note: NA indicates not available. 
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8.3.4 Anticancer effects of isolated compounds from Artabotrys crassifolius 
 
 The cut-off point for anticancer compounds was suggested to be 10 µM 
(Brahemi et al. 2010). According to the American National Cancer Institute (NCI), 
pure compounds could be considered as active for a GI50 value of less than 4 µg/mL 
(Abu-Dahab and Afifi 2007).  
 
Based on the NCI criterion, artabotrine (1) was highly active in HCT-116 
colorectal and MCF-7 breast carcinoma cell lines with GI50 values of 3.34 ȝ0     
(1.07 µg/mL) DQGȝ0(1.12 µg/mL) respectively (Figure 8.6±8.7; Appendix F). 
This was in accordance with the study of Wijeratne et al. (1995), where artabotrine 
(Artabotrys zeylanicus) exhibited strong inhibitory effects on both camptothecin-
resistance and wild-type P388 leukemia cell lines with respective GI50 values of    
ȝ0 DQGȝ0. However, Ding et al. (2006) showed that artabotrine (synthetic 
compound) was less effective against HeLa cervical, BEL-7404 hepatocellular, A549 
lung, CNE nasopharyngeal, KB oral and PC-3 prostate carcinoma cell lines. 
 
Moreover, lysicamine (4) potently inhibited the growth of HCT-116 colorectal 
and MCF-7 breast carcinoma cell lines with GI50 values of 3.44 µM (1 µg/mL) and 
3.93 µM (1.14 µg/mL) respectively. Different results were obtained by Silva et al. 
(2007), Nakano et al. (2013), Omar et al. (2013) and Kang et al. (2014), who reported 
moderate activity of lysicamine (Unonopsis lindmanii, Annona reticulata, Annona 
squamosa, Phoebe grandis and Liriodendron tulipifera) against HEp-2 laryngeal, 
MT-1 and MT-2 leukaemia, MCF-7 breast, Hep G2 hepatocellular carcinoma and 
A375 melanoma cell lines with GI50 values ranging from 16.25 ȝ0WRȝ0. 
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FIGURE 8.6 Anticancer effects of isolated compounds from Artabotrys crassifolius against MCF-7 (ER+) breast carcinoma cell line. 
Results are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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FIGURE 8.7 Anticancer effects of isolated compounds from Artabotrys crassifolius against HCT-116 colorectal carcinoma cell line. 
Results are expressed as mean ± standard deviation (error bar) of three independent experiments performed in triplicate, n = 9. 
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Nevertheless, the GI50 value of liridine (2) was found to be higher than 10 µM 
when tested on MCF-7 breast and HCT-116 colorectal carcinoma cell lines. Similar 
works were done by Osorio et al. (2006), Silva et al. (2007), Sichaem et al. (2011) 
and Liu et al. (2014), in which liridine (Rollinia pittieri, Duguetia glabriuscula, 
Artabotrys spinosus and Polyalthia plagioneura) displayed moderate activity against 
U937 leukaemia, HEp-2 laryngeal, HeLa cervical, KB oral and SGC-7901 gastric 
carcinoma cell lines with GI50 values ranging from 12.4 ȝ0WRȝ0.            
 
Similarly, atherospermidine (3) gave a GI50 value of more than 10 µM for both 
MCF-7 breast and HCT-116 colorectal carcinoma cell lines. This was in contrary to 
the findings of Wu et al. (1989) and Hsieh et al. (2001), who observed significant 
inhibitory effects of atherospermidine (Artabotrys uncinatus) on KB oral, Hep 2,2,15 
and Hep G2 hepatocellular carcinoma cell lines with respective GI50 values of         
ȝJP/JP/DQGJP/+RZHYHU2VRULRet al. (2006) demonstrated 
that atherospermidine (Pseudomalmea boyacana) was less potent against U937 
leukaemia cell line with a GI50 YDOXHRIȝJP/.            
   
Considering the structures of the isolated compounds, the presence of N-
methoxy group may play an important role in the pharmacological properties of 
artabotrine (1) as most of the reported 4,5-dioxoaporphines were N-methylated or 
unsubstituted. Additionally, liridine (2), atherospermidine (3) and lysicamine (4) 
possessed the same basic skeleton with different substitution patterns, where methoxy 
substituent at the C-3 position may reduce the inhibitory effect of liridine (2) or even 
result in an inactive compound as atherospermidine (3), while hydrogen substituent at 
the same position may enhance the pharmacological action of lysicamine (4). 
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8.4 CONCLUSION 
 
Exploration of the in vitro pharmacological activity of isolated compounds 
from Artabotrys crassifolius revealed that artabotrine may be a potential therapeutic 
agent in view of its dual-acting antibacterial and anticancer properties. Hence, further 
studies are required to elucidate the mechanisms underlying the observed inhibitory 
effect of artabotrine. 
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CHAPTER IX 
 
CONCLUSION AND FUTURE PERSPECTIVES 
 
Being as one of the most evolved and complex ecosystems in the world, the 
tropical rainforest of Malaysia serves a vast untapped biodiversity of natural resources. 
This has led to the current investigation on the in vitro antibacterial, antifungal, 
anticancer and antioxidant activities of Artabotrys crassifolius. 
 
Among the crude extracts evaluated, hexane and chloroform extracts of bark 
displayed promising antibacterial activities against ATCC and clinical strains with 
zones of inhibition ranging from 8.23±0.25 mm to 13.70±0.26 mm and 7.75±0.25 mm 
to 13.68±0.28 mm respectively. However, all the crude extracts were shown to be 
devoid of antifungal activity except for hexane extract of bark which was able to 
inhibit the growth of the tested Candida species with zones of inhibition ranging from 
7.81±0.27 mm to 9.77±0.25 mm. Additionally, chloroform extract of bark was highly 
active against all of the tested carcinoma cell lines with GI50 values ranging from  
4.23 µg/mL to 9.45 µg/mL, whereas hexane extract of bark strongly inhibited the 
growth of MDA-468 breast and HCT-116 colorectal carcinoma cell lines with 
respective GI50 values of 6.10 µg/mL and 16.45 µg/mL. Moreover, ethanol extract of 
bark that possessed the highest total phenolic and flavonoid contents      
(268.29±12.36 mg GAE/g and 179.54±4.98 mg CE/g) was found to demonstrate 
pronounced scavenging activities against ABTS cation and DPPH radicals with IC50 
values of 16.50 µg/mL and 16.54 µg/mL respectively, as well as extremely high 
antioxidant power with FRAP value of 1884.35±83.78 µmol Fe(II)/g. 
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The chromatographic separation of chloroform extract of bark led to the 
isolation of four alkaloids, namely artabotrine, liridine, atherospermidine and 
lysicamine. Among the compounds isolated, artabotrine exhibited high antibacterial 
properties with respective MIC and MBC values ranging from 1.25 µg/mL to             
5 µg/mL and 1.25 µg/mL to 20 µg/mL against all of the tested ATCC and clinical 
bacterial strains, with the exception of Actinobacillus sp. and Klebsiella sp.. 
Furthermore, artabotrine was highly active in HCT-116 colorectal and MCF-7 breast 
carcinoma cell lines with GI50 YDOXHVRIȝ0DQGȝ0UHVSHFWLYHO\    
 
As a conclusion, exploration of the in vitro pharmacological properties of 
Artabotrys crassifolius revealed that artabotrine with dual antibacterial and anticancer 
activities may represent a new generation of potential drug candidates for the 
treatment of bacterial infections and cancer. Therefore, further in vivo studies and 
clinical trials are needed to ascertain the efficacy, safety and mechanisms of action of 
artabotrine prior to application in the pharmaceutical industry as natural therapeutic 
agents. 
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APPENDIX A 
 
Extraction yields of crude extracts of Artabotrys crassifolius. 
 
Extraction yield 
Crude extract 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
       
Extraction yield (g) 25.87 16.18 65.03 25.45 53.92 192.38 
       
Extraction yield (%) 1.99 1.24 5.00 0.53 1.13 4.02 
       
 
 
 
 
 
 
 
 
308 
 
APPENDIX B1 
 
Streak plates of ATCC bacterial strains. 
 
   
 
 
 
 
B. cereus ATCC 10876 B. subtilis ATCC 21332 L. monocytogenes ATCC 15313 
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Streak plates of ATCC bacterial strains (continued). 
 
      
 
 
 
 
 
 
M. luteus ATCC 10240 P. vulgaris ATCC 13315 R. equi ATCC 33701 
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Streak plates of ATCC bacterial strains (continued). 
 
      
 
 
 
 
 
 
S. aureus ATCC 11632 S. epidermidis ATCC 12228 S. pyogenes ATCC 19615 
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Streak plates of ATCC bacterial strains (continued). 
 
      
 
 
 
 
 
 
C. freundii ATCC 22636 E. coli ATCC 10536 K. pneumoniae ATCC 13883 
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Streak plates of ATCC bacterial strains (continued). 
 
      
 
 
 
 
 
 
P. aeruginosa ATCC 10145 S. enteritidis ATCC 13076 S. typhimurium ATCC 14028 
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APPENDIX B2 
 
Streak plates of clinical bacterial strains. 
 
      
 
 
 
 
E. faecalis MRSA MSSA 
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Streak plates of clinical bacterial strains (continued). 
 
      
 
 
 
 
 
 
ORCNS OSCNS S. agalactiae 
315 
 
Streak plates of clinical bacterial strains (continued). 
 
      
 
 
 
 
 
 
S. pneumoniae Actinobacillus sp. Enterobacter sp. 
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Streak plates of clinical bacterial strains (continued). 
 
      
 
 
 
 
 
 
E. coli ESBL-EC ESBL-KP 
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Streak plates of clinical bacterial strains (continued). 
 
      
 
 
 
 
 
 
Klebsiella sp. Moraxella sp. Serratia sp. 
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APPENDIX B3 
 
Antibacterial activities of crude extracts of Artabotrys crassifolius against ATCC strains. 
 
Microorganism 
Zone of inhibition (mm) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Streptomycin 
sulphate 
        
GRAM-POSITIVE BACTERIA 
       
        
B. cereus ATCC 10876 6.00±0.00 6.00±0.00 6.00±0.00 9.77±0.25 9.26±0.25 6.72±0.26 18.67±0.28 
        
B. subtilis ATCC 21332 6.00±0.00 6.00±0.00 6.00±0.00 11.31±0.27 9.31±0.27 6.00±0.00 18.74±0.25 
        
L. monocytogenes ATCC 15313 6.00±0.00 6.00±0.00 6.00±0.00 13.27±0.25 13.68±0.28 6.31±0.27 17.74±0.25 
        
M. luteus ATCC 10240 6.00±0.00 6.00±0.00 6.00±0.00 9.75±0.25 7.77±0.25 6.77±0.25 19.79±0.26 
        
P. vulgaris ATCC 13315 6.00±0.00 7.69±0.27 6.33±0.28 12.27±0.25 10.82±0.28 6.83±0.28 11.75±0.25 
        
R. equi ATCC 33701 6.00±0.00 6.00±0.00 6.00±0.00 12.29±0.26 11.32±0.28 6.00±0.00 16.69±0.27 
        
S. aureus ATCC 11632 6.00±0.00 6.00±0.00 6.00±0.00 12.70±0.26 8.79±0.26 6.27±0.25 12.79±0.26 
        
S. epidermidis ATCC 12228 6.00±0.00 6.00±0.00 6.00±0.00 8.23±0.25 6.00±0.00 6.00±0.00 6.00±0.00 
        
S. pyogenes ATCC 19615 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 15.81±0.27 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. A zone of inhibition of 
6 mm corresponds to the diameter of the disc and indicates no zone of inhibition observed.  
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Antibacterial activities of crude extracts of Artabotrys crassifolius against ATCC strains (continued). 
 
Microorganism 
Zone of inhibition (mm) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Streptomycin 
sulphate 
        
GRAM-NEGATIVE BACTERIA 
       
        
C. freundii ATCC 22636 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 15.79±0.26 
        
E. coli ATCC 10536 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 13.81±0.27 
        
K. pneumoniae ATCC 13883 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 
        
P. aeruginosa ATCC 10145 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 
        
S. enteritidis ATCC 13076 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 13.27±0.25 
        
S. typhimurium ATCC 14028 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 8.27±0.25 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. A zone of inhibition of 
6 mm corresponds to the diameter of the disc and indicates no zone of inhibition observed.  
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APPENDIX B4 
 
Antibacterial activities of crude extracts of Artabotrys crassifolius against clinical isolates. 
 
Microorganism 
Zone of inhibition (mm) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Streptomycin 
sulphate 
        
GRAM-POSITIVE BACTERIA 
       
        
E. faecalis 6.00±0.00 6.00±0.00 6.00±0.00 10.74±0.25 6.00±0.00 6.00±0.00 6.00±0.00 
        
MRSA 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 
        
MSSA 6.00±0.00 6.00±0.00 6.00±0.00 12.33±0.28 10.31±0.27 6.81±0.27 9.77±0.25 
        
ORCNS 6.00±0.00 6.00±0.00 6.00±0.00 9.32±0.28 8.82±0.28 6.00±0.00 16.33±0.28 
        
OSCNS 6.00±0.00 6.00±0.00 6.00±0.00 10.32±0.28 7.75±0.25 6.00±0.00 14.33±0.28 
        
S. agalactiae  6.71±0.26 8.24±0.25 6.81±0.27 13.23±0.25 9.24±0.25 8.76±0.25 15.77±0.25 
        
S. pneumoniae 6.29±0.26 8.28±0.26 7.21±0.26 13.70±0.26 9.79±0.26 7.79±0.26 14.71±0.26 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. A zone of inhibition of 
6 mm corresponds to the diameter of the disc and indicates no zone of inhibition observed.  
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Antibacterial activities of crude extracts of Artabotrys crassifolius against clinical isolates (continued). 
 
Microorganism 
Zone of inhibition (mm) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Streptomycin 
sulphate 
        
GRAM-NEGATIVE BACTERIA 
       
        
Actinobacillus sp. 6.00±0.00 6.00±0.00 6.00±0.00 12.27±0.25 9.78±0.26 7.79±0.26 13.77±0.25 
        
Enterobacter sp. 6.00±0.00 6.00±0.00 6.00±0.00 13.30±0.26 6.00±0.00 6.00±0.00 6.00±0.00 
        
E. coli 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 
        
ESBL-EC 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 7.30±0.26 
        
ESBL-KP 6.00±0.00 6.00±0.00 6.00±0.00 12.76±0.25 8.69±0.27 10.71±0.26 17.71±0.26 
        
Klebsiella sp. 6.00±0.00 6.00±0.00 6.00±0.00 12.73±0.25 8.79±0.26 6.32±0.28 12.80±0.26 
        
Moraxella sp. 6.00±0.00 6.00±0.00 6.00±0.00 9.80±0.26 6.00±0.00 6.00±0.00 6.00±0.00 
        
Serratia sp. 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. A zone of inhibition of 
6 mm corresponds to the diameter of the disc and indicates no zone of inhibition observed.  
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APPENDIX C1 
 
Streak plates of clinical fungal strains. 
 
  
  
 
C. albicans C. glabrata 
C. parapsilosis C. tropicalis 
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APPENDIX C2 
 
Antifungal activities of crude extracts of Artabotrys crassifolius against clinical isolates. 
 
Microorganism 
Zone of inhibition (mm) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Amphotericin 
B 
        
YEASTS 
       
        
C. albicans 6.00±0.00 6.00±0.00 6.00±0.00 7.81±0.27 6.00±0.00 6.00±0.00 22.24±0.25 
        
C. glabrata 6.00±0.00 6.00±0.00 6.00±0.00 9.75±0.25 6.00±0.00 6.00±0.00 18.76±0.25 
        
C. parapsilosis 6.00±0.00 6.00±0.00 6.00±0.00 9.77±0.25 6.00±0.00 6.00±0.00 24.74±0.25 
        
C. tropicalis 6.00±0.00 6.00±0.00 6.00±0.00 9.30±0.26 6.00±0.00 6.00±0.00 21.31±0.27 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. A zone of inhibition of 
6 mm corresponds to the diameter of the disc and indicates no zone of inhibition observed.  
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APPENDIX D 
 
Anticancer effects of crude extracts of Artabotrys crassifolius against human carcinoma cell lines. 
 
Concentration (µg/mL) 
MCF-7 (ER+) breast carcinoma cell growth (%) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol Quercetin 
        
6.25 98.80±1.95 97.25±2.92 97.10±2.68 99.34±0.19 62.82±1.66 96.60±2.04 NA 
        
12.5 98.05±3.18 94.08±4.92 95.23±4.38 85.85±22.54 37.76±2.48 96.14±3.40 NA 
        
25 97.46±3.11 84.77±3.50 94.48±4.51 70.22±4.70 23.98±1.63 95.34±3.18 NA 
        
50 94.40±4.86 66.20±2.28 92.31±4.30 8.04±0.71 ±53.62±5.04 96.43±2.85 NA 
        
100 63.02±4.34 31.35±2.99 96.16±2.47 ±78.73±6.01 ±81.14±6.18 81.24±4.36 NA 
 
       
200 ±81.36±2.42 ±75.44±7.49 40.04±9.41 ±79.61±2.91 ±89.91±5.95 29.72±6.69 NA 
 
       
 
       
GI50 (µg/mL) 109.01 73.25 182.25 33.13 9.45 160.64 5.33 
 
       
TGI (µg/mL) 143.64 129.37 >200 54.63 32.73 >200 NA 
 
       
LC50 (µg/mL) 178.27 176.19 >200 83.45 48.84 >200 NA 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. NA indicates not 
available. 
 
325 
 
Anticancer effects of crude extracts of Artabotrys crassifolius against human carcinoma cell lines (continued). 
 
Concentration (µg/mL) 
MDA-468 (ER±) breast carcinoma cell growth (%) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol Quercetin 
        
6.25 87.02±7.03 83.26±7.31 96.02±2.32 48.79±5.65 26.09±4.23 79.69±4.63 NA 
        
12.5 75.37±8.69 72.52±5.82 93.15±5.40 32.45±7.77 ±7.44±18.75 64.60±7.06 NA 
        
25 66.21±5.42 53.05±4.84 91.97±5.18 12.40±4.85 ±30.15±18.08 61.54±6.45 NA 
        
50 48.07±5.35 14.16±11.63 89.84±7.09 ±90.65±1.42 ±91.69±0.40 55.19±9.29 NA 
        
100 ±63.63±19.96 ±86.55±6.48 85.73±7.32 ±92.44±0.87 ±85.97±1.31 26.62±2.25 NA 
 
       
200 ±70.85±14.47 ±86.44±5.48 79.29±5.80 ±92.74±0.73 ±85.36±0.85 24.22±2.32 NA 
 
       
 
       
GI50 (µg/mL) 47.34 26.96 >200 6.10 4.23 59.09 22.88 
 
       
TGI (µg/mL) 71.52 57.03 >200 28.01 11.11 >200 NA 
 
       
LC50 (µg/mL) 93.90 81.85 >200 40.14 33.06 >200 NA 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. NA indicates not 
available. 
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Anticancer effects of crude extracts of Artabotrys crassifolius against human carcinoma cell lines (continued). 
 
Concentration (µg/mL) 
HCT-116 colorectal carcinoma cell growth (%) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol Quercetin 
        
6.25 87.39±5.22 99.28±0.50 95.82±1.33 87.17±10.95 71.78±10.18 97.45±3.41 NA 
        
12.5 91.61±4.22 96.32±3.36 91.71±4.66 69.18±7.60 17.37±5.65 94.48±6.65 NA 
        
25 85.05±8.13 98.64±1.90 93.98±6.86 8.40±4.25 ±17.59±21.93 72.24±4.57 NA 
        
50 83.76±9.94 87.58±2.68 88.91±7.37 ±18.97±5.01 ±89.26±13.75 55.13±3.02 NA 
        
100 37.19±6.61 45.81±5.95 92.30±4.67 ±47.67±6.11 ±95.60±3.22 33.27±3.38 NA 
 
       
200 ±97.45±2.50 ±0.18±18.35 84.62±7.93 ±89.22±7.89 ±99.30±0.45 4.70±7.90 NA 
 
       
 
       
GI50 (µg/mL) 86.25 94.98 >200 16.45 8.75 61.73 21.47 
 
       
TGI (µg/mL) 127.62 199.61 >200 32.67 18.71 >200 NA 
 
       
LC50 (µg/mL) 164.76 >200 >200 105.61 36.30 >200 NA 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. NA indicates not 
available. 
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APPENDIX E1 
 
Absorbance of gallic acid and catechin used for the preparation of standard curve  
for the total phenolic and flavonoid contents of crude extracts of Artabotrys crassifolius. 
 
Concentration (µg/mL) 
Absorbance 
Gallic acid (765 nm) Catechin (510 nm) 
   
5 0.20±0.01 0.09±0.00 
   
10 0.39±0.01 0.18±0.00 
   
15 0.59±0.01 0.27±0.01 
   
20 0.76±0.02 0.35±0.02 
   
25 0.95±0.01 0.48±0.01 
   
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX E2 
 
Total phenolic and flavonoid contents of crude extracts of Artabotrys crassifolius. 
 
Total phenolic and flavonoid content 
Crude extract 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
       
Total phenolic content (mg GAE/g) 29.30±5.23 45.84±4.40 154.91±4.26 22.37±3.41 87.65±3.51 268.29±12.36 
       
Total flavonoid content (mg CE/g) 9.48±4.53 15.47±2.97 84.47±6.61 6.29±4.27 37.15±4.79 179.54±4.98 
       
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX E3 
 
Antioxidant potentials of crude extracts of Artabotrys crassifolius using ABTS cation radical scavenging assay. 
 
Concentration (µg/mL) 
ABTS cation radical scavenging activity (%) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol Trolox 
        
3.125 7.46±5.75 2.28±1.39 10.66±3.80 6.95±8.43 2.76±1.58 15.97±4.76 24.50±4.79 
        
6.25 4.24±3.99 1.94±1.59 10.29±4.49 4.25±5.54 1.30±0.92 20.61±4.90 45.58±3.42 
        
12.5 5.48±4.69 2.76±1.14 19.27±4.53 4.02±6.31 4.62±2.69 37.77±5.69 89.24±3.19 
        
25 6.66±5.38 6.59±0.61 39.04±3.29 6.94±6.34 18.70±2.35 75.99±5.06 99.66±0.21 
        
50 13.37±3.79 21.88±1.62 86.50±4.71 8.73±8.95 39.59±3.18 99.66±0.20 99.71±0.12 
        
100 28.45±7.88 55.96±3.92 99.76±0.26 22.12±10.58 85.80±2.47 99.86±0.06 99.72±0.15 
        
        
IC50 (µg/mL) >100 91.26 30.77 >100 61.27 16.50 6.88 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX E4 
 
Antioxidant potentials of crude extracts of Artabotrys crassifolius using DPPH radical scavenging assay. 
 
Concentration (µg/mL) 
DPPH radical scavenging activity (%) 
Crude extract Positive control 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
Ascorbic 
acid 
        
3.125 0.98±1.46 1.02±0.67 2.23±1.16 0.64±0.61 1.08±1.13 9.81±0.19 16.22±3.84 
        
6.25 1.20±0.18 1.23±0.83 7.15±3.05 1.00±1.06 2.33±0.98 19.49±1.94 40.46±6.38 
        
12.5 3.01±0.25 2.71±1.70 16.34±3.77 1.75±0.64 4.92±2.13 37.95±2.11 84.87±7.77 
        
25 5.13±0.99 7.14±2.05 27.35±4.20 2.35±0.96 11.86±2.27 75.21±1.40 94.01±1.09 
        
50 9.96±2.22 16.63±3.38 49.14±4.94 7.57±2.49 21.93±1.80 92.88±1.46 95.22±0.97 
        
100 21.23±8.45 31.97±5.16 80.67±7.44 19.17±7.22 47.67±0.83 95.47±2.37 95.34±0.64 
        
        
IC50 (µg/mL) >100 >100 51.37 >100 >100 16.54 7.59 
        
AAI <0.38 <0.38 0.75 <0.38 <0.38 2.32 5.07 
        
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX E5 
 
Absorbance of FeSO4Â7H2O used for the preparation of standard curve  
for the antioxidant potentials of crude extracts of Artabotrys crassifolius using FRAP assay. 
 
Concentration (µM) 
Absorbance 
FeSO4Â7H2O (593 nm) 
  
50 0.45±0.06 
  
100 1.04±0.05 
  
150 1.61±0.06 
  
200 2.23±0.04 
  
250 2.83±0.03 
  
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX E6 
 
Antioxidant potentials of crude extracts of Artabotrys crassifolius using FRAP assay. 
 
FRAP value 
Crude extract 
Leaves 
hexane 
Leaves 
chloroform 
Leaves 
ethanol 
Bark 
hexane 
Bark 
chloroform 
Bark 
ethanol 
       
FRAP value (µmol Fe(II)/g) 92.26±5.99 286.22±29.32 979.57±57.17 67.64±23.40 572.90±35.10 1884.35±83.78 
       
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. 
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APPENDIX F 
 
Anticancer effects of isolated compounds from Artabotrys crassifolius against human carcinoma cell lines. 
 
Concentration (µM) 
MCF-7 (ER+) breast carcinoma cell growth (%) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Quercetin 
      
0.05 94.99±4.66 93.79±6.36 93.97±3.24 91.59±2.94 NA 
      
0.1 92.78±5.85 94.71±2.27 94.33±3.77 90.78±7.31 NA 
      
0.5 93.20±3.33 92.24±9.56 91.75±5.47 91.85±4.69 NA 
      
1 92.37±6.56 92.80±5.62 94.14±3.51 84.59±9.07 NA 
      
5 24.17±1.84 86.29±2.39 92.68±2.93 37.32±7.24 NA 
      
10 ±15.27±7.54 76.57±4.04 90.21±5.21 13.94±8.02 NA 
      
      
GI50 (µM) 3.49 >10 >10 3.93 5.33 
      
TGI (µM) 8.06 >10 >10 >10 NA 
      
LC50 (µM) >10 >10 >10 >10 NA 
      
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. The GI50 value for 
positive control is in µg/mL. NA indicates not available. 
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APPENDIX F 
 
Anticancer effects of isolated compounds from Artabotrys crassifolius against human carcinoma cell lines (continued). 
 
Concentration (µM) 
HCT-116 colorectal carcinoma cell growth (%) 
Isolated compound Positive control 
Artabotrine Liridine Atherospermidine Lysicamine Quercetin 
      
0.05 95.44±2.95 96.19±2.87 93.46±1.65 95.26±2.34 NA 
      
0.1 96.61±1.56 97.04±2.69 96.09±1.14 96.24±5.16 NA 
      
0.5 97.16±1.56 97.39±1.42 96.32±2.15 90.93±4.34 NA 
      
1 95.94±2.11 98.05±1.41 97.16±2.38 75.66±7.44 NA 
      
5 17.46±3.62 90.45±5.36 91.71±5.34 33.57±6.90 NA 
      
10 5.64±2.31 57.58±10.37 85.38±9.43 9.54±1.81 NA 
      
      
GI50 (µM) 3.34 >10 >10 3.44 21.47 
      
TGI (µM) >10 >10 >10 >10 NA 
      
LC50 (µM) >10 >10 >10 >10 NA 
      
Note: Results are expressed as mean ± standard deviation of three independent experiments performed in triplicate, n = 9. The GI50 value for 
positive control is in µg/mL. NA indicates not available. 
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APPENDIX G 
 
List of conferences, seminars and trainings attended. 
 
Title Organizer Venue Date 
    
CONFERENCE 
    
11th International Conference on Natural 
Products (ICNP) 2011 (Poster Presentation) 
Institute of Bioscience and Faculty of Science, 
Universiti Putra Malaysia; 
Malaysian Natural Products Society (MNPS) 
Palm Garden Hotel, 
IOI Resort, Putrajaya 
14±16 Nov 2011 
    
Exhibition Showcase of UNMC Global Research 
Workshop 2012 (Poster Presentation) 
Graduate School,   
The University of Nottingham Malaysia Campus 
Foyer,  
Block A, UNMC 
24 Apr 2012 
    
Graduate School Research Showcase 2012 
(Poster Presentation) 
Graduate School,   
The University of Nottingham Malaysia Campus 
Foyer,  
Block B, UNMC 
18 May 2012 
    
Graduate School Research Showcase 2013 
(Poster Presentation ± Best Visual Flair) 
Graduate School,   
The University of Nottingham Malaysia Campus 
Foyer,  
Block B, UNMC 
10 May 2013 
    
1st European Conference on Natural Products 
(ECNP) 2013 (Poster Presentation) 
DECHEMA Biotechnologie DECHEMA-Haus, 
Frankfurt am Main, 
Germany 
22±25 Sep 2013 
    
5th Global Summit on Medicinal and Aromatic 
Plants (GOSMAP) 2013 (Oral Presentation) 
V. Sivaram Research Foundation (VSRF) and 
Century Foundation Bangalore;  
Universiti Teknologi MARA 
Miri Marriott Resort 
& Spa, Miri, Sarawak 
8±12 Dec 2013 
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List of conferences, seminars and trainings attended (continued). 
 
Title Organizer Venue Date 
    
SEMINAR 
    
Merck Thin Layer Chromatography Seminar Faculty of Medicine and Health Sciences,  
Universiti Putra Malaysia 
Main Lecture Hall, 
FMHS, UPM 
30 Jun 2011 
  
 
 
Fisher Seminar  Fisher Scientific Sdn Bhd CB01,  
Block C, UNMC  
8 Sep 2011 
  
 
 
Biacore and Microcal Seminar  GE Healthcare; Interscience Sdn Bhd BA06,  
Block B, UNMC 
12 Sep 2011 
  
 
 
Horizon Technology Seminar Orbiting Scientific and Technology Sdn Bhd Holiday Villa Subang, 
Subang Jaya 
23 Sep 2011 
    
Proteomics and Metabolomics Seminar Alpha Analytical Sdn Bhd Grand Dorsett Subang 
Hotel, Subang Jaya 
26 Mar 2012 
    
Faculty of Science Research Seminar 2012  
(Oral Presentation) 
Faculty of Science,   
The University of Nottingham Malaysia Campus 
F1A10,  
Block F1, UNMC 
18 Apr 2012 
    
Sample Preparation and LC Columns Seminar Agilent Technologies Sdn Bhd;  
IT Tech Research Sdn Bhd 
Carlton Holiday Hotel 
and Suites, Shah Alam 
23 Apr 2012 
    
National Laboratory Productivity and 
Technology Seminar 
Lesoshoppe Sdn Bhd; 
Evergreen Engineering and Resources 
BA05,  
Block B, UNMC 
17 Jan 2013 
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List of conferences, seminars and trainings attended (continued). 
 
Title Organizer Venue Date 
    
TRAINING 
    
Demonstrating Skills in Laboratory Practicals Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
17 Jan 2011 
    
Getting Going on Your Thesis Graduate School,   
The University of Nottingham Malaysia Campus 
BA05,  
Block B, UNMC 
18 Feb 2011 
    
Planning Research and Time Management 
 
Graduate School,   
The University of Nottingham Malaysia Campus 
BA05,  
Block B, UNMC 
2 Mar 2011 
    
Creative Thinking Graduate School,   
The University of Nottingham Malaysia Campus 
BA05  
Block B, UNMC 
13 May 2011   
 
  
 
 
Working Effectively in Research Graduate School,   
The University of Nottingham Malaysia Campus 
BA05,  
Block B, UNMC 
24 Jun 2011 
    
What Do I Want to Get Out of A Conference? Graduate School,   
The University of Nottingham Malaysia Campus 
BA05,  
Block B, UNMC 
12 Aug 2011 
    
Nature of PhD Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
10 Oct 2011 
    
Critical Thinking Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
21 Oct 2011 
    
Library Information Skills and Endnote Briefing Library Services, 
The University of Nottingham Malaysia Campus 
GD14,  
Block G, UNMC 
17 Nov 2011 
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List of conferences, seminars and trainings attended (continued). 
 
Title Organizer Venue Date 
    
TRAINING 
    
Using Posters to Communicate Research Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
5 Dec 2011 
    
Understanding What Interviewers Are Looking 
For 
Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
13 Feb 2012 
    
Communicating Your Accomplishments and 
Goals Effectively 
Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
20 Feb 2012 
    
Creating A Poster in PowerPoint Graduate School,   
The University of Nottingham Malaysia Campus 
EA21,  
Block E, UNMC 
22 Feb 2012 
    
Presentation Skills Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
5 Mar 2012 
    
Communicating Your Research Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
7 Mar 2012 
    
Academic Writing and Getting Published Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
14 Mar 2012 
    
Meet The Editors Graduate School,   
The University of Nottingham Malaysia Campus 
BA05,  
Block B, UNMC 
21 Mar 2012 
    
Further Presentation Skills Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
2 May 2012 
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List of conferences, seminars and trainings attended (continued). 
 
Title Organizer Venue Date 
    
TRAINING 
    
How to Use Mendeley in Research Library Services, 
The University of Nottingham Malaysia Campus 
TCR 3,  
Block F2, UNMC 
4 May 2012 
    
Word Essentials for Researchers Graduate School,   
The University of Nottingham Malaysia Campus 
GD14,  
Block G, UNMC 
6 Mar 2013 
    
How to Write A Press Release Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
7 Mar 2013 
    
Preparing For Your Annual Review Graduate School,   
The University of Nottingham Malaysia Campus 
BA64,  
Block B, UNMC 
31 May 2013 
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APPENDIX H1 
 
Abstract for 11th International Conference on Natural Products (ICNP) 2011. 
 
PHYTOCHEMICAL SCREENING, ANTIBACTERIAL AND 
ANTIOXIDANT ACTIVITIES OF ARTABOTRYS CRASSIFOLIUS 
 
Tan Kok Kwan1, Khoo Teng Jin1 and Christophe Wiart1  
 
1School of Pharmacy, Faculty of Science, The University of Nottingham Malaysia Campus, 
Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia. 
Corresponding author: tkk20118@yahoo.com.sg 
 
The tropical rainforest of Malaysia is considered as one of the most evolved and 
diverse rainforest in the world. Screening of medicinal plants for biologically active 
compounds has become an important source of discovering and developing novel 
drugs. The aims of the present study were to determine the phytochemical 
constituents, as well as to evaluate the antibacterial and antioxidant properties of 
Artabotrys crassifolius. The leaves and bark of Artabotrys crassifolius were extracted 
sequentially using hexane, chloroform and ethanol to obtain the respective extracts. 
The prepared extracts were then subjected to phytochemical analysis for the presence 
of alkaloids, cardiac glycosides, flavonoids, saponins, tannins and terpenoids. The 
antibacterial activity of the extracts was tested against both Gram-positive bacteria 
(Bacillus cereus and Staphylococcus aureus) and Gram-negative bacteria 
(Escherichia coli and Pseudomonas aeruginosa) using Kirby-Bauer disc diffusion 
assay whereas DPPH radical scavenging assay was employed to investigate the 
antioxidant activity of the extracts. Among the bacteria examined, Staphylococcus 
aureus was found to be the most susceptible bacteria with zones of inhibition of 
12.70±0.26 mm and 8.79±0.26 mm exerted by hexane and chloroform extracts of bark 
respectively. In addition, ethanol extract of bark demonstrated the highest DPPH 
radical scavenging activity of 95.47±2.37% with IC50 value of 16.54 µg/mL, followed 
by ethanol extract of leaves displaying DPPH radical scavenging activity of 
80.67±7.44% with IC50 value of 51.37 µg/mL. Current findings suggested that the 
observed antibacterial and antioxidant activities may be attributed to the presence of 
alkaloids and flavonoids. In conclusion, hexane and chloroform extracts of bark, as 
well as ethanol extract of leaves and bark could be the potential sources of natural 
antibacterial and antioxidant agents respectively. 
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APPENDIX H2 
 
Poster for 11th International Conference on Natural Products (ICNP) 2011. 
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APPENDIX H3 
 
Abstract for Faculty of Science Research Seminar 2012. 
 
EVALUATION OF THE ANTIBACTERIAL, ANTIOXIDANT AND 
ANTICANCER ACTIVITIES OF ARTABOTRYS CRASSIFOLIUS 
 
Tan Kok Kwan1, Khoo Teng Jin1 and Christophe Wiart1  
 
1School of Pharmacy, Faculty of Science, The University of Nottingham Malaysia Campus,  
Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia. 
Corresponding author: tkk20118@yahoo.com.sg 
 
The tropical rainforest of Malaysia is considered as one of the most evolved and 
diverse rainforest in the world. Screening of medicinal plants for biologically active 
compounds has become a vital source of discovering and developing novel drugs. The 
aims of the present study were to determine the phytochemical constituents, as well as 
to evaluate the antibacterial, antioxidant and anticancer properties of Artabotrys 
crassifolius. The leaves and bark of Artabotrys crassifolius were extracted 
sequentially with hexane, chloroform and ethanol to obtain the respective extracts. 
The prepared crude extracts were then subjected to phytochemical screenings for the 
presence of alkaloids, cardiac glycosides, flavonoids, phenolic compounds, saponins, 
tannins and terpenoids. The antibacterial activity of the extracts was tested against 
both Gram-positive bacteria (Bacillus cereus and Staphylococcus aureus) and Gram-
negative bacteria (Escherichia coli and Pseudomonas aeruginosa) using Kirby-Bauer 
disc diffusion assay. The DPPH radical scavenging assay was conducted to 
investigate the antioxidant activity of the extracts whereas MTT assay was performed 
to assess the cytotoxicity of the extracts against HCT-116 colorectal carcinoma cell 
line. Among the bacteria examined, Staphylococcus aureus was found to be the most 
susceptible bacteria with zones of inhibition of 12.70±0.26 mm and 8.79±0.26 mm 
exerted by hexane and chloroform extracts of bark respectively. In addition, ethanol 
extract of bark possessed the highest DPPH radical scavenging activity with IC50 
value of 16.54 µg/mL, followed by ethanol extract of leaves with IC50 value of    
51.37 µg/mL. Among the extracts studied, chloroform and hexane extracts of bark 
displayed potent cytotoxicity with GI50 values of 8.75 µg/mL and 16.45 µg/mL 
respectively. Current findings suggested that the observed antibacterial, antioxidant 
and anticancer activities may be attributed to the occurrence of the phytochemical 
constituents analysed. In conclusion, hexane and chloroform extracts of bark 
exhibited promising antibacterial and anticancer activities while ethanol extract of 
leaves and bark demonstrated prominent antioxidant activity. Further studies need to 
be carried out to ascertain the pharmacological potentials of these extracts prior to 
application in the pharmaceutical field as natural antibacterial, antioxidant and 
anticancer agents. 
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APPENDIX H4 
 
Press release for Graduate School Research Showcase 2012. 
 
TREASURES OF RAINFOREST:  
THE SOURCE OF NEW MEDICINES 
 
Tan Kok Kwan1, Khoo Teng Jin1 and Christophe Wiart1 
 
1School of Pharmacy, Faculty of Science, The University of Nottingham Malaysia Campus,  
Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia. 
Corresponding author: tkk20118@yahoo.com.sg 
 
Throughout the history of mankind, plants have been used extensively as a 
source of medicines for a wide variety of human ailments. According to the World 
Health Organisation, approximately 80% of the people in developing countries still 
rely on traditional medicines for their primary health care needs. Having a wide array 
of therapeutic properties, plants have become an indispensable pharmacological tool 
in which many modern drugs today have been isolated from, especially plant-based 
products for therapeutic purposes in health care. 
 
Nevertheless, the research and development in the area of medicinal plants has 
been continuously expanding due to several driving factors such as rise in population, 
insufficient supply of drugs in certain parts of the world, prohibitive cost of treatments 
for common ailments, side effects of several allopathic drugs in current usage as well 
as development of resistance to currently used drugs for diseases. Therefore, 
exploitation of medicinal plants for biologically active compounds is of great 
potential and could be an excellent source of providing new vistas for novel drug 
discovery and development.  
 
The tropical rainforest of Malaysia is considered as one of the most evolved 
and diverse ecosystems in the world. It is a unique natural heritage that serves a vast 
untapped biodiversity of natural resources. This has led to the current investigation on 
the pharmacological potentials of an indigenous medicinal plant named Artabotrys 
crassifolius in order to explore the antibacterial, antioxidant and anticancer properties 
of the plant prior to application in pharmaceutical industry as a potentially promising 
therapeutic agent. 
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APPENDIX H5 
 
Poster for Exhibition Showcase of UNMC Global Research Workshop 2012. 
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APPENDIX H6 
 
Poster for Graduate School Research Showcase 2012. 
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APPENDIX H7 
 
Press release for Graduate School Research Showcase 2013. 
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Tan Kok Kwan1, Khoo Teng Jin1 and Christophe Wiart1 
 
1School of Pharmacy, Faculty of Science, The University of Nottingham Malaysia Campus,  
Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia. 
Corresponding author: tkk20118@yahoo.com.sg 
 
According to the World Health Organisation, approximately 80% of the 
people in developing countries still rely on traditional medicines for their primary 
health care needs. Plants have been used extensively as a source of medicines for a 
wide variety of human ailments throughout the history of mankind due to several 
driving factors such as rise in population, insufficient supply of drugs in certain parts 
of the world, prohibitive cost of treatments for common ailments, side effects of 
several allopathic drugs in current usage as well as development of resistance to 
currently used drugs for diseases.  
 
Having a wide array of therapeutic properties, plants have become an 
indispensable pharmacological tool in which many modern drugs today have been 
isolated from, especially plant-based products for therapeutic purposes in health care. 
Nevertheless, the research and development in the area of medicinal plants has been 
continuously expanding as exploitation of medicinal plants for bioactive compounds 
is of great potential and could be an excellent source of providing new vistas for novel 
drug discovery and development.  
 
The tropical rainforest of Malaysia is regarded as one of the most evolved and 
complex ecosystems in the world that serves a vast untapped biodiversity of natural 
resources. This unique natural heritage has brought renewed interest in the screening 
of indigenous medicinal plants for bioactive compounds and could be the plus factor 
that makes natural products excellent candidates for screening programme prior to 
application in pharmaceutical industry as potentially promising therapeutic agents. 
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APPENDIX H8 
 
Poster for Graduate School Research Showcase 2013. 
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APPENDIX H9 
 
Abstract for 1st European Conference on Natural Products (ECNP) 2013. 
 
PHARMACOLOGICAL PROPERTIES OF  
AN INDIGENOUS MEDICINAL PLANT,   
ARTABOTRYS CRASSIFOLIUS HOOK.F. & THOMSON 
(ANNONACEAE) 
 
Kok Kwan Tan1, Teng Jin Khoo1 and Christophe Wiart1 
 
1School of Pharmacy, Faculty of Science, The University of Nottingham Malaysia Campus,  
Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia. 
 
Introduction 
The tropical rainforest of Malaysia is regarded as one of the most evolved and 
complex ecosystems in the world that serves a vast untapped biodiversity of natural 
resources. Exploitation of indigenous medicinal plants for bioactive compounds is of 
great potential and could be an excellent source of providing new vistas for novel 
drug discovery and development. 
Objectives 
The study was undertaken to evaluate the pharmacological properties of Artabotrys 
crassifolius including antibacterial, antioxidant and anticancer activities of the plant.  
Methodology 
The leaves and bark of Artabotrys crassifolius were extracted sequentially using 
hexane, chloroform and ethanol. The prepared crude extracts were subjected to 
antibacterial activity against ATCC and clinical strains using Kirby-Bauer disc 
diffusion method. The ABTS cation and DPPH radical scavenging assays were 
conducted to assess the antioxidant potential of the extracts whereas MTT assay was 
performed to investigate the anticancer effect of the extracts against breast and 
colorectal carcinoma cell lines.  
Results 
Among the bacteria examined, Streptococcus pneumoniae was found to be the most 
susceptible bacteria with zones of inhibition of 13.70±0.26 mm and 9.79±0.26 mm 
exerted by hexane and chloroform extracts of bark respectively. As for the antioxidant 
potential, ethanol extract of bark possessed the highest scavenging activity against 
ABTS cation radical with IC50 value of 16.50 µg/mL, followed by ethanol extract of 
leaves with IC50 value of 30.77 µg/mL. Among the extracts studied, chloroform and 
hexane extracts of bark displayed the most potent cytotoxicity against MDA-468 
breast carcinoma cell line with respective GI50 values of 4.23 µg/mL and 6.10 µg/mL.  
Conclusion 
Hexane and chloroform extracts of bark exhibited promising antibacterial and 
anticancer activities while ethanol extract of leaves and bark demonstrated prominent 
antioxidant activity. Further studies need to be carried out to ascertain the 
pharmacological potentials of these extracts prior to application in the pharmaceutical 
industry as natural therapeutic agents. 
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The tropical rainforest of Malaysia is regarded as one of the most evolved and 
complex ecosystems in the world that serves a vast untapped biodiversity of natural 
resources. Exploitation of indigenous medicinal plants for bioactive compounds is of 
great potential and could be an excellent source of providing new vistas for novel 
drug discovery and development. The study was undertaken to evaluate the in vitro 
pharmacological properties of Artabotrys crassifolius including antibacterial, 
antifungal and anticancer activities of the plant. The leaves and bark of Artabotrys 
crassifolius were extracted sequentially using hexane, chloroform and ethanol. The 
prepared crude extracts were subjected to antibacterial and antifungal activities 
against clinical strains using Kirby-Bauer disc diffusion method whereas MTT assay 
was performed to investigate the anticancer effect of the extracts against human breast 
and colorectal carcinoma cell lines. Among the bacteria examined, Streptococcus 
pneumoniae was found to be the most susceptible bacteria with zones of inhibition of 
13.70±0.26 mm and 9.79±0.26 mm exerted by hexane and chloroform extracts of bark 
respectively. Nevertheless, among the extracts studied, only hexane extract of bark 
demonstrated antifungal activity against Candida species with zones of inhibition 
ranging from 7.81±0.27 mm to 9.77±0.25 mm. As for the anticancer effect, 
chloroform and hexane extracts of bark displayed the most potent cytotoxicity against 
MDA-468 breast carcinoma cell line with respective GI50 values of 4.23 µg/mL and 
6.10 µg/mL. Examination of the in vitro pharmacological properties of Artabotrys 
crassifolius revealed that hexane and chloroform extracts of bark may be a significant 
source of novel bioactive compounds in view of their promising antibacterial, 
antifungal and anticancer activities. Further studies need to be carried out to ascertain 
the pharmacological potentials of these extracts prior to application in the 
pharmaceutical industry as natural therapeutic agents. 
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